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Abstract vii
T cell independent type-1 B cell activation is characterised by the B cell response to LPS. 
This has been extensively studied by Coutinho and Möller who obtained bell shaped dose 
response curves for LPS-induced antigen specific antibody secreting cell (ASC) 
formation. Based on their experiments, Coutinho and Möller proposed the one signal 
model of B cell activation which suggested that surface immunoglobulin (slg) passively 
binds to LPS (focusing it to the B cell surface) and that high doses of LPS induce B cell 
paralysis (Coutinho and Möller, 1975). The passive (non-signalling) role for slg 
proposed by Coutinho and Möller is at odds with more recent experiments that 
demonstrate that slg-mediated signals have an integral role in regulating B cell behaviour. 
A possible role for a slg-mediated (antigen) signal is as a negative regulator of the LPS- 
induced B cell differentiation to ASCs. This thesis examines this possibility in an effort to 
reconcile Coutinho's and Möller’s original experimental data with current knowledge 
about the antigen signal.
The experiments described in this thesis do not support Coutinho's and Möller’s 
conclusion that high doses of LPS induce B cell paralysis. In the absence of high dose 
paralysis the down turn in LPS-induced polyclonal ASC formation could be accounted for 
by media effects or a toxic contaminant in Coutinho's and Möller’s preparation of LPS, 
whereas the decline in antigen-specific ASC number could be due to a slg-mediated 
signal. This prediction was tested by including trinitrophenol (TNP)-Ficoll in B cell 
cultures stimulated with LPS. TNP-Ficoll caused a dose-dependent decline in the number 
of LPS-induced anti-TNP ASCs. Thus, these results support the premise that slg- 
mediated signals have a negative regulatory role in the production of LPS-induced ASCs.
In subsequent experiments, cyclosporine A (CsA) was used in an attempt to block the 
inhibitory effect of slg-mediated signals on LPS-induced ASC formation. These 
experiments revealed that slg could mediate two intracellular signals that differed in their 
sensitivity to CsA, threshold of activation, and effect on B cell behaviour. The CsA 
sensitive signal was required for anti-Ig induced proliferation, whereas the CsA 
insensitive signal inhibited proliferation and LPS-induced ASC formation. In addition, 
the results indicated that the two slg-mediated signals were independently regulated. 
Further experiments using monoclonal anti-Ig antibodies supported this conclusion. 
Furthermore, these experiments suggested that the pattern of slg-mediated signalling was 
determined by the physical form of the substitute antigen. Finally, the independence of 
the two slg-mediated signals was confirmed through the use of B cells from CBA/N mice,
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which do not proliferate in response mitogenic anti-Ig antibodies but are susceptible to the 
slg-mediated inhibitory signal.
It was possible that the inhibitory signal induced by anti-Ig antibodies required the co­
ligation of slg and FcyRIIB. This possibility was examined through the use of a 
FcyRIIB blocking antibody and F(ab’)2 fragments of anti-Ig antibodies. The results 
demonstrated that co-ligation of slg and FcyRIIB was not required for anti-Ig mediated 
inhibition of LPS-induced ASC formation. However, FcyRIIB-mediated signals did 
inhibit the CsA sensitive signal that was required for B cell proliferation. Thus, co­
ligation of slg and FcyRIIB appeared to selectively inhibited one component of the 
antigen signal. In a similar manner, interleukin (IL)-4 only affected one component of the 
antigen signal. Thus, IL-4 enhances the CsA sensitive signal without effecting the CsA 
insensitive signal.
An alternative explanation for the observed B cell behaviour was that it represented the 
response of different B cell populations, rather than being the result of different slg- 
mediated signals. Experiments with electronically purified sIgDhi/CD23hi and 
slgD*0/CD23'° B cell populations showed that both populations were susceptible to the 
two slg-mediated signals. When stimulated with anti-Ig alone, or in combination with IL- 
4, the sIgDhi/CD23hi population appeared to be more sensitive to the slg-mediated 
positive signal for growth. However, in the presence of LPS, both B cell populations 
responded in a remarkably similar manner. Therefore, these results support to conclusion 
that ligation of slg can induce more that one signal.
Combined, the experiments described in this thesis have led to the conclusion that slg 
binding to its ligand can induce the activation of different independently regulated 
intracellular signalling pathways. The results suggest that differences in the physical form 
of the antigen will affect its binding to slg, producing a unique ligand receptor interaction. 
This physical difference in the interaction between slg and antigen appear to be translated 
into distinct patterns of intracellular signalling. In this way the antigen its self can direct 
the B cell response. For LPS-induced B cell activation, slg-mediated signals shut down 
ASC formation while promoting B cell proliferation. Thus these results reveal a 
previously unrecognised role for the antigen signal in the regulation of TI type-1 B cell 
activation. In an immune response this may result in the proliferation of the small number 
of B cells that have a high degree of specificity for LPS while inducing antibody 
production from the large number of B cells with low specificity for LPS.
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General introduction
General introduction
1.1 Introduction
Antigen recognition by lymphocytes is a necessary event in the generation of adaptive 
immune responses and follows the basic rules first proposed in Burnet’s clonal selection 
theory (Burnet 1959). This theory suggested that lymphocytes would each possess a 
different antigen receptor, and that antigen recognition “selected” the appropriate 
responding cell. Burnet also suggested that antigen recognition would lead to clonal 
proliferation through which the population size of antigen specific cells could be 
increased and memory cells generated (Burnet 1959). In addition, Bumet suggested that 
clonal deletion of lymphocytes that recognised self-antigens would provide a mechanism 
of self-tolerance. These three principal components of clonal selection theory have 
subsequently been demonstrated experimentally (MacLennan and Gray 1986, Gray and 
Skarvall 1988, Gu et al., 1991, McHeyzer-Williams et al., 1993), confirming the broad 
details of the adaptive immune response envisaged by Burnet (Bumet 1959). The 
detailed behaviour of the adaptive immune system has been the subject of much recent 
research that has revealed an astonishing degree of cell interaction and molecular agility. 
Examination of the role of the antigen signal in these responses has revealed that antigen 
recognition can induce a diverse range of behaviours (Andersson et al., 1974, Julius et 
al., 1984, Nemazee and Biirki 1989b, Gu et al., 1991, Peqanha et al., 1991, Grandien 
et al., 1993, Hartley et al., 1993, Parry et al., 1994b, Shokat and Goodnow 1995, 
Tarlinton et al., 1997). The biochemical characterisation of the antigen signal has also 
exposed a complex pattern of intracellular signalling cascades which interact with each 
other and with signals from other receptors (Bijsterbosch and Klaus 1985, Harnett et 
al., 1991, Carter and Fearon 1992, Snapper et al., 1995a, Doody et al., 1996, Sato et 
al., 1996, Kiener et al., 1997, Li et al., 1997). However, despite substantial progress 
in the characterisation of the antigen signal, no cohesive model has arisen for how this 
signal may induce such variable responses. The role played by antigen recognition and 
subsequent signalling in the adaptive immune response is discussed further below, with 
particular emphasis on the B lymphocyte.
1.2. B lymphocytes view their environment and mediate effector 
functions through immunoglobulins
B lymphocytes survey their environment through surface immunoglobulin (slg) which 
allows these cells to bind and internalise antigen. In addition to being expressed on the 
cell surface, immunoglobulins (Ig) can also be secreted into serum where they act as 
effector molecules or antibodies promoting the neutralisation and clearance of pathogens. 
The difference between cell surface and secreted forms of Ig is that the latter lacks the 
intermembrane and cytoplasmic regions that retain slg within the cell membrane. A
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typical Ig molecule consists of two pairs of heavy and light chain proteins (reviewed in 
Davies and Metzger 1983, Alzari et a l, 1988). The shorter light chain associates with 
the heavy chain to form a heterodimer that is held together by a disulphide bond (Figure
1.1) . The two heterodimers combine to form an Ig molecule that is stabilised by further 
disulphide bonds formed between the heavy chains (Alzari et a l, 1988). Thus, Ig 
molecules have bilateral symmetry. The N-terminus of both the heavy and light chains 
contains a highly variable region, and it is the combination of these regions that form the 
antigen binding pocket (Davies et al, 1983, Alzari et a l, 1988). Therefore, each 
antibody has two antigen binding sites, one at the N-terminus of each arm of the 
heterodimer (Figure 1.1). In contrast, the amino acid sequence of the C-terminus of the 
heavy chain is conserved (Figure 1.1) (Davies et a l, 1983, Alzari et a l, 1988). It is 
through this constant region that antibodies mediate effector functions by binding to 
cellular receptors or complement (Davies et al, 1983). Enzymatic digestion has allowed 
for the preparation of different fragments of Ig. Papain cuts above the disulfide bonds 
that join the constant regions of the heavy chain generating a monovalent fragment of 
antigen binding known as the F(ab), and an Fc portion (Figure 1.1). In contrast, pepsin 
cuts below this disulphide bond producing a divalent antigen-binding fragment known 
as F(ab')2 (Figure 1.1).
Immunoglobulins are encoded by multiple genes that can be rearranged 
Within the murine genome, the genes that encode Ig are found in component parts and 
the final molecule is assembled from numerous alternatives (reviewed in Hon jo 1983). 
The germline configuration of Ig heavy chain genes consists of between 200 to 1000 
alternative variable (Vh ) genes, twelve to fifteen diversity (Dh ) genes, four joining (Jh ) 
genes and eight constant (Ch ) region genes (Honjo 1983). In contrast to the heavy 
chain, there are two light chains, kappa (k) and lambda (3.). The k light (L) chain is 
encoded by multiple (-250) Vl  genes, five Jl  genes and one Cl  gene, whereas the 
chromosomal arrangement of the X light chain genes consists of only two Vl  genes, and 
four paired Jl  and Cl  genes (Honjo 1983). These genes are rearranged during B cell 
development to assemble and juxtapose a single Vh , Dh  and Jh  section together for the 
heavy chain and a Vl  and Jl  for the light chain (section 1.3) (reviewed in Alt et a l, 
1992, Schatz e ta l, 1992, Coffman et a l, 1993). Following Ig gene rearrangement, the 
VDJ sections of the heavy chains are transcribed in association with a Ch  gone (Figure
1.2) , and the recombined VJ light chain genes are expressed with a single a Cl  region 
gene (Alt et a l, 1992, Schatz et a l, 1992, Coffman et a l, 1993). The numerous 
combinatorial choices in constructing the VDJ and the VJ sections provide a mechanism
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antigen binding region
Heavy Chain
Light Chain variable region
-S-S- constant region
site of papain cut
that produces a monovalent
F(ab) fragment.
site of pepsin cut that produces 
a divalent F(ab)2 fragment.
— Fc region
(  c o o h )  ( c o o h )
Figure 1.1 The basic structure of antibody
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by which antigen receptors with a diverse range of specificities can be generated.
Despite the range of possible Ig gene combinations, each B cell expresses only one set 
of rearranged Ig genes with a single antigen specificity and light chain isotype. This 
phenomenon is known as allelic and isotype exclusion.
The constant region o f the heavy chain determines the effector function o f antibody 
A complete Ig molecule can be assembled with a number of different alternative constant 
regions of the heavy chain of Ig, referred to as isotypes. The mouse possesses eight 
isotypes and all newly developed B cells express a receptor with two isotypes, initially 
IgM is expressed and as the B cell matures IgD is also expressed (Figure 1.4). The 
process of changing Ch  genes is known as isotype switching. Murine B cells can 
switch to one of four different IgG isotypes or to IgA or IgE. Isotype switching plays 
an important role in the regulation of the immune response, as different antibody 
isotypes have specialised functions. Thus, IgG2a, IgG2b and IgG3 antibodies are able 
to fix and activate serum proteins (complement) that promote the destruction and 
clearance of extracellular pathogens. In contrast, IgE antibodies can bind to receptors on 
other cells of the immune system such as mast cells and, following cross-linking of the 
bound IgE, these cells degranulate releasing mediators of inflammation that can aid in the 
clearance of parasitic infections. Thus, the ability of B cells to switch isotypes allows 
for the production of antibodies that help target an appropriate immune response to a 
particular pathogen or antigenic challenge.
The Ch  genes are organised within the murine genome in the following sequence:
5' p -  5 -  y3 -  yl -  y2b -  y2a -  e -  a  3' (Honjo 1983, Coffman et a l, 1993, 
Stavnezer 1996). The DNA between the Ch  genes contains switch regions located at 
the 5’ end of each gene with the exception of Ch $ (Coffman et ah, 1993, Stavnezer 
1996). During isotype switching the DNA between switch regions is excised, the 
strands rejoined, and the DNA transcribed in its new order (Figure 1.3) (Coffman et a l, 
1993, Stavnezer 1996). Thus, for a B cell to switch from IgM to IgG l, the genes for p 
-  8 -  y3 are deleted and the genes for VDJh  and Cyl heavy chain are transcribed 
together to form the Ig heavy chain (Coffman et al., 1993, Stavnezer 1996). As 
switching from one isotype to another involves the deletion of the intervening DNA the 
B cell cannot switch back, therefore, iso type switching may only proceed in the 5' to 3' 
direction (Figure 1.3) (Coffman et a l, 1993). As the genes for the light chain and 
variable region of the heavy chain are not altered during switching, the specificity of the 
antibody remains the same (Coffman et a l, 1993, Stavnezer 1996). Thus, only the 
function of the antibody changes in response to isotype switching (Coffman et a l, 1993, 
Stavnezer 1996).
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1.3 The primary B cell repertoire is determined during B cell 
development
In the hone marrow pluripotent haematopoietic stem cells give rise to B cell precursors 
that may develop into one of two separate B cell lineages, B la (CD5+) or B2 (CD5"), 
that differ in their behaviour and activation requirements (reviewed in Rolink and 
Melchers 1992, Kantor and Hertzenberg 1993, Tarlinton 1994). As the animal matures 
the number of CD5+ B cell precursors in the bone marrow declines, whereas precursors 
of the B2 (often called conventional) B cell population continue to be produced for the 
life of the animal (Hayakawa et a i, 1985). The CD5+ and conventional B cell 
populations may represent distinct B cell lineages and can be distinguished in the adult 
mouse by their expression of different cell surface antigens, their anatomical location and 
their capacity for self renewal. In the adult mouse CD5+ B cells predominantly occupy 
the peritoneal and pleural cavities, appear to preferentially respond to carbohydrate 
antigens and are capable of self renewal (Hayakawa et al., 1986, Herzenberg et al.,
1986, Forster et a i, 1991). In contrast, conventional B cells express CD23 and have 
higher levels of slgD and lower levels of the major histocompatibility (MHC) class II 
antigen than B la cells. These B cells are predominantly found in the spleen and lymph 
nodes and do not have the capacity for self-renewal but are replenished from the bone 
marrow throughout the life of the animal (Rolink et al., 1992, Kantor et al., 1993).
The four stages o f conventional B cell development
The process of conventional B cell development can be divided into four stages that 
proceed from pro-B cells to pre-B cells to immature B cells and finally to mature B cells 
(Figure 1.4) (reviewed in Hardy 1990). Pluripotent haematopoietic stem cells generated 
in the bone marrow give rise to the B cell precursors known as pro-B cells (Hardy 
1990). It is during the pro-B cell stage that Ig gene rearrangement commences with the 
fusion of the heavy chain Dh  and Jh  genes on both chromosomes (Figure 1.4) (Alt et 
al., 1984). In pro-B cells where the DJh  rearrangement is successful (translatable), the 
fusion of the Dh  and Jh  segments is followed by the rearrangement and fusion of the 
VH gene to the DJh  genes (Tonegawa 1983, Alt et a l, 1984). If the first rearrangement 
of the Vh  genes is untranslatable, the process is repeated on the other chromosome 
(Tonegawa 1983, Alt et al., 1984). Where both rearrangements are unsuccessful 
maturation is halted (Alt et al., 1984). It has been proposed that pro-B cells that have 
untranslatable rearrangements on both chromosomes are deleted by apoptosis (reviewed 
in Osmond et al., 1994). The successful joining of the Vh  to the DJh  segments marks 
the progression from the pro-B cell stage to the pre-B cell stage (Figure 1.4) (Hardy 
1990).
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Pre-B cells express a functional antigen receptor
Following the productive rearrangement of the VDJh  genes, these genes are transcribed 
in association with the Cp heavy chain gene to form a functionally rearranged Ig heavy 
chain (Figure 1.4) (Alt et a i, 1992, Schatz etal., 1992, Coffman etal., 1993, Stavnezer 
1996). In addition to producing the heavy chain, pre-B cells also make “surrogate” Ig 
light chain proteins co and t, that are encoded by the VpreB and X5 genes, respectively 
(Tsubata and Reth 1990, Nishimoto et ai, 1991). The Ig heavy chain and surrogate 
light chains combine to produce an immature form of Ig that can he expressed on the 
pre-B cell surface (Tsubata et a i, 1990, Nishimoto et a i, 1991, Lassoued et al., 1993). 
The expression of the immature antigen receptor on the pre-B cell surface requires it to 
be associated with Igoc and Igß, two components of the mature B cell antigen receptor 
that are involved in signal transduction (section 1.6) (Hombach et al., 1990, Lassoued et 
al., 1993). The immature form of slg expressed on pre-B cells has been shown to be a 
functional signalling molecule as ligation with anti-X5 antibodies induces calcium 
mobilisation (Lassoued et al, 1993). Although the role of these slg-mediated signals in 
B cell development is not entirely clear, they may be involved in allelic exclusion at the 
Ig heavy chain locus (Loffert et al., 1996). In addition, it has been proposed that signals 
generated through slg binding a ligand, as yet unidentified, may promote pre-B cell 
survival (reviewed in Desiderio 1994, Melchers et al., 1994, Pleiman et al., 1994a). 
Thus, signals generated by the antigen receptor of pre-B cells may result in the positive 
selection of developing B cells based on the expression of a functional Ig heavy chain 
(Gu etal., 1991, Tarlinton etal., 1997).
Signals from the antigen receptor on pre-B cells regulate the expression o f the Ig light 
chain genes
Light chain gene rearrangement commences after the formation of a functional Ig heavy 
chain and begins with the rearrangement of k on one of the two chromosomes 
(Tonegawa 1983, Alt et al., 1984). Signals from the antigen receptor on pre-B cells 
may play a role in promoting the rearrangement of the light chain Ig genes (Desiderio 
1994, Melchers et al., 1994, Pleiman et al., 1994a). As described for the heavy chain 
genes, the Vl  and Jl  genes are rearranged prior to expression of the VJl  with Cl  
region (Tonegawa 1983, Alt et al., 1984). If there is no productive rearrangement of 
the k genes on either chromosome, the process is repeated using the X genes (Tonegawa 
1983, Alt et al., 1984). Once the light chain genes have been productively rearranged, 
they are transcribed and combine with the heavy chain to form a mature Ig molecule that 
is expressed on the surface of the developing B cell in association with Iga and Igß 
(Figure 1.4) (Melchers et al., 1994). The expression of slgM marks the progression of 
the developing lymphocyte from the pre-B to the immature B cell stage (Hardy 1990). 
Once slgM is expressed, transcription of the VpreB and X5 genes is down-regulated
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(Schatz et al, 1992, Melchers et al, 1994). Thus, slg-mediated signals appear to 
regulate the transcription of the genes encoding the surrogate light chain (Desiderio 
1994, Melchers et al, 1994, Pleiman et al, 1994a).
The antigen signal can inhibit the expression o f proteins required for Ig gene 
rearrangement
Following expression of IgM on the surface of immature B cells the rearrangement of Ig 
genes is halted (Alt et al, 1992, Schatz et al., 1992, Coffman et al, 1993). The 
cessation of Ig gene rearrangement is in part controlled by the down-regulation of the 
expression of the recombinase activation genes, RAG-1 and RAG-2 (Ma et al, 1992). 
The RAG genes are expressed in lymphoid precursor cells and their expression is 
required for gene recombination (Schatz et al., 1989, Oettinger et al, 1990). Both RAG 
genes are expressed during Ig gene rearrangement, but levels progressively decline 
during the transition from an immature to a mature B cell (Melchers et al, 1994). Mice 
which lack RAG-1 or RAG-2 are viable but have no mature T or B lymphocytes (Alt et 
a l, 1992). It is thought that slg-mediated signals induce the down-regulation of RAG 
gene expression (Ma et al, 1992). Support for the role of an antigen signal in regulating 
RAG gene expression can be obtained from in vitro experiments where the treatment of 
immature B cell lines with anti-IgM antibodies inhibits RAG gene expression (Ma et al, 
1992). In addition, a combination of phorbol 12-myristate 13-acetate (PMA) and 
calcium ionophores, which partially reproduces some of the signalling events mediated 
by slg (section 1.6) (Klaus et al, 1986), causes the down-regulation of RAG gene 
expression (Schatz et al, 1992). Thus, there appears to be a feedback mechanism from 
slg-mediated signals that regulates RAG gene expression (Schatz et al, 1992).
1.4 The fate of the developing B cell is determined by its interaction 
with antigen
The number of immature B cells produced that express slgM far exceeds the number that 
leave the bone marrow and develop into mature B cells (reviewed in Osmond 1986). 
This suggests that a large number of developing B cells are being deleted within the bone 
marrow. The B cells that are exported to the periphery are thought to have survived a 
process of negative selection (reviewed in Nossal 1994, Melchers et al, 1995). There 
is also evidence to indicate that B cells undergo a positive selection at earlier stages of 
differentiation to determine which cells will progress onto the next phase of development 
(Desiderio 1994, Melchers et al, 1994, Pleiman et al, 1994a). The outcome of these 
slg-mediated selective processes is discussed below.
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1.4.1. Negative selection o f  self-reactive B cells - a choice between 
deletion and anergy
The final product of Ig gene rearrangement during development is a B cell that expresses 
a functional Ig with a single, randomly chosen, specificity. As Ig gene rearrangement is 
random it is inevitable that some B cells will be specific for self-antigens. These self­
reactive B cells must be silenced in order to maintain self-tolerance and thereby prevent 
detrimental autoimmune responses (reviewed in Basten et a i, 1991, Nossal 1992). 
Burnet originally proposed that self-tolerance would occur as the result of cellular 
deletion following the interaction between the antigen receptor and a self-antigen (Burnet 
1959). It has subsequently been demonstrated that this form of negative selection can 
occur during B cell development in the bone marrow, and is in part responsible for self­
tolerance in the primary B cell repertoire (Nemazee and Btirki, 1989b, Nemazee and 
Btirki 1989a, Hartley et al., 1991, Goodnow 1992). In addition, immature self-reactive 
B cells may also be silenced by the induction of a state of non-responsiveness (anergy) 
(Nossal and Pike 1980, Pike et al., 1982, Nemazee and Btirki, 1989b, Hartley et a i, 
1993). As illustrated in the following sections, the choice for the self-reactive B cell 
between clonal deletion or anergy appears to be dependent on the physical form of the 
antigen.
Anti-Ig antibodies provided the initial experimental evidence fo r  clonal deletion 
Lawton and Cooper demonstrated that mice treated from birth with anti-IgM antibodies 
failed to develop B cells (Lawton and Cooper 1974). Similar results were obtained in 
neonatal mice where treatment with anti-IgM antibodies resulted in the deletion of all 
developing B cells, excluding pro-B cells which do not express any form of slg 
(Opstelten and Osmond 1985). These results indicated that ligation of slg on developing 
B cells could cause the deletion of the cell. Additional in vitro experiments using 
WEHI-231 cells showed that anti-Ig antibodies could induce apoptosis in these cells 
(Hasbold and Klaus 1990). As the WEHI-231 cell line has been used as a model for 
immature B cells (Tisch et al., 1988), these results have led to the suggestion that clonal 
deletion of self-reactive B cells occurs through the induction of apoptosis (Hasbold et 
al., 1990).
B cells that recognise membrane bound self-antigens undergo clonal deletion 
Additional support for clonal deletion has been obtained through a second experimental 
approach involving the use of transgenic mice that express Ig genes specific for self­
antigens. Nemazee and Btirki developed a transgenic mouse model where B cells 
expressed slgM specific for epitopes within the H-2^ allele of MHC class-I. In mice 
that expressed the H-2^ allele for MHC class-I, the anti-H-2^ transgenic B cells 
developed normally (Nemazee and Btirki, 1989b). In contrast, the progeny of a cross
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between the transgenic H-2^ mouse and the H-2^ MHC mice lacked B cells, indicating 
that exposure to the self-antigen prevented the appearance of H-2^ specific B cells in the 
periphery (Nemazee and Biirki, 1989b). In additional experiments, bone marrow from 
the anti-H-2^ IgM transgenic mice was adoptively transferred into irradiated H-2^ 
recipients. Although B cell precursors that expressed low levels of anti-H-2^- IgM could 
be detected in the bone marrow, no anti-H-2^ B cells could be found in the periphery 
(Nemazee and Biirki, 1989a). From these experiments Nemazee and Biirki concluded 
that self-reactive anti-H-2^ B cells were deleted in the bone marrow following 
recognition of the self-antigen by slg.
Similar results were obtained in a transgenic mouse model in which mice expressed two 
transgenes, where one encoded a novel self-antigen, hen egg lysozyme (HEL), and the 
other expressed anti-HEL Ig (Goodnow et a l, 1988). In the mice that express only anti- 
HEL Ig, B cells appear to develop normally and, following activation, secrete anti-HEL 
antibodies (Goodnow et a l, 1988). However, in double transgenic mice where HEL is 
expressed as a membrane protein (HELmembL self-reactive B cells are absent in the 
periphery (Hartley et a l, 1991, Goodnow 1992). In additional experiments using B 
cells from mice that express the transgenes for anti-HEL Ig, HELmemb and bcl-2, 
transgenic B cells with an immature phenotype were found in the periphery (Hartley et 
a l, 1993). Constitutive expression of bcl-2 has been shown to inhibit the onset of 
apoptosis, and to prolong the life of lymphocytes (McDonnell et a l, 1989, Strasser et 
al, 1990, Strasser et a l, 1991). Thus, these results indicate that the inhibition of 
apoptosis by bcl-2 allows immature self-reactive B cells to escape deletion in the bone 
marrow (Hartley et a l, 1993, Merino et a l, 1994). The experimental results from the 
two transgenic model systems clearly indicate that a slg-mediated signal induced by the 
interaction with membrane bound self-antigens can cause apoptosis in developing self­
reactive B cells resulting in clonal deletion.
Soluble self-antigens induce a hyporesponsive state in self-reactive B cells 
Unlike clonal deletion, anergy was thought not to involve rapid deletion of self-reactive 
B cells, but instead the development of a non-responsive state (Nossal et a l, 1980, Pike 
et al, 1982, Goodnow et a l, 1988, Hartley et a l, 1993). Clonal anergy was 
demonstrated in transgenic mice that expressed anti-HEL slg and soluble HEL. In these 
double transgenic mice, HEL-specific B cells were released from the bone marrow and 
appeared in the periphery. These cells expressed normal levels of slgD but only 
expressed a low level of anti-HEL slgM (Goodnow et a l, 1989). Unlike normal B 
cells, the transgenic B cells did not secrete significant amounts of antibody when 
stimulated in vivo with HEL coupled to sheep red blood cells, or in vitro with 
lipopolysaccharide (LPS) (Goodnow et a l, 1989, Brink et a l, 1992). Originally it was
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raising the question of the role of such anergic cells. However, it has since been 
demonstrated that the anergic HEL-specilic B cells in the double transgenic mice have a 
short life span, surviving for only three to four days, in contrast to non-transgenic B 
cells which live four to five weeks (Hartley et a l, 1993, Fulcher and Basten 1994).
Anergic B cells can be activated and rescued from death 
While self-reactive 'anergic' B cells in the double transgenic mice appear to be 
functionally silenced and are deleted a short time after being exported to the periphery, it 
is still possible to reverse the tolerising effect of self-antigens (Eris et al, 1994). Eris et 
al., (1994) demonstrated that anergic B cells would secrete antibody when cultured with 
activated T cells. Thus, anergy may represent a transitional state for the B cell in which 
signals from activated T cells could induce B cell activation rescuing it from death and 
resulting in antibody production, whereas in the absence of stimulatory T cell signals the 
B cell would be deleted. The reversal of anergy by activated T cells would be an 
unlikely event, however, as self-reactive B cells would have to receive T cell help within 
three to four days of leaving the bone marrow in an environment where self reactive T 
cells would also be tolerant (Fulcher et a l, 1994).
Thus, the interaction between slg and self-antigens is responsible for the induction of 
tolerance in the primary B cell repertoire (Brink et a l, 1992, Cooke et al., 1994, Monroe 
1996). As illustrated by the HEL transgenic mice, different physical forms of the same 
antigen can induce distinct types of tolerance, or at least determine the time it takes a self 
reactive cell to die (Hodgkin and Basten 1995, Fulcher et al., 1996). The different B 
cell response to membrane bound or soluble self-antigens suggests that their interaction 
with slg results in distinct patterns of intracellular signalling. In the HEL transgenic 
system this may simply reflect the degree of slg cross-linking induced by the self­
antigen (reviewed in Goodnow 1992). If the strength of the slg-mediated signal is 
simply proportional to the level of slg cross-linking, then the membrane bound self­
antigens - which presumably cause a higher density of slg cross-linking - would deliver 
a stronger signals when compared to soluble self-antigens (Goodnow 1992). Thus, 
membrane bound self-antigens could induce a signal that exceeds the threshold for clonal 
deletion, whereas soluble self-antigens may induce a sub-threshold antigen signal 
allowing the self-reactive B cell to enter the periphery in search of additional activation 
signals, in the absence of which the anergic B cell dies (Hodgkin et al., 1995).
1.4.2. Antigen driven positive selection
In addition to inducing tolerance the antigen signal is also involved in the positive 
selection of developing B cells (Gu et al., 1991, Nadel et a l, 1993, Lam et a l, 1997,
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Tarlinton et al., 1997). The requirement for positive selection in B cell development was 
proposed as a result of analysis of the Vh  chain genes represented in the pre-B cell and 
peripheral B cell population that revealed that the gene usage substantially differed 
between the two populations (Gu et al., 1991). Gu et al, (1991) suggested that this 
difference was the result of antigen dependent positive selection based on the expression 
of particular Vh  chain genes. It is probable that positive selection during the pre-B cell 
stage occurs through the interaction of the immature slg with an unidentified ligand or 
ligands (Gu et al., 1991). Thus, in order to reach the periphery, developing B cells 
must survive a two stage process involving both positive and negative selection.
Thus far, this discussion has focused on the multiple roles that the antigen signal plays 
during B cell development. Clearly, the antigen signal regulates the primary repertoire 
by selecting cells that express a functional slg by positive selection and by inducing self­
tolerance. Therefore, the antigen signal can have opposing roles in B cell development 
by inducing cell survival or deletion. However, it is not obvious whether these 
apparently contradictory effects are due to variation in the antigen signal, or are the result 
of differences in the B cell based on maturation state or other signals it has received. 
Multiple and contradictory effects of slg-mediated signals on B cell behaviour are also 
apparent in the varied roles that the antigen signal plays during B cell activation resulting 
in the formation of antibody secreting cells (ASCs).
1.5 B cell activation - what role does the antigen signal play?
B cell activation occurs as a result of antigen exposure to mature B cells. However, this 
response can be divided into two types based on the requirement for the involvement of 
T cells. Thus, B cells may be activated in either a T cell dependent (TD) or T cell 
independent manner (TI). The latter model can be sub-divided further into TI type-1 and 
TI type-2 categories. While there is no single definitive stimulatory role for the antigen 
signal in all forms of B cell activation, this signal plays an important regulatory role in 
the B cell response to both TD and TI antigens. This is discussed in the following 
sections.
1.5.1 An overview of TD B cell activation
In recent years TD B cell activation has been studied in considerable detail and can now 
be broken down into a sequence of steps (Figure 1.5). The initial step is the recognition 
of antigen by the B cell, which occurs through slg binding to epitopes within the 
antigen. The subsequent antigen signal induces a number of changes in the B cell 
including de novo expression of cell surface receptors involved in T cell-B cell 
collaboration. Captured antigen is also internalised and, if it contains protein, is
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processed and presented in association with class-II MHC on the B cell surface (Figure 
1.5). Antigen presentation by B cells allows the B cell to interact with antigen-specific T 
cells initiating a dialogue that results in T cell activation and the provision of T cell help. 
This help is delivered through the interaction between novel cell surface molecules on the 
T cell and by the secretion of soluble cytokines, which together induce B cell activation 
and differentiation to ASCs (Figure 1.5). The influence of the antigen signal and the 
steps involved in TD B cell activation are described in greater detail below.
B cells process antigen and present it in association with class-II MHC 
Antigen presentation by the B cell is a crucial step in successful B cell T cell 
collaboration, and is initiated when slg binds to antigen and internalises it via receptor- 
mediated endocytosis (reviewed in Lanzavecchia 1990, Neefjes and Ploegh 1992, 
Neefjes and Momburg 1993). Although slg binding to antigen can induce an 
intracellular signal, this signal is not required for the processing and presentation of 
antigen (Davidson et al., 1990). Receptor mediated endocytosis directs the intact 
antigen into an acidic endosomal compartment from where the antigen is transferred into 
lysosomes (Lanzavecchia 1990, Neefjes et al., 1992, Neefjes et al., 1993). During the 
passage from the endosome to the lysosome, intact protein antigen is degraded into 
peptides that subsequently associate with class-II MHC molecules (Harding et al.,
1991). Once bound, the peptide stabilises the conformation of class-II MHC and the 
peptide / class-11 MHC complex is exported to the B cell surface via the trans-golgi 
network (Lanzavecchia 1990, Neefjes et al., 1992, Neefjes et al., 1993).
Contact dependent signals between T and B cells amplify the initial antigen- 
dependent activating signals
Prior to the internalisation of antigen, the interaction between antigen and slg generates 
transmembrane signals that can induce B cell migration in the spleen to the outer 
periarteriolar lymphoid sheath (PALS) where T cell-B cell collaboration is initiated by T 
cell recognition of antigen presented on the surface of the B cell (van den Eertwegh and 
Claassen 1992, Kelsoe and Zheng 1993). Antigen recognition by T cells occurs through 
the binding of the T cell antigen receptor (TCR) to the peptide / class-II MHC complex 
on the antigen presenting B cell (Figure 1.5, C) (Kronenberg et al., 1986, Allison and 
Lanier 1987, Davis and Bjorkman 1988). The antigen signal also results in the 
expression of the B cell surface molecules, B7.1 and B7.2 (Hathcock et al., 1994, 
Lenschow et al., 1994). The interaction between B7.2 and its ligand, CD28, in 
combination with the interaction between the TCR and the peptide / class-II MHC 
complex, induces the de novo expression of CD40L on the T cell (de Boer et a l, 1993, 
Klaus et al., 1994) and increases the expression of B7.2 on the B cell (Hathcock et al., 
1994, Stack et al., 1994). The binding of CD40 to its ligand further up regulates the
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Figure 1.5 Events in T cell B cell collaboration
This Figure summarises some of the events that result in sucessful T cell B 
cell colaboration as described in section 1.5. Adapted from Hodgkin and 
Kehry (1992), Kehry and Hodgkin (1993), and Hodgkin and Basten (1995)
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expression of B7.2, intensifying the level of costimulation to the T cell and thereby 
further raising the expression of CD40L (Ranheim and Kipps 1993, Hasbold et al.,
1)94, Roy et al., 1995). Thus, the interaction between the T and B cell surface antigens 
p'ogressively amplifies the activating signals for both lymphocytes (Hodgkin et al.,
1)95). The result of this interaction is in part dependent on the activation state of the 
T cell, as dictated by previous encounter with antigen (Lassila et al., 1988, Ronchese 
aid Hausmann 1993, Morris et al., 1994). However, at a minimum the interaction 
bitween class-II MHC and the TCR, combined with B7.2 binding to CD28, stimulates T 
cdl activation and the provision of T cell help delivered through CD40L and cytokines 
(Figure 1.5, C) (Noelle and Snow 1991, Hodgkin and Kehry 1992, Kehry and Hodgkin 
H93, Hodgkin et al., 1995). Thus, slg-mediated signals can promote TD B cell 
axtivation by up-regulating the expression of B7.2, thereby promoting T cell activation 
aid the provision of T cell help. Given this role for slg-mediated signals it would not be 
uireasonable to conclude that the antigen signal played an obligatory role in this form of 
Ecell activation, as originally proposed by Bretscher and Cohn (Bretscher and Cohn 
1)68, Bretscher and Cohn 1970). However, experimental evidence from in vitro 
systems where T cell activation was not dependent on antigen presentation by the B cell 
hive demonstrated that the slg-mediated signals themselves are not essential for TD B 
Cill activation (Augustin and Coutinho 1980, Brian 1988, Hodgkin et al., 1990) beyond 
tie requirement to bring antigen specific cells together.
t  cells can be activated by T cell contact and secreted cytokines in the absence o f 
ai antigen signal
The first indication that the antigen signal was not obligatory for B cell activation came 
fom in vitro experiments with alloreactive T cell clones that could induce B cell 
dfferentiation to ASCs in the absence of an antigen signal (Augustin et al., 1980). 
lowever, these conclusions were considered controversial. In separate experiments, 
sg-mediated signals were found to be required for the activation of small naive B cells 
by T cell clones (Julius et al., 1982) and for antigen specific B cell activation (Zubler 
aid Kanagawa 1982). Subsequent work using T cell membranes provided support for 
tie view that the slg-mediated signals were not obligatory in TD B cell activation. These 
ecperiments allowed the minimum requirement for TD B cell activation to be identified. 
Thus, stimulation of B cells with membranes prepared from activated, but not resting, T 
oil clones induced B cell proliferation but not antibody production (Brian 1988, 
lodgkin et al., 1990). In contrast, the combination of IL-4 and IL-5 and activated T 
oil membranes enhanced the previously observed proliferation and induced B cell 
dfferentiation to ASCs (Hodgkin et al., 1990). In each of these experiments the B cell 
rsponse was polyclonal and occurred in the absence of antigen (Brian 1988, Hodgkin 
e al., 1990). The essential T cell derived and contact-dependent ligand expressed on the
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T cell surface following activation was subsequently identified as a ligand for CD40, a 
cell surface molecule constitutively expressed on B cells (Armitage et al., 1992, 
Hollenbaugh et al., 1992). Support for the role of CD40L in TD B cell activation was 
provided by Noelle et al., who demonstrated that B cell proliferation and antibody 
production stimulated by activated T cell membranes and stimulatory cytokines could be 
inhibited by anti-CD40L antibodies (Noelle et al., 1992a). In addition, stimulation of B 
cells with recombinant CD40L and IL-4 was shown to be sufficient to induce B cell 
proliferation and antibody production (Armitage et al., 1992, Spriggs et al., 1993).
Thus, the interaction between CD40 and its ligand appears to represent an essential step 
in TD B cell activation (Figure 1.5, D). Further, these experiments demonstrate that B 
cell proliferation and polyclonal antibody production can be induced in the absence of a 
slg-mediated signal.
T cell cytokines can amplify TD B cell activating signals
TD B cell activation to Ig secretion requires the presence of cytokines that are produced 
by the activated T cells (Figure 1.5, D) (Coffman et al., 1988, Mosmann and Coffman 
1989, Schmitz et al., 1993). Cytokines have been divided into two groups based on 
their expression by two clones of T cells, referred to as T helper (Th) type-1 and Th 
type-2 (reviewed in Coffman et al., 1988, Mosmann et al., 1989). The Th type-1 
cytokines promote cell mediated immunity and include: IL-2, tumour necrosis factor-a 
(TNF-a), and interferon-y (IFN-y) (Coffman et al., 1988, Mosmann et al., 1989). In 
contrast, the Th type-2 cytokines are stimulators of B cell responses and include: IL-4, 
IL-5, IL-6 and IL-10 (Coffman et al., 1988, Mosmann et al., 1989). In mice one of the 
most potent Th type-2 cytokines for inducing TD antibody production is IL-4 (Coffman 
et al., 1988). IL-4 can promote TD B cell activation by enhancing the B cell response to 
slg and CD40 mediated signals (Howard et al., 1982, Hodgkin et al., 1991a, 
Banchereau et al., 1993, Lane et al., 1993, Maliszewski et al., 1993), and by up- 
regulating the expression of B7.2, class-II MHC and CD40 (Valle et al., 1989, 
Hathcock et al., 1994, Stack et al., 1994). In this way the presence of IL-4 can amplify 
the activation signals between T and B cells.
Early TD antibody production in the foci
Antigen activated B cells migrate to the edge of the PALS where, following successful T 
cell-B cell collaboration, they proliferate and differentiate into ASCs (Liu et al., 1991c, 
Kelsoe et al., 1993). This response leads to the formation of an antibody secreting foci 
(ASF) at this site (Jacob et al., 1991a). ASCs are formed within four to six days after 
exposure to TD antigens, and the early antibody produced is IgM. However, over time 
the B cells undergo isotype switching and secrete IgG (Jacob et al., 1991a). Antibody 
production within the foci is maintained for approximately 10 days after the initial
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exposure to antigen (Jacob et ai, 1991a) before the activated cells dissipate through 
apoptosis (Smith et a i, 1996).
The antigen signal controls the selection o f high affinity B cells 
Soon after ASF appeal', germinal centers begin to form in the follicular region of the 
splenic white pulp. Germinal centers are populated by B cells, T cells and a unique 
antigen presenting cell, the follicular dendritic cell (FDC) ((reviewed in Van Rooijen 
1993, Tew et a i, 1997). FDCs express Fc and complement receptors which can retain 
antigen-antibody complexes for periods greater than a year (Nossal et a i, 1965, Tew et 
a i, 1997). It is within the germinal centers that high affinity ASCs are generated 
(reviewed in Liu et a i, 1992, Berek and Ziegner 1993, MacLennan 1994, Wagner and 
Neuberger 1996). Germinal centres arise from a small population of B cells (founder 
cells) that migrate to the primary lymphoid follicles and undergo rapid proliferation (Liu 
et a i, 1991c, Jacob and Kelsoe 1992). It has been suggested that these founders may 
have been previously activated in the foci (Jacob et a i, 1992). The proliferation of the 
founder gives rise to centrobiasts, a rapidly dividing (6-7 hr division time) population of 
cells which do not express slg (Liu et a i, 1991c, McHeyzer-Williams et a i, 1993). It is 
throught that during the division of the founder cells or centrobiasts that point mutations 
are introduced into the variable region of the Ig genes (Berek et a i, 1991, Jacob et ai, 
1991b). This process is known as somatic hypermutation and can lead to changes in the 
specificity or affinity of antibodies (MacLennan 1991, Wagner et a i, 1996).
Centrobiasts give rise to centrocytes, a non-dividing population of cells that express the 
newly mutated slg (Liu et a i, 1992, MacLennan 1994). As the mutations in the variable 
region of the Ig genes are random, it is possible that they may improve antigen binding. 
However, they may also change the specificity of Ig so that it now recognises self­
antigens. Thus, as for the primary B cell repertoire, the specificity of the B cells that 
have undergone somatic hypermutation must be tested and self-reactive B cells again 
deleted (Nossal 1992, MacLennan 1994). Centrocytes that express high affinity 
antigen-specific antibody undergo positive selection that is thought to induce the up- 
regulation of the cell survival gene bcl-2, whereas cells that express slg which has a 
reduced affinity for antigen, die presumably due to the absence of an antigen signal 
(Kelsoe 1996, Tarlinton and Smith 1997). In contrast, B cells that have developed 
autoreactivity undergo negative selection that is thought to induce apoptosis and maintain 
self tolerance (Han et a i, 1995, Pulendran et a i, 1995, Shokat et a i, 1995, Galibert et 
a i, 1996). The antigen signal generated as a result of slg binding to antigen presented 
by FDCs in part determines the fate of B cells undergoing selection (Kelsoe 1996, 
Tarlinton et a i, 1997). However, while it is clear that the antigen signal regulates B cell 
selection in the germinal center, it is not obvious how ligation of slg can both promote B
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cell survival if induced by foreign antigen and induce cell death if mediated by self 
antigen. The resolution may depend on the site of antigen exposure. It is possible that 
when FDC present antigen to the B cell additional stimulatory receptors are engaged that 
will be absent from B cells seeing antigen in serum or on the surface of other cell types 
(Liu et a i, 199 Id, Liu et a i, 1991 e).
The germinal centre response also results in the formation of memory B cells (reviewed 
in Berek et a i, 1991, Nahm et al., 1992, Gray 1993). The signals that regulate the 
developmental choice between B cell differentiation to ASCs or memory cells are still 
unclear but may involve an antigen signal (McHeyzer-Williams et a i, 1993).
These examples illustrate the different effects that slg-mediated signals have on different 
aspects of the B cell response to TD antigens. Although the antigen signal is not 
required for TD B cell activation, it does promote B cell activation in response to these 
antigens. Thus, slg-mediated signals could be considered to be positive regulators of T 
cell-B cell collaboration. In addition, slg-mediated signals help to maintain B cell 
tolerance following somatic hypermutation. Therefore, the antigen signal can also have 
a negative effect on B cells activated by TD antigens. Clearly, slg-mediated signals have 
inhibitory and stimulatory effects on B cell behaviour induced by TD antigens. A 
similarly complex role for the antigen signal is also found for the TI response as 
described in the following sections.
1.5.2. T cell independent B cell activation
TI antigens were initially identified because of their ability to induce an immune response 
in nude mice which lack T cells (reviewed in Kindred 1979). Subsequent experiments 
on the response of B cells from CBA/N mice which carry an x-linked immunodeficiency 
(.xid) (Berning et al., 1980, Thomas et al., 1993) have subdivided TI antigens into two 
further types. TI type-1 antigens are able to induce antibody production in CBA/N B 
cells, whereas TI type-2 antigens are not (reviewed in Mosier et al., 1977, Mond et a i, 
1978, Scher 1982b). In addition to differing in their effect on CBA/N B cells, TI type-1 
and TI type-2 antigens also differ in their requirement for slg-mediated signals to induce 
B cell activation. TI type-2 antigens, which are characterised by large multivalent 
polysaccharides that contain repetitive epitopes, induce B cell activation through 
extensive cross-linking of slg (Mosier and Subbarao 1982, Mond et a i, 1995). In 
contrast, TI type-1 antigens, exemplified by LPS, are thought to induce B cell activation 
in a manner that is independent of the antigen signal (Coutinho and Möller 1975).
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LPS - A TI-type I antigen
LPS is a major component of the cell wall of gram-negative bacteria and it has a structure 
consisting of three sections: a polysaccharide region (the O-antigen); a core region; and 
lipid-A (Figure 1.6) (reviewed in Raetz 1990, Rietschel et al., 1994). The O-antigen is 
the most distal component of LPS from the bacterial cell wall and is a hydrophilic 
polymer that consists of oligosaccharides made up of repeating glycosyl residues (Raetz 
1990, Rietschel et al., 1994). As gram negative bacteria synthesise O-antigens that 
contain different numbers of glycosyl residues, these antigens exhibit a high degree of 
heterogeneity (Raetz 1990, Rietschel et al., 1994). The O-antigen is covalently linked to 
lipid-A by the core region (Figure 1.6) (Raetz 1990, Rietschel et al., 1994). The core 
region is composed of hetero-oligosaccharides and can be divided into outer and inner 
regions (Raetz 1990, Rietschel et al., 1994). It is the inner core region that binds to 
lipid-A, a phosphoglycolipid composed of fatty acids linked by ester and amine bonds to 
a glucosamine backbone (Figure 1.6) (Raetz 1990, Rietschel et al., 1994). The 
composition of lipid-A is highly conserved and it is thought that lipid-A provides LPS 
with its capacity to activate B cells (Andersson et al., 1973, Raetz 1990, Rietschel et al, 
1994).
LPS-induced B cell responses
LPS is a potent stimulator of the immune system that can induce B cell proliferation and 
antigen-specific as well as polyclonal antibody production (Andersson et al., 1972, 
Kearney and Lawton 1975). In vivo LPS-induced ASC formation may be antigen 
specific as demonstrated by the use of LPS-hapten conjugates (Lange et al., 1983, 
Claassen et al., 1986). Antigen specific antibody is primarily IgM, however, LPS can 
also induce the production of IgG2b and low levels of IgG3 (Claassen et al., 1986). 
Therefore, LPS can induce isotype switching, and as with TD antigens this is regulated 
by cytokines. Thus, in vitro LPS and IFN-y induce the production of IgG2a and 
inhibit the production of IgG3 (Snapper and Paul 1987, Snapper et al., 1988b), whereas 
the combination of LPS and IL-4 promotes the production of IgGl and IgE (Coffman et 
al., 1986, Snapper et al., 1988a). While B cells stimulated with LPS are capable of 
isotype switching, they do not undergo somatic hypermutation and affinity maturation 
(Mosier et al., 1982) Therefore, the LPS-induced antibody response is generally of low 
affinity (Smith et al., 1985). Finally, although LPS does not induce the formation of 
memory B cells there is evidence of a weak recall response. Rats immunised and 
subsequently challenged with trinitrophenol conjugated to LPS (TNP-LPS) produce a 
higher concentration of antibody with a different isotype profile than non-immunised 
animals (Zhang et al., 1988).
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Figure 1. 6 Positioning of LPS on the bacterial cell wall.
This figure illustrates the approximate orientation of LPS on the 
bacterial cell wall, where Lipid A is proximal, and the O-antigen is 
distal, to the outer membrane. Because of the exposed and highly 
variable nature of the O-antigen, most antibodies which are directed 
against LPS are specific for epitopes with this region. Taken from 
Ulevitch and Tobias (1995), with the permission of the Annual Review 
of Immunology. Volume 13 cl 995, by Annual reviews Inc.
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How does LPS-induce B cell activation ?
While CD 14 has been identified as a receptor for LPS on the surface of macrophages 
this antigen is not expressed on B cells and an alternative LPS receptor is yet to be found 
(Ziegler-Heitbrock and Ulevitch 1993, Ulevitch and Tobias 1995). Thus, the precise 
mechanism by which LPS-induces B cell activation is still to be defined. However, a 
long-standing explanation of how a non-specific mitogen such as LPS can give rise to 
specific antibody is due to Coutinho and Möller (reviewed in Coutinho et al., 1975). 
They suggested that antigen- or hapten-specific slg could passively focus hapten-LPS to 
the specific B cell and thereby promote the differentiation of antigen-specific B cells at 
hapten-LPS concentrations that were lower than required to induce a polyclonal response 
(Coutinho et a l, 1974a). Based on these conclusions, Coutinho and Möller proposed 
the one-signal model of B cell activation in which they suggested that all B cell 
activation, TD and TI, could be induced through the delivery of one antigen non-specific 
activating signal that did not involve any slg-mediated signal (Coutinho et a l, 1975, 
Alarcon-Riquelme and Möller 1990, Möller et a l, 1991).
Th e influence o f slg-mediated signals on LPS-induced B cell activation 
In contrast to Coutinho's and Möller's conclusions, separate experiments revealed that 
the antigen signal could have a negative influence on LPS-induced B cell activation. In 
these experiments the antigen signal was shown to inhibit LPS-induced ASC formation 
with little effect on LPS-induced proliferation (Andersson et al., 1974, Kearney et al, 
1976, Andersson et a l, 1978, Kearney et a l, 1978, Grandien et a l, 1993). Although 
divalent anti-Ig reagents could inhibit LPS-induced ASC formation, monovalent F(ab) 
fragments were shown to have no effect (Andersson et a l, 1974, Andersson et al, 
1978). Thus, it appears that cross-linking of slg with divalent anti-Ig reagents can 
induce a signal which inhibits LPS-induced B cell differentiation to ASCs.
TI type-2 B cell activation requires a slg-mediated signal
TI type-2 B cell activation is typically induced by large multivalent polysaccharide 
antigens that contain repeated identical epitopes such as polymerised flagellin, 
haptenated-Ficoll, high molecular weight dextran and pneumococcal polysaccharide 
(Feldmann and Basten 1971, Coutinho and Möller 1973b, Coutinho et a l, 1974b, 
Mongini et a l, 1982, Mongini et a l, 1984). In addition, anti-p dextran and anti-5- 
dextran have been used in vitro to mimic TI type-2 B cell activation, allowing the 
characterisation of the B cell response to this class of antigens (Peganha et a l, 1991, 
Peganha et a l, 1993, Snapper et a l, 1995a, Snapper and Mond 1996). The multivalent 
nature of these antigens is essential to induce B cell activation through extensive cross- 
linking of slg (Mond et a l, 1995). Thus, while polymerised flagellin can induce B cell 
activation, flagellin monomer does not (Feldmann et a l, 1971). A similarly dramatic
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effect of polymerisation can be seen when the B cell response to soluble anti-p or anti-8 
is compared to that induced by those same antibodies chemically coupled to dextran 
(Pe^anha et a l, 1991, Snapper et a l, 1995a).
When used to stimulate B cells, TI type-2 antigens alone induce proliferation, whereas in 
combination with Th type-2 cytokines they also induce antibody production (Peganha et 
al, 1991, Pe^anha et al, 1993). The antibody produced in vivo is predominantly IgM 
and IgG3 (Golding and Rittenberg 1982, Claassen et a l, 1986). As described for TD 
and TI type-1 antigens, the antibody isotype induced by TI type-2 antigens is regulated 
by cytokines as demonstrated in vitro. Thus, anti-8-dextran in combination with IL-4 
and IL-5 enhances IgM production and induces switching to IgGl (Peganha et al,
1993) . In contrast, B cells cultured with anti-Ig-dextran, IFN-y and IL-5 undergo 
isotype switching to produce IgG3 and IgG2a (Snapper et a l, 1987, Snapper et al, 
1992). Further, anti-8-dextran in combination with TGF-ß and supernatants (sn) 
containing IL-4 and IL-5 have been shown to induce switching to IgA (Snapper et al, 
1991). These results clearly indicate the dependence of TI type-2 antigens on cytokines 
to induce antibody production. Despite this requirement, Th type-2 antigens can induce 
antibody production in the absence of T cells leading to the suggestion that natural killer 
cells may also provide the cytokines required for antibody production (Snapper et al,
1994) . In addition, as described for TI type-1 antigens, TI type-2 B cell activation does 
not induce somatic hypermutation and affinity maturation (Mosier et a l, 1982), or the 
generation of memory B cells (Zhang et a l, 1988).
A comparison of the role of the antigen signal in distinct types of B cell activation 
illustrates, again, the principle that this signal can have different and occasionally 
contradictory effects on B cells. Thus, slg-mediated signals can promote TD B cell 
activation but are not themselves obligatory. In contrast, slg may inhibit antibody 
production induced by TI type-1 antigens, but is not required for activation and 
proliferation. Finally, in TI type-2 B cell activation, slg provides an essential activating 
signal. These diverse effects of the antigen signal on B cell activation could be due to 
variation in the slg-mediated signal as a result of the interaction of slg with different 
physical forms of antigen. Thus far, this discussion has focused on the diversity of B 
cell responses induced by the antigen signal. What then are the components of the slg- 
mediated signal that could be differentially activated in response to different antigens? 
This question is addressed in the following sections.
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1.6 The antigen (slg-mediated) signal
The B :ell antigen receptor consists of multiple subunits
The c(mplete B cell antigen receptor (BCR) is made up of two components which have 
different functions: antigen recognition and signal transduction (reviewed in Cambier 
and Campbell 1990, Clark et al, 1992, Reth 1992, Pleiman et al., 1994a, Reth 1994). 
Antigtn recognition occurs primarily through slg, whereas signalling occurs through 
associited proteins (Cambier et al., 1990, Clark et al., 1992, Pleiman et al., 1994a).
The cytoplasmic region of slgM and slgD consists of only three amino acids. The other 
isotypes have somewhat longer cytoplasmic tails; slgA has 14 amino acids, whereas 
slgG and slgE have 28 amino acids (Cambier et al, 1990, Reth 1992, Pleiman et al, 
1994a. Thus, the cytoplasmic tails of slgM and D were thought to be too short to be 
involved in signal transduction. This lead to the suggestion that slg-mediated signalling 
must (ccur through slg-associated proteins (Hombach et al, 1988). These signalling 
proteins were later identified as Iga and Igß (Hombach et al, 1990, Kim et al, 1993, 
Sanchez et a l, 1993).
Iga ard Igß are extensively glycosolated proteins composed of an Ig-like extracellular 
domaii attached to long cytoplasmic tails of 61 and 48 amino acids, respectively 
(Hoimach et al, 1990, Kim et al, 1993, Sanchez et al, 1993). These two proteins 
form c heterodimer which can be co-expressed on the B cell surface with Ig. The 
associition of IgM with the Igot/ß heterodimer is essential for the successful transport 
and expression of IgM on the B cell surface (Hombach et al, 1988, Hombach et al, 
1990, Campbell et a l, 1991). The cytoplasmic regions of both Iga and Igß contain a 
conseived amino acid sequence called an immunoreceptor tyrosine-based activation 
motif ITAM) (Cambier 1995). This motif is characterised by a conserved amino acid 
sequence: D/E-X7-D/E-X2-Y-X2-L/I-X7-Y-X2-L/I in single amino acid letter code, 
whereX is any amino acid (Cambier 1995). The tyrosine residues within the ITAM 
have feen shown to be essential for signal transduction as substitution mutations of the 
tyrosine residues within the ITAM abolish the signalling function of the Iga/ß 
heteroiimer (Sanchez et a l, 1993). ITAMs are also found in the cytoplasmic tails of 
other molecules which are involved in signal transduction including components of the T 
cell artigen receptor (TCR) (CD3y, 5, e and rj) and Fc receptors (yRII2a, eR lß  and 
eRly)(Reth 1989, Clark et al, 1992, Sanchez et al, 1993).
Signa, transduction through the BCR commences with the activation o f protein tyrosine 
kinases
Signa transduction by the BCR involves the activation of a number of intracellular 
signaling pathways (reviewed in Cambier and Campbell 1992, Cambier et al, 1994,
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Gold and Defranco 1994, Harnett 1994, Bolen 1995, DeFranco 1997). Surface Ig- 
mediated signalling begins with the activation of protein tyrosine kinases (PTKs) that 
associate with the cytoplasmic tail of the Igoc/ß heterodimer. The kinases include: 
p72syk , p53/561yn, p55blk, p59fVn and p56lck (Clark 1992, Bolen 1995). One 
of the protein tyrosine kinases (PTK) activated after slg cross-linking appears to be 
p72syk (Hutchcroft e ta l, 1991, Weiss and Littman 1994). Once activated, p72sY  ^may 
undergo autophosphorylation and phosphorylate other PTKs associated with the Igot/ß 
heterodimer (Cambier et a l, 1994, Pleiman e ta l, 1994a, Bolen 1995) The 
phosphorylation of the PTKs results in their activation, and they in turn phosphorylate 
tyrosine residues within the ITAM (Kimura et al., 1996). The phosphorylation of the 
ITAM induces a conformational change in the cytoplasmic region of the Iga/ß 
heterodimer which reveals additional binding sites for kinases known as SH2 domains 
(Johnson et al., 1995, Takata and Kurosaki 1996). The conformational change of the 
Igoc/ß heterodimer brings about the re-orientation of the PTKs leading to heightened 
activation of these enzymes by cross- and auto-phosphorylation (Kurosaki et al., 1995, 
Takata et a l, 1996).
Ligation o f slg mediates the activation o f different signal transduction pathways
The PTKs associated with the IgO(/ß heterodimer bind and phosphorylate phospholipase
C-y(PLC-Y) (Carter e ta l,  1991a), GTPase activating protein (GAP) (Kawauchi et al,
1994) and phosphatidylinositol 3-kinase (PI-3 kinase) (Pleiman et al., 1994b). After 
slg cross-linking, each of these proteins are activated by phosphorylation (Figure 1.7) 
(Carter et a l, 1991a, Gold et a l, 1992, Cambier et a l, 1994). Once activated PLC-y, 
GAP, and PI-3 kinase initiate three separate signal transduction pathways (Figure 1.7). 
The activation of PLC-y results in the hydrolysis of inositol containing phospholipids 
within the cell membrane and the generation of the secondary messengers inositol 1,4,5- 
trisphosphate (IP3) and diacylglycerol (DAG) (Berridge and Irvine 1989, Valentine et 
a l, 1992). The production of IP3 mobilises calcium ions which in turn leads to the 
activation of the calcium dependent calmodulin kinase (Figure 1.7) (Valentine et al,
1995) . Calmodulin activates calcineurin which dephosphorylates the nuclear factor for 
activated T cells (NF-AT) promoting its migration from the cytoplasm into the nucleus 
(Figure 1.7) (Choi e ta l, 1994, Venkataraman e ta l,  1994). In contrast, DAG activates 
protein kinase C (PKC), (Nishizuka 1991) which can eventually lead to the activation of 
junB , a component of the transcription factor AP-1 (Figure 1.7) (Huo and Rothstein 
1995).
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Figure 1.7. A simplified view of slg-mediated signalling.
This figure illustrates some of the intracellular signalling pathways that are activated in response to 
cross-linking of slg, and which ultimatly lead to the regulation of transcription. Also illustrated is 
how signalling from the IL-4 receptor and the CD21/CD19/CD81 complex can amplify the slg- 
mediated signals. Addapted from DeFranco (1997), Gold and DeFranco (1994), Harnet (1994) and 
Cambier and Campbell (1992).
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The downstream signalling events after the phosphorylation of GAP inelude the 
aetivation of p21ras (Gold et a l, 1993, Harwood and Camhier 1993), whieh in turn 
leads to the activation of the mitogen activated protein (MAP) kinases (Harnett 1994).
The MAP kinases phosphorylate transcription factors that include c-jun (Pulverer et al., 
1991), and can induce the expression of egr-1 and c-fos (Figure 1.7) (DeFranco 1993, 
DeFranco 1997). Finally, activation of PI-3 kinase induces the downstream activation 
of phospholipase C-y (Camhier et al., 1994, Harnett 1994). In addition, PKC-^ is also 
activated and, it is thought that PKC-£ can interact with NF-kB and thereby promote 
transcription (Figure 1.7) (Liu et al., 1991a). Thus, each of the three signal transduction 
pathways ultimately influences the activity of DNA binding proteins through which 
transcription is regulated. Combined, these pathways result in the transcription of erg-1, 
c-m ycjun  and c-fos, all of which assist in the regulation of genes involved in B cell 
activation (Camhier et al., 1992, Gold et al., 1994).
although this pathway is not well understood 
The antigen signal can be amplified by the signalling o f co-receptors 
The signalling induced by the BCR may be amplified through the involvement of co­
receptors. One candidate is CD 19 (reviewed in van Noesel et al., 1993a, Tedder et al., 
1994, Fearon and Carter 1995). CD 19 is expressed on the B cell surface in association 
with CD21 (complement receptor-2), CD81 (TAPA-1) and Leu-13 (Matsumoto et al., 
1991, Bradbury et a l, 1992, Matsumoto et a l, 1993). Combined, these molecules may 
form a unique signal transduction complex that can enhance BCR mediated signalling 
(Tedder et a l, 1994, Fearon et al., 1995)). CD 19 has been shown to associate with slg 
and is phosphorylated by PTKs bound to the Igot/ß heterodimer following ligation of the 
BCR (Chalupny et a l, 1993, van Noesel et al., 1993b). In addition, co-ligation of slg 
and CD 19 has been shown to lower the threshold of B cell activation and to induce a 
synergistic increase in calcium mobilisation and the activation of PLC-y and PI-3 kinase 
(Figure 1.7) (Carter et a l, 1991b, Carter et a l, 1992). The role of CD21 may be to 
promote co-ligation of CD 19 and slg by forming a bridge between the two complexes. 
This may occur when slg binds to antigen that is part of an immune complex containing 
complement, and CD21 binds to the complement component (van Noesel et al., 1993a, 
Fearon et a l, 1995). The co-ligation of slg and CD21 has been shown to enhance B cell 
antibody production (Dempsey et a l, 1996). Finally, the role of CD81 and Leu-13 in 
this complex is less clear. However, ligation of Leu-13 has been reported to activate 
PTKs (Schick et a l, 1993). Thus, intracellular signals induced by the 
CD21/CD19/CD81 complex could augment slg-mediated signalling through the 
enhanced activation of PLC-yand PI-3 kinase (Figure 1.7).
General introduction 29
1.7 Aims of this thesis
When the effect of slg-mediated signals in different forms of B cell activation is 
compared it is clear that the antigen signal does not have a single definitive role. While 
the role of the antigen signal in TD and TI type-2 B cell activation is relatively clear, its 
effect on LPS-induced B cell activation remains to be determined. According to 
Coutinho and Moller's one signal model of B cell activation slg-mediated signals do not 
have a role in activating or regulating the B cell response (Coutinho et al., 1974a, 
Coutinho et al., 1975, Möller et al., 1991). However, their conclusion is inconsistent 
with the effect of the antigen signal on TD and TI type-2 B cell activation, as well as the 
experimental evidence that slg-mediated signals can inhibit LPS-induced ASC formation 
(Andersson et al., 1974, Kearney et al., 1976, Grandien et al., 1993). Thus, the aim of 
this thesis is to reconcile these opposing views by re-examining the experimental 
foundation of the one signal model.
Chapter 2
The one signal theory of 
B cell activation revisited: 
A role for surface 
im m unoglobulin in 
regulating T-independent 
antibody responses
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2.1 Introduction1
The one signal theory of B cell activation, first proposed almost 20 years ago (Coutinho 
and Möller 1974, Coutinho and Möller 1975) argued against an active signalling role for 
surface immunoglobulin (slg) in B cell activation. The theory still holds considerable 
interest today for a number of reasons. First, the model has been re-formulated to 
conlorm to new information of T-B collaboration and to re-state arguments against the 
evidence for a role of slg mediated signals in activation (Möller, et al., 1991). Second, 
one component of this theory - the proposal that one non-antigen specific signal is 
sufficient to activate B cells in the absence of antigen binding - is consistent with recent 
discoveries of the CD40-mediated B cell activation path by T cells (Noelle. et a i, 1992a, 
Hodgkin and Kehry 1993, Parker 1993). The model is, however, at odds with the 
overwhelming evidence for a slg mediated signal (Cambier and Campbell 1990) and its 
role in T-dependent (TD) and some T-independent (TI) antibody responses (Peganha. et 
al., 1991, Cooke, et al., 1994). The arguments and experimental basis of the one signal 
mocel then are worthy of re-examination in a modem context. In this paper we look at 
the experimental foundations of this theory and find that they suggest an alternate theory 
that ironically, invokes a critical role for the transmission of a signal by slg.
Experimental Foundations.
Three key empirical observations formed the foundation of the one signal theory of B 
cell activation (Figure 1). The first was that the dose response of B cells to polyclonal B 
cell activators (PBAs), such as lipopolysaccharide (LPS), generated a bell shaped dose 
respnse curve when total antibody secreting cells (ASCs) were measured in culture 
(Figure 2.1a) (Andersson. et a l, 1978). An antigen specific response, as detected by the 
nun her of anti-hapten ASCs, formed a subset of the total response and gave a similar 
bellshaped dose curve (Andersson, et al., 1978). The second experiment used LPS that 
had been coupled to the hapten (4-hydroxy-3,5-dinitrophenyl)acetyl (NNP). The dose 
respnse curves for both the anti-hapten and total Ig secreting cell number were again 
bell shaped.
1. This chapter has been published as a theoretical article in Immunology and Cell 
Bioogy (Mamchak and Hodgkin (1995) 73:266-271), and is presented here in thesis 
fomat. It has been included as a chapter as it describes the theoretical foundations on 
whi;h the experimental work described in this thesis is based.
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Figure 2.1. The experimental foundation of the one signal theory of
B cell activation.
A. The dose response curve for LPS-induced total (t), or antigen specific 
(h), antibody secreting cell formation is bell shaped, with the specific 
antigen response forming a subset of the polyclonal response. B. By 
haptenating the LPS, the specific response displays a maximum at lower 
concentrations than the polyclonal response. C. Shows a similar experiment 
to that shown in (A) except that competing hapten is included in culture. 
The presence of the competitor does not affect the ability of LPS to induce 
the hapten specific response. D. Addition of free hapten to B cells 
stimulated with haptenated LPS inhibits the shift in dose curve seen in (B) 
and generates dose response curves that are similar to those seen in the 
presence of LPS alone, where the antigen specific response is a subset of 
the total antibody response (A).
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However, peak production of antigen specific cells occurred at lower concentrations than 
the polyclonal response (Figure 2.1b) (Coutinho. et al., 1974a). In the third experiment 
(Figure 2.1c and d) the NNP-specific fraction of the polyclonal response induced by 
LPS stimulation could not he blocked by soluble hapten (Figure lc), whereas the 
leftward shift in antigen specific response following stimulation with NNP-LPS was 
inhibited (Figure Id) (Coutinho, et al, 1974a).
Coutinho and Möller's interpretation of these data (Coutinho and Möller 1975) is 
illustrated in Figure 2.2. To explain the bell shaped dose curves it was assumed that all 
B cells possessed similar receptors for PBAs that were independent of the slg antigen 
receptor. It was also assumed that the response to any PBA would be dose dependent 
and that high levels of receptor binding induced a state of non-responsiveness (also 
referred to as paralysis). The occurrence of antigen-specific responses at low doses of 
haptenated LPS was proposed to occur because B cells with specificity for the hapten 
would use their slg receptor to (passively) focus the LPS to their surface, thereby 
increasing interaction with the LPS receptor. Thus, hapten (or LPS)-specific B ceils 
reached optimal and paralytic doses of LPS at lower concentrations than non-specific 
cells. To interpret the third experiment (Figure 2.1c and d) it was assumed that soluble 
hapten could block slg-mediated focussing of LPS via hapten binding. Coutinho and 
Möller also noted that the inability of free hapten to inhibit the subset of anti-hapten B 
cells stimulated by LPS (Figure lc) implied that antigen binding was not actually 
required for LPS to induce differentiation of antigen specific B cells (Coutinho and 
Möller 1975).
Although their experiments dealt exclusively with TI B cell stimulation, Coutinho and 
Möller extrapolated from their data to propose a model that included TD responses. This 
general model proposed that all B cell activation occurred through the focussing by slg 
of one-non-antigen specific activating signal delivered either by a PBA or an antigen 
specific T cell (Coutinho and Möller 1975, Möller, et al, 1991). Recently, Möller et a l 
strongly defended this model with a version of TD B cell activation where the only 
important role for slg was that of processing antigen (Möller, et al, 1991). Thus, by 
this view the specific B cell accumulates antigen derived peptides in association with 
MHC class II molecules on its surface, allowing recognition by MHC restricted helper T 
cells. Antigen recognition by collaborating T cells leads to the provision of a non-antigen 
specific set of B cell activating signals similar to those provided by the PBA (Coutinho 
and Möller 1974). Given that this theory evolved from studies on LPS, it is remarkable 
that this latter prediction was to some extent correct. Some T cell clones can activate B 
cells in vitro in this manner and, furthermore, once activated, the T helper cell delivers
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Receptors Y L PS ^  slg/no binding L|J slg/anti-hapten
Figure 2.2 The one signal model of B cell activation by LPS.
The top panel shows the stimulation of non-hapten binding B cells by 
hapten-LPS. Interaction between LPS and its receptor on B cells induces a 
bell shaped dose curve, where at low concentrations receptor engagement 
is limiting, and at high occupation levels the LPS signal is paralytic. The 
lower panel illustrates how hapten recognition by slg can alter the 
equilibrium of LPS binding by providing additional receptors for LPS 
capture. Importantly, however, binding hapten plays only a passive role in 
focussing LPS and doesn't alter the sensitivity of the B cell to LPS 
stimulation.
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cell-cell contact and lymphokine-mediated signals that are sufficient to induce polyclonal 
B cell proliferation and antibody production (Hodgkin, et al, 1990, Hodgkin and Kehry 
1992). Thus, the essential signals to drive B cell differentiation to Ig secretion do not 
include antigen, although such signals may play other important roles (discussed further 
below).
2.2 The two signal theory
The most important competing theory of the time had a different history. Bretscher and 
Cohn's two signal model of B cell activation was a theoretical attempt to explain how a 
cell could distinguish self from non-self antigens (Bretscher and Cohn 1970). They 
argued that this could be achieved with two antigen recognition events, one supplied by 
B cell antigen recognition, and the second by associative recognition of another antigenic 
determinant by a helper mechanism (in modem terms a helper T cell). Both the two 
signal theory and the one signal model were consistent with this constraint, as even a 
passive role for slg collecting antigen satisfies this requirement. The important difference 
is that Bretscher and Cohn argued that the first signal alone, without the second signal, 
must lead to tolerance. Hence a passive role for the B cell antigen receptor was not 
sufficient - the B cell had to perceive its contact with antigen to prime for the second 
signals or, in their absence, to tolerise (Bretscher and Cohn 1970).
With the benefit of hindsight, the ensuing debate was an interesting one. An 
experimental inductive model battling a theoretical deductive construction for numerical 
supremacy (one signal or two?). And, as is often the case, there was good evidence for 
both models, although not in the same systems. The chief point of difficulty was 
whether the first signal existed, and if so how was it triggered and what was its role?
2.3 The slg mediated signal
In recent years the molecular mechanism of triggering the B cell surface Ig receptor has 
begun to be unravelled. In order to be expressed on the cell surface Ig must associate 
with the gene products from mb-1 and B-29, Ig a  and Ig ß respectively (Reth. et al, 
1991). These molecules form a heterodimer which functions as the signalling component 
of slg (Pleiman. et al., 1994a). Crosslinking of slg by antigen brings the receptor 
complexes together to form a lattice. The formation of the receptor lattice can directly 
activate Ig a /ß  associated src-related kinases resulting in cross-phosphorylation and the 
activation of other kinases and their substrates (Pleiman, et al, 1994a). Downstream of 
these initial activation events second messengers result in the movement of cytoplasmic
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factors into the nucleus where they regulate gene transcription (Cambier and Campbell 
1990).
The consequence of slg signalling depends on both the maturation state of the B cell and 
receipt of other signals. An early role for the signal in deletion of immature, self reactive 
cells in the bone marrow is implied from recent studies (Nemazee and Biirki 1989b). 
Once the B cell has matured and entered the periphery, the slg mediated signal can 
mediate various effects under different conditions. This can be illustrated with three 
examples corresponding to B cell activation by T cells and by two different TI activation 
protocols.
Role o f antigen in TD responses
B cells exposed to antigen undergo a number of rapid changes that prepare them for 
interaction with T cells. These events include migration to T cell areas of lymphoid tissue 
(van Rooijen 1992), increased expression of adhesion and MHC molecules, and the de 
novo synthesis of ligands for CD28 (Cooke, et al., 1994, Lenschow. et a i, 1994). in 
addition, antigen stimulated B cells are more sensitive to the helper signals provided by 
the T cell including ligation of CD40 on the B cell (Lane, et a l, 1993). Hence, it appears 
that antigen stimulation of the B cell will significantly promote interaction between the T 
and B cell. Furthermore, provision of the first signal (antigen), in the absence of T cell 
help, will apparently lead to a shorter B cell hall' life (Fulcher and Basten 1994), as 
predicted by the two signal theory (Bretscher and Cohn 1970). In addition to playing a 
role in early T-B interaction the antigen signal is implicated in the re-selection of high 
affinity B cells following somatic hypermutation in the germinal centre (Liu. et al,
1989).
Role o f antigen in TI responses
TI antigens have been divided into two categories: 1) TI-1 antigens (which include LPS) 
are all PBAs, and, 2) TI-2 antigens that are less mitogenic but are also multimeric 
polysaccharides (Scher 1982b). As has been already described, the TI-1 response does 
not require antigen recognition although slg can focus the PBA and generate a specific 
response. Interestingly, treating LPS stimulated cells with anti-Ig reagents actually 
inhibits Ig secretion (this attribute will be discussed in greater detail below). B cell 
activation by TI-2 antigens are mimicked in vitro by anti-Ig and anti-Ig-dextran 
conjugates . In contrast to TI-1 activation, these agents seem to be critically dependent 
on the transmission of a slg mediated signal rendering the cells sensitive to the 
differentiating effects of a range of cytokines (Snapper and Mond 1993).
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2.4 Multiple roles for the B cell antigen signal
The obvious conclusion from the above discussion is that there is no universal role for 
the slg-mediated signal. Therefore, the attempts of earlier workers to explain all of B cell 
behaviour within a single model necessarily underestimated the inherent complexity of 
the system. The multiple B cell differentiation paths and roles for slg presumably 
evolved so that immunoglobulin production could be highly regulated and evoke classes 
of response appropriate to different categories of antigen. Of interest though, is the 
partial success of early logical arguments founded on either an experimental or 
theoretical base to predict B cell behaviour. The conclusions reached were valid for some 
modes of B cell activation and not others. For example, the two signal theory is 
approximately met by the current view of T-B collaboration but is inconsistent with 
activation by TI antigens or for T cell activation. The one non-specific mechanism is 
correct in predicting that the actual B cell activation events would occur without an 
obligatory role for antigen stimulation, however, under most situations in vivo, the 
enhancing effects of B cell antigen stimulation may be necessary.
2.5 An alternative theory of bell shaped curves for LPS activation
Anti-Ig and antigen stimulation during LPS exposure enhances B cell proliferation while 
inhibiting Ig secretion (Andersson. et al., 1974, Kearney, et al, 1976). The use of 
F(ab')2 and F(ab) fragments of anti-Ig have shown that inhibition of PBA induced 
antibody production requires crosslinking of slg and is not mediated by Fc receptors 
(Andersson, et al, 1974, Grandien. et al, 1993). These observations have not been 
satisfactorily placed within a theoretical framework. It seems reasonable to suggest that 
haptenated LPS, which is after all a multivalent antigen, could have the same effect as 
anti-Ig such that at a given concentration hapten specific B cells will receive a signal that 
inhibits Ig secretion and promotes proliferation. By this model, illustrated in Figure 2.3, 
the hapten (or LPS)-specific B cell population will focus low concentrations of LPS to 
the surface, as argued by Coutinho and Möller (Coutinho and Möller 1975), but 
increasing concentrations eventually result in sufficient binding of the receptor to 
transmit a slg mediated signal that inhibits differentiation to Ig secretion and therefore 
generates the familiar bell shaped curve.
This alternative would not explain how similar curves are generated by the polyclonal 
response to LPS (Figure 1). Here, however, our data is at odds with Coutinho and 
Möller as we find that LPS-induced dose response curves can be complex, with the
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Figure 2.3. An alternative explanation of LPS induced bell shaped
dose response curves.
This model argues that the true LPS dose curve follows a standard 
sigmoidal response (upper curve). For the anti-hapten response there will 
he a concentration region where hapten binding succeeds in focussing 
LPS to the surface without transmitting a signal. Higher concentrations 
result in slg mediated signalling that promotes proliferation but prevents 
Ig secretion.
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shape critically dependent on starting cell density and time of assay (Mamchak and 
Hodgkin, manuscript in preparation). If carefully performed, little inhibition is seen even 
at extremely high LPS concentrations (>5()() mg/ml). Thus, we believe that the bell curve 
for total antibody production may be an artefact of the rapid growth of stimulated B cells 
and the complex kinetics of ASC formation at high doses of LPS. Upon re-examining 
the early literature it is apparent that the published bell shaped curves for anti-hapten 
responses are usually striking, showing inhibition to background levels at higher 
concentrations. In contrast the inhibition of the total Ig response at high LPS 
concentrations is less convincing with the peak response reduced by as little as 50% 
(Andersson. et al., 1972, Coutinho, et al, 1974a, Coutinho and Möller 1975).
2.6 Implications of slg signalling inhibiting Ig production
The proposed negative signal transmitted by slg during LPS stimulation would have the 
effect of ensuring that specific antibodies induced by LPS will be drawn from the low 
affinity range (Figure 2.4). Consistent with this prediction Smith et al (Smith, et al., 
1985) immunised C57BL/6 mice with TD and TI antigens coupled to the hapten (4- 
hydroxy-3-nitrophenyl)acetyl (NP). Anti-NP secreting hybridomas prepared from mice 
immunised with NP-LPS were of IgM subclass and of significantly lower affinity than 
those obtained from TI-2 or TD antigen priming. In fact, many of the LPS induced B 
cell clones were of such low affinity they were unable to be detected in a conventional 
plaque assay. Furthermore, the high affinity B cell response in the C57BL/6 mouse uses 
the 11 light chain and both the TI-2 and TD responses were dominated by 1 bearing B 
cells. In contrast the NP-LPS response consisted of low affinity k bearing B cells 
(Smith, et al., 1985). This result suggests that the higher affinity 11 bearing precursor 
cells were not stimulated, consistent with an active suppression by antigen recognition.
Why would slg actively maintain low affinity responses to TI-1 antigens? One 
possibility is that the mechanism serves as a form of memory cell generation. By 
proliferating rather than differentiating to Ig secretion, the higher affinity cells could 
form an expanded pool of specific cells to draw upon during subsequent antigen 
exposure. Alternatively, additional proliferation may be required for differentiation to 
non-IgM subclasses. Class switching will only be useful for higher affinity cells due to 
the significantly lower avidity of IgG compared to IgM. Other possibilities are that the 
high affinity B cells may differentiate into some other non-Ig secreting effector cell, or 
that high affinity antibody may be disadvantageous to an important effector function 
directed against LPS bearing microorganisms (ie complement activation).
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Figure 2.4. Selection of low affinity cells by haptenated LPS.
The curve in the upper panel shows a frequency distribution of B cell 
affinity for hapten. From the arguments outlined in the text it is proposed 
that only B cells that fall into a moderate affinity group (category A) will 
be stimulated by haptenated-LPS to secrete IgM. High affinity cells 
proliferate but won't secrete Ig. The function of this latter pathway of B cell 
response is unknown.
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Evaluating the validity of these arguments and the importance of slg in LPS responses 
will require further experiments. Of interest though is that the data that served as the 
foundation for a theory purporting to eliminate a role for antigen signalling in B cell 
activation, may ultimately help establish its importance.
Chapter 3
Materials and methods
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3.1. Experimental animals
B cells were prepared from mice aged between 6 to 14 weeks. CBA/H mice were 
obtained from the animal facility at the John Curtin School of Medical Research 
(JCSMR, Canberra, Australia), or purchased from the Animal Resources Centre (Perth, 
Australia) and housed at the Centenary Institute of Cancer Medicine and Cell Biology 
(Sydney, Australia). Male CBA/N mice were obtained from the Walter and Eliza Hall 
Institute (WEHI, Melbourne, Australia). Prior to use CBA/N mice were housed within 
the animal facility at the Centenary Institute. All animals housed at the Centenary 
Institute were kept in microisolator cages under specific pathogen free conditions.
3.2. B cell preparation
Reagents
Red blood cell (RBC) lysis buffer: 10 mM potassium bicarbonate, 0.15 M ammonium 
chloride, 0.1 mM ethylenediaminetetraacetic acid (EDTA) and 5% fetal calf serum 
(FCS), pH 7.3.
RPMI/1640: A powder preparation of RPMI/1640 with L-glutamine was purchased 
from Trace (Sydney, Australia. Multicell product No 60 001PF) and made up in 
irrigation water obtained from Baxter Health Care (Old Toongabbie, Australia). The 
medium was supplemented further with, 1 g/L sodium bicarbonate, 4.6 g/L N-(2- 
hydroxyethyl) piperazine-N-2-ethanesulfonic acid (Hepes), 100 pg/ml streptomycin 
sulfate and 60 pg/ml benzylpenicillin. The supplemented media is referred to as RPMI 
(Hepes).
Cytotoxicity medium (CTM): RPMI (Hepes) was further supplemented with 10 mM 
Hepes and 0.3% bovine serum albumin (BSA), pH 7.4. BSA was obtained from Sigma 
(St Louis, MO. product No. A-9543) and contained < 0.1 ng/mg endotoxin.
B cell medium (BCM): At JCSMR BCM was prepared by supplementing RPMI 
(Hepes) with 10% heat inactivated (45 minutes at 56°C) FCS (HI FCS; Commonwealth 
Serum Laboratories, Melbourne) which had been previously screened for low intrinsic B 
cell mitogenicity, 5x10'^ M mercaptoethanol, 10 mM Hepes pH 7.4, 0.1 mM non- 
essential amino acids (Sigma, St Louis, MO), 1 mM sodium pyruvate (Gibco BRL, 
Grand Island, New York), 2 mM glutamine (Sigma, St Louis, MO), 60 pg/ml benzyl 
penicillin and 100 pg/ml streptomycin. At the Centenary Institute BCM was made using 
commercially prepared RPMI/1640 that contained 2 mM L-glutamine (Gibco BRL,
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Grand Island, NY). This media was used to prepare BCM as described above with the 
exception that the 2 mM glutamine was not added.
All solutions were sterilised by filtration through 0.2 pm membranes (Millipore,
Bedford, MA) and stored at 4°C.
T cell depleting antibodies: A cocktail of the rat anti-mouse CD4, RL172 anti-CD8,
31M, and anti-Thyl, 30H-12 (Ledbetter and Herzenherg 1979) were used for T cell 
depletion. Hyhridomas for the anti-CD8 and anti-CD4 antibodies were a gift from Dr H 
R MacDonald (Lausanne, Switzerland). These antibodies were used as hybridoma 
supernatants (sn) for T cell depletion.
The hyhridomas were grown in mixed lymphocyte culture (MLC) medium. MLC 
medium was prepared with 100 g of DMEM (Gibco, Grand Island, NY. product No. 
430-1600) dissolved in 10 L of double distilled water, supplemented with 40 g D- 
glucose, 60 mg folic acid, 360 mg L-asparagine, 1.160 g L-arginine HC1 and 20 g 
sodium bicarbonate. The solution was sterilised by filtration through 0.2 pm membranes 
and stored at 4°C. Prior to use MLC media was supplemented with, 2 mM glutamine, 1 
mM sodium pyruvate, 10 mM HEPES, 50 ml HI FCS, 5 x lO'^M 2-ME, 60 pg/ml 
penicillin and 100 pg/ml streptomycin. The hybridoma sn were titrated using a 
colourimetric assay to determine the optimal dilution for T cell depletion.
Complement: Rabbit or guinea pig complement, which had been screened for low 
toxicity, was used to deplete antibody treated T cells. Each batch was tested to determine 
the optimal specific killing dilution. Rabbit complement was obtained lyophilized from 
Cederlane Laboratories (Hornby, Ontario). Lyophilized guinea pig complement was 
obtained from the Institute of Medical and Veterinary Science (Adelaide, Australia) and 
used at a final concentration of 2 mg/ml. The complement was dissolved and diluted in 
cold CTM immediately prior to use. The complement solution was filter sterilised by 
passage through a 0.2 pm membrane, and kept on ice until use.
Percoll: Percoll was purchased from Pharmacia (Uppsala, Sweden), and a 100% stock 
solution was prepared by diluting 9 parts percoll with 1 part 10 x concentrated sterile 
phosphate buffered saline (PBS). The 100% stock solution has a density of 1.123 g/ml 
at 20°C and was diluted to 75%, 65% and 50% percoll solutions with sterile 1 x PBS 
(having densities of 1.0945 g/ml, 1.0819 g/ml, and 1.062 g/ml at 20°C, respectively). 
All percoll solutions were kept sterile and stored at 4°C.
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Staining antibodies: The anti-B220 FITC conjugate was a gift from Dr P. Lalor (WEHI, 
Melbourne), whereas the anti-B220-PE was purchased from PharMingen (San Diego, 
CA). Both antibodies were titrated on unseparated B cell populations and the staining 
analysed on the FACScan to determine the optimal concentration for staining.
Methods
Colourimetric assay for titrating antibody concentration
To monitor the efficacy of T cell depleting antibodies a colourimetric assay was 
developed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT). 
Thymic lymphocytes (thymocytes) were used as the target cells. These cells were 
prepared by resecting thymi from mice and preparing single cell suspensions by pressing 
gently through stainless steel sieves. These cells were washed in CTM before use. The 
MTT assay was performed by preparing two-fold serial dilutions of antibody containing 
hybridoma sn across a 96 well round bottom microtitre plate in a final volume of 50 |al 
CTM (Nunc, Denmark). A total of 10^ thymocytes in CTM were then added to each 
well and the cells kept on ice for 30 minutes. The cells were then washed by 
centrifugation at 500 x g for 2 mins, and resuspension in 100 pi CTM. These cells were 
spun again and the sn removed. The pelleted thymocytes were resuspended in 100 pi of 
complement solution (see below), diluted in CTM and the cells incubated at 37°C for 30 
mins. Cells were then washed again and resuspended in 100 pi CTM. To each well 10 
pi of MTT solution was added and the plate incubated at 37°C for one hour. During the 
incubation an insoluble formazan precipitate is formed that is resuspended in 100 pi of 
isopropanol containing 0.04 M HC1. The optical density (OD) of each well was then 
read at a wavelength of 570 nm against a reference of 650 nm using a ThermoMAX® 
colourimetric plate reader (Molecular Devices, Palo Alto, CA).
Preparation of B cells
Mice were killed by CO2 asphyxiation, the spleens removed and placed in RPMI 
(Flepes) containing 10% FCS (RPMI/10% FCS). A single cell suspension was prepared 
by dispersing the spleens through a wire mesh. The spleen cells were washed by 
centrifugation at 500 x g for 5 mins and resuspended in RPMI/10% FCS. The cells 
were pelleted again and resuspended in 5 ml RBC lysis buffer / spleen. The cells were 
then washed again in RPMI/10% FCS and viable cell number counted by trypan blue 
exclusion using an improved Neubauer Haemocytometer (Germany). To remove 
adherent cells, the cells were then resuspended at 1 x 10^ viable cells / ml in RPMI 
(Flepes) containing 2% FCS and 10 ml aliquots placed in plastic petri dishes (Falcon 
1005, Becton and Dickinson, Palo Alto, CA). These petri dishes were incubated in a 
humidified atmosphere, at 37°C and 5% CO2 for one hour, to allow adherent cells to 
attach to the plastic. The non-adherent cells were recovered by rinsing the base of the
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petri dishes with 10 mis of warm RPMI/10% FCS/plate. Recovered cells were then 
washed twice in cold CTM, and the viable cell number determined by trypan blue 
exclusion.
To deplete T cells, splenic cells were resuspended at 10^ viable cells / ml in cold CTM, 
and a cocktail of anti-T cell antibodies (1/100 dilution of 30H-12, 1/5 dilution of 31M 
and 1/30 dilution of RL172) was added and left on ice. After 30 minutes the cells were 
washed twice, the cells counted and resuspended in CTM at 10^ viable cells/ml. 
Complement was then added and the cells incubated in a water bath at 37°C for 45 
minutes. Following the incubation, the cells were washed and resuspended in BCM.
The viable cell number was again determined by trypan blue exclusion. Unless 
otherwise stated the B cell population produced following this method was used in the 
experiments described in this thesis.
Flow cytometry
The purity of the unseparated B cell preparation was determined by flow cytometric 
analysis using a Becton and Dickinson FACScan (Palo Alto, CA). An aliquot of 
approximately 10^ cells were transferred into plastic 5 ml tubes (Falcon 2054, Becton 
and Dickinson, CA) and washed in sterile PBS containing 5% FCS (PBS/FCS). Cells 
were stained with 20 pi of phycoerythrin (PE) labelled anti-B220 antibody (RA3- 
6B2)(Coffman 1982) or a fluorescein isothiocyanate (F1TC) anti-B220 antibody 
conjugate diluted in PBS / 5% FCS. The cells were incubated on ice for 30 minutes, 
after which time they were underlaid by pasteur pipette with 300 pi of HI FCS and 
washed in 1 ml of cold PBS/5% FCS. The B cells were resuspended in 500 pi of 
PBS/FCS and kept on ice until analysis. Routine analysis of the unseparated B cell 
preparation revealed that it contained greater than 85% B220+ cells. Analysis of the data 
was conducted using CellQuest software (Becton and Dickinson) version 1 or 2.
Preparation of small and large B cells
When required, small and large B cells were prepared by separation on a percoll density 
gradient. A discontinuous percoll gradient was prepared by layering 2.5 mis of 75%, 
65% and 50% percoll in pre-cooled 15 ml centrifuge tubes (Falcon, Becton and 
Dickinson, Palo Alto, CA). Cells were then added to the percoll gradient in 2.5 mis of 
RPMI/10% FCS at a cell density of 2 x 10^ cells/ml. Gradients were then centrifuged at 
1835 x g for 25 minutes at 4°C, with the brake off. Large B cells were obtained from 
the interface between the 65% and 50% layers, whereas small dense B cells were 
obtained from the interface between the 65 and 75% layers. After recovery cells were 
washed in RPMI/10% FCS by centrifugation at 1322 x g at 4°C for five minutes. Cells
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were washed a further three times in BCM at 1101 x g at 4°C for five minutes. The 
viable cell number was determined by trypan blue exclusion.
3.3. Methods for monitoring B cell responses
Reagents
Antibodies : Goat anti-mouse IgM (galgM) antibody was purchased from Cappel (West 
Chester, PA, catalogue No. 0611-0201). Rat anti-mouse kappa antibody, 187.1 
(Gilligan et al., 1988), rat anti-mouse IgM antibody, 331.12 (Kincade et al., 1981) and 
mouse anti-mouse IgDa allotype antibody, AMS 15.1 (Stall and Loken 1984), and rat 
anti-ß galactosidase antibodies, GL113 and GL117 were prepared and purified by Ms S. 
Hwa Chin (JCSMR, Canberra). Purified rat anti-mouse IgM antibody, BET-2 (Kung et 
al., 1981), mouse anti-mouse IgD antibody, AMS9.1 (Stall et al., 1984) and rat anti­
mouse FcyRIIB, 2.4G2, were gifts from Dr P. Lalor (WEHI, Melbourne). Purified rat 
anti-mouse IgD, 1.19 (Julius et a l, 1984), and rat anti-mouse IgM, B7.6 (Brines and 
Klaus 1992), were prepared and purified by Dr J. Hasbold (Centenary Institute, 
Sydney). Rabbit anti-mouse IgG antibody and its F(ab’)2 fragment were purchased 
from Serotec (Oxford, UK. catalogue Nos. STAR37 and STAR8B, respectively).
The GL113 and GL117 were used as rat IgGl and IgG2a isotype controls, respectively.
Sheep anti-mouse Ig antibody (salg) and sheep anti-mouse Ig antibody coupled to horse 
radish peroxidase (salg-HRP) were obtained from Silenus (Melbourne, Victoria - 
catalogue No. BE23A and PD12F, respectively). Sheep anti-mouse total Ig antibody 
coupled to alkaline phosphatase (salg-AP) was purchased from Silenus (Melbourne, 
Victoria - catalogue No. DAP) and used at a final concentration of 1 ftg/ml. Prior to use 
salg was stored at -20°C, whereas salg-HRP and salg-AP were stored at 4°C.
The hybridoma cells for 187.1, 331.12 and AMS15.1 were a gift from Dr P. Lalor 
(WEHI, Melbourne), whereas the hybridomas for 1.19 and B7.6 were provided by Dr 
G. Klaus (National Institute for Medical Research, Mill Hill, UK). The hybridomas for 
GL113 and GL117 antibody were provided by Dr J. Abrams (DNAX, Palo Alto, CA).
Cyclosporin A (CsA): CsA was a gift from the Sandoz Pharmaceuticals Corporation 
(Switzerland). A 1 mg/ml stock solution of CsA stock was prepared in dimethyl 
sulfoxide (DMSO) and stored at -20°C.
LPS: LPS isolated by phenol extraction from Salmonella typhosa was obtained from 
Sigma (St Louis, MO.). LPS was dissolved in BCM, the solution sterilised by filtration
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through 0.2 pm membranes and stored at 4°C. This mode of sterilisation was compared 
to boiling and UV irradiation and was found to yield LPS preparations with equivalent 
potency (personal communication, Dr Hodgkin. Centenary Institute, Sydney).
IL-4: Recombinant murine IL-4 expressed in Escherichia coli and purified by affinity 
chromatography using the anti-IL-4 antibody, 11B11 (Ohara and Paul 1985), was a 
generous gift from Dr R. Kastelein (DNAX, Palo Alto).
Ficoll and TNP-Ficoll: Ficoll-400 was obtained from Pharmacia (Uppsalla, Sweden).
A 20 mg/ml stock solution of Ficoll-400 was prepared in BCM and sterilised by filtration 
through 0.2 pm membranes. Ficoll haptenated with TNP (TNP-Ficoll) was a gift from 
Dr P. Lalor (WEHI, Melbourne).Ficoll solutions were stored at 4°C.
PMA: PMA was purchased from Sigma (St Louis, MO). A 10 pg/ml stock solution 
was prepared in double distilled water and sterilised by filtration through 0.2 pm 
membranes. The stock solution was stored at -20°C until required.
All solutions were diluted to the desired concentration in BCM immediately prior to use.
-^ H-Thvmidine: ^H-methyl 1,2, thymidine at 1 mCi/ml was obtained from Amersham, 
(Uppsala, Sweden - catalogue No. TRK565) or ICN Pharmaceuticals Inc (Costa Mesa, 
CA. - catalogue No. 2404205). A stock solution, prepared by making a 1/20 dilution of 
the ^H-thymidine concentrate in BCM, was stored at 4°C.
Carbonate Buffer: 0.02 M Na2CÜ3 and 0.076 M NaHCOß, pH 9.1.
Acetate buffer: 0.05 M sodium acetate, pH 5.0.
PBS Tween-20 (PBS/T): PBS containing 0.05% Tween 20 (Sigma, St Louis, MO.) 
PBS/T-BSA: PBS/T containing 1%.
The carbonate, and acetate buffers and PBS/T-BSA were sterilised by passage through 
0.2 pm membranes and kept at 4°C, whereas PBS/T was stored at room temperature.
Horseradish peroxidase (HRP) substrate: 25 mg of 3-amino-9-ethylcarbazole (AEC) 
was dissolved in 2 mis of dimethyl formamide (DMF). The AEC solution was then 
added to 10 mis of 0.05 M acetate buffer, and filtered through a 0.2 pm membrane to 
remove the precipitate. This solution was diluted with 85 mis of acetate buffer, to which
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40 pi of 30% H2O2 had been added. The HRP substrate was kept in the dark at 4°C 
and used within one week.
Alkaline Phosphatase (AP) substrate: 15 mg of 5-bromo-4-chloro-3-indoylphosphate 
toluidine (BCIP) and 30 mg of p-nitroblue tetrazolium chloride (NBT) were dissolved in 
1 ml of DMF. This solution was immediately diluted in a 100 mis of buffer containing 
0.1 M NaHCC>3 and 1 mM MgCl2, pH 9.8. The AP substrate could be kept at 4°C in 
the dark for up to a week.
TNP-BSA: TNP was conjugated to BSA resulting in a conjugation ratio of 16 TNP : 1 
BSA (TNP16-BSA). This reagent was prepared and provided by Dr P. Lalor (WEHI, 
Melbourne). The TNP-BSA conjugate was used as a coat for ELISpot assays to 
determine the number of anti-TNP ASCs. This solution was stored in the dark at 4°C.
ELISpot plates: In all ELISpot assays Millipore microtiter 96-well filtration plates 
(Germany, catalogue No. STHA09610) were used.
Methods
Measuring B cell proliferation
B cell proliferation was determined by ^H-thymidine incorporation over a 4 hr pulse. In 
a typical experiment, B cells were diluted to the desired starting cell density in BCM, and 
placed in 96-well flat-bottom plates (Nunc, Denmark) to a final volume of 200 pl/well. 
The B cells were incubated in a humidified atmosphere at 37°C and 5% CO2. After the 
desired incubation period, 20 pi of ^H-thymidine in BCM, containing 1 pCi, was added 
to each well. The plates were then incubated for a further 4 hours at 37°C. After the 
second incubation, plates were harvested by a 96-well cell harvester (Pharmacia Wallac 
1295-004 Betaplate^M _ Turku, Finland) which transferred the cells of each well to 
glass fibre filter mats (Pharmacia Wallac, Turku, Finland). These filter mats were then 
dried in an oven and, once dry, the filters were placed in bags and scintillant added. The 
bags were then sealed and the level of ^H-thymidine incorporation per well determined 
in a BetaplateTM liquid scintillation counter (Pharmacia Wallac 1205, Turku, Finland).
Measuring antibody production using an ELISpot assay
The number of antibody secreting cells was determined by a modified ELISpot assay 
based on the assay, originally described by Sedgwick and Holt (1983) (Sedgwick and 
Holt 1983). B cells were cultured in BCM, under various experimental conditions, at a 
starting cell density of 5 x 10^ cells/well in 96-well flat-bottom microtitre plates and a 
final volume of 200 pl/well. The B cells were incubated in a humidified atmosphere at 
37°C and 5% CO2. After the desired incubation period cells were harvested and
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transferred into fresh 96-well round-bottom plates and washed twice in BCM (Nunc, 
Denmark) by centrifugation . The cells were then counted and diluted to the desired 
density in BCM, and transferred into ELISpot plates. These ELISpot plates were coated 
with 100 plAvell salg or TNP-BSA in carbonate buffer and incubated overnight at 4°C. 
The following day the coat solution was flicked out and the plates blocked with 200 
plAvell of PBS containing 2% FCS for an hour at 37°C. Wells were then washed three 
times in 200 pi PBS. Once transferred, to ELISpot plates the cells were placed in a CO2 
incubator at 37°C, and left undisturbed for 4 hr. After incubation the fluid in the well 
was flicked out of the wells, and the plates washed three times with PBS, and three 
times with PBS/T. The plates were blotted dry and then processed for spot formation by 
adding 100 pi of salg-HRP or salg-AP in PBS/T-BSA to each well, and the plates left 
overnight at 4°C. The following day plates were washed four times with PBS. After 
washing 100 pl/well of the appropriate HRP or AP substrate was added to each well. 
The plates were then monitored for the formation of spots. The reaction was stopped by 
washing the plates thoroughly in tap water. Plates were allowed to dry on the bench and 
the number of spots per well counted using a low power microscope.
Chapter 4
An alternate view of 
B cell responses to LPS: 
The absence of high dose 
paralysis
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4.1. Introduction
Coutinho and Möller's concept of a non-specific B cell activating signal (1975d) has 
been borne out by experiments which revealed that in the absence of an antigen signal, 
activated T cell membranes, or the interaction between CD40 and its ligand, was 
sufficient to stimulate B cell proliferation and, in combination with Th type-2 
lymphokines, antibody secretion (Brian 1988, Hodgkin et a i, 1991b, Kehry et a l,
1992, Noelle et al., 1992a, Noelle et al., 1992b, Armitage et al., 1993, Spriggs et al., 
1993). However, the proposed non-signalling role for slg has not withstood the test of 
time. It is now clear that slg can mediate transmembrane and intracellular signals 
(reviewed in Cambier et al., 1990, Cambier et al., 1992, Reth 1992, Cambier et al., 
1994, DeFranco 1997) and that these signals play subtle and variable roles in the 
regulation of B cell behaviour that are dependent on the type of B cell activator and the 
differentiation state of the cell (Andersson et al., 1974, Kishimoto et al., 1975, 
Brunswick et al., 1988, Hasbold et al., 1990, Peganha et al., 1991, Brines et al., 1992, 
Grandien et al., 1993, Parry et al., 1994a, Snapper et al., 1995a). In chapter 2 a 
hypothesis is described which attempts to reconcile the one signal model with slg- 
mediated signalling. This hypothesis suggests that the antigen signal may have played a 
role in the generation of bell-shaped dose response curves for LPS-induced antigen- 
specific ASC formation that formed the basis of the original one signal theory (Mamchak 
and Hodgkin 1995). This chapter experimentally re-examines two important 
conclusions of Coutinho and Möller (1975d); the inhibitory nature of high doses of LPS, 
and the lack of any role for slg-mediated signalling in the anti-hapten response.
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4.2. Results
4.2.1. Dose response curves for LPS-induced ASC formation do not 
provide evidence of high dose paralysis
To examine the parameters under which stimulation with LPS generated bell-shaped 
dose response curves, B cells were cultured in media containing LPS under varying 
culture conditions. The variables explored were: dose, time in culture, starting cell 
population, ^H-TdR incorporation, and the generation of ASCs. The initial experiment 
was performed using a B cell population prepared from spleen cells that had been 
depleted of RBCs, adherent cells and T cells. After 3 days in culture, B cell 
differentiation into ASCs was apparent at very low concentrations (10 ng/ml) of LPS, 
and the number of ASC increased in a dose-dependent manner up to 30 pg/ml (Figure 
4.1 A). However, at higher concentrations of LPS a small decline in the number of 
ASCs was observed (Figure 4.1 A). The dose response curve obtained on day 4 
resembled that from the previous day, with the exception that the maximal response 
occurred at a lower dose (1 pg/ml) of LPS (Figure 4. IB). As before, there was a 
modest reduction in the number of ASCs at high (10-1000 pg/ml) concentrations of LPS 
(Figure 4 .IB). On day 5, the dose-response curve differed from that seen on the 
previous two days (Figure 4.1C). While the maximal response occurred at 1 |ig/ml, 
there was no decline in ASC number at high doses of LPS (Figure 4.1C). An additional 
feature of LPS-induced ASC formation was that the total number of ASCs increased 
over time. Thus, the maximal response on day 5 represented a 33% increase over that 
obtained on day 3 (Figure 4.1A-C).
4.2.2. The dose response curve for LPS-induced proliferation is 
dependent on the time of assay
In conjunction with measuring LPS-induced ASC formation, the pattern of proliferation 
was also determined (Figure 4.1D-F). After 3 days the dose response curve for LPS- 
induced proliferation appeared to be conventional, where the level of ^H-TdR 
incorporation corresponded to dose (Figure 4.1D). The following day the apparently 
simple relationship between LPS dose and ^H-TdR incorporation had deteriorated 
(Figure 4. IE). In contrast, to the results obtained on day 3, the day 4 dose response 
curve had a biphasic pattern, with peaks of ^H-TdR incorporation occurring at 20 ng/ml 
and 1 mg/ml (Figure 4. IE). This biphasic pattern of response was also evident on day 5 
(Figure 4. IF). Further, unlike the increase in LPS-induced ASC number between days 
3 to 5, the overall level of ^H-TdR incorporation decreased with time (Figure 4.1D-F).
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The results illustrated in Figure 4.1 do not support Coutinho and Möller’s (1975d) tenet 
of high dose paralysis by LPS. Instead they suggest that B eell differentiation may he 
delayed at high doses of LPS but will occur late in the time course. However, it is 
possible that the discrepancy between these results and those described by Coutinho and 
Möller (1974a/b, 1975a) were the product of using different starting cell populations.
To eliminate this possibility the experiment described in Figure 4.1 was repeated using 
RBC depleted spleen cells in an attempt to better approximate the culture conditions 
originally used by Coutinho and Möller (Coutinho et al., 1973, Coutinho et al., 1974a).
4.2.3. The dose response curves for LPS stimulation of RBC depleted 
spleen cells do not show evidence of high dose paralysis
In cultures containing RBC depleted spleen cell, LPS-induced ASC, were detected after 
48 hours in culture, however, the down turn in ASC number at high doses of LPS 
illustrated in Figure 4.1, panels A and B, was not evident (Figure 4.2B, inset). Instead 
there was a dose-dependent increase in the number of ASCs with the maximal response 
forming a plateau that extended over a two log increase in LPS concentration (Figure 
4.2B). The dose response curve obtained on the following day was similar to that 
obtained on day 2, with the exception that the overall number of ASCs had increased by 
approximately ten fold (Figure 4.2C). Finally, on day 4 while the number of ASCs was 
almost identical to that seen on the preceding day at LPS doses below 100 fig/ml, at 
higher concentrations the number of ASCs had increased by two fold over that observed 
on day 3 (Figure 4.2C and D).
4.2.4. The dose response curves for LPS-induced 3H-TdR incorporation 
indicate that proliferation precedes differentiation to ASCs
As before, the level of proliferation of RBC deleted spleen cells was also determined 
(Figure 4.2E-H). In contrast to LPS-induced ASC formation, proliferation was above 
the background at all LPS concentrations after only 24 hrs (Figure 4.2E). On day 2, the 
level of ^H-TdR incorporation had increased, generating a dose response curve where 
proliferation was proportional to dose below 6|ig/ml and at higher concentrations the 
level of ^H-TdR incorporation formed a plateau (Figure 4.2F). On the following day the 
overall level of proliferation had declined (Figure 4.2G), and by day 4 it had almost 
returned to background with the exception of cultures containing 1 mg/ml LPS. In these 
cultures the level of ^H-TdR incorporation was still approximately twice that obtained at 
lower doses (Figure 4.2H).
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Figure 4.2. High doses of LPS do not induce B cell paralysis.
Spleen cells were obtained from CBA/H mice and depleted of RBCs, as described in section 3.2. These
cells were then cultured in BCM (10^ cells / 200(4.1 well) containing varying concentrations of LPS as 
described in Figure 4.2. Panels A-D illustrate the results obtained for ASC formation as measured by 
Elispot assay ( ■  ), whereas panels E-G show the pattern of proliferation as determined by 3H-TdR 
incorporation assay ( O )• For both ASC formation and 3H-TdR incorporation the results are plotted using
the same scale to allow direct comparison of the data obtained on different days. Both the Elispot and 3H- 
TdR incorporation assays were performed as described in chapter 3. Inset in panel B shows the detail of 
the LPS-induced ASC response on day 2. The data illustrated represent the mean of triplicate cultures ± 1 
x SEM. Background proliferation ( #  ) and ASC formation ( □  ) are indicated.
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Although there are a number of differences between the dose response curves for ASC 
formation illustrated in Figures 4.1 and 4.2 neither set of data provides evidence of 
obligatory high dose paralysis as described by Coutinho and Möller (1975d). Instead 
these data suggest that B cell differentiation into ASCs was commensurate with the level 
of stimulation by LPS. However, at very high doses of LPS there appears be a slight 
delay in this response in cultures containing the more purified B cell population (Figure 
4.1A and B). This delay in B cell differentiation was not apparent in the dose response 
curves for B cell proliferation (Figures 4.1 and 4.2). Finally, a comparison of the 
results obtained for proliferation and ASC formation indicate that LPS-induced B cell 
proliferation precedes differentiation, and that ASCs persist in culture without dividing.
4.2.5. Dose response curves for LPS-induced proliferation are 
influenced by the starting cell density and the time of assay 
An obvious difference between the two experiments, illustrated in Figures 4.1 and 4.2, 
was the shape of the dose response curves obtained for proliferation. As both 
experiments were conducted under similar culture conditions it is possible that the 
variation between the two experiments was due to differences in the cell population and / 
or starting cell densities between the two experiments. A simple experiment to determine 
if differences in the two cell populations were responsible for the variation in pattern 
proliferation LPS-induced proliferation of RBC depleted spleen cells and B cells using 
the same starting cell density (Figure 4.3). The results obtained from this experiment 
demonstrated that the two cell populations generated virtually identical dose response 
curves and displayed the same pattern of behaviour as illustrated in Figure 4 .1D-F. 
Therefore, it would appear that the differences between the dose response curves for 
proliferation illustrated in Figures 4.1 and 4.2 were a reflection of the starting cell 
densities used in the two experiments. The influence of cell density on LPS-induced 
proliferation was previously observed by Andersson et al., (1978) and Melchers et ai, 
(1975b). Given the similarity in the dose response curves of RBC depleted spleen cells 
and the more purified B cell population it was decided to use the second population in 
subsequent experiments in order to reduce the influence of other cell types in the B cell 
response to LPS.
To further examine the role of starting cell density in generating the complex dose 
response curves for LPS-induced proliferation B cells were cultured at different starting 
cell densities and ^H-TdR incorporation measured over a number of days. As illustrated 
in Figure 4.4, the shape of the dose response curve was affected by both the starting cell 
density and the time of harvest. One of the most notable general features was that early 
in culture (days 1 and 2) the level of ^H-TdR incorporation at each starting cell density
cp
m
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Figure 4.3. RBC depleted spleen cells and B cells produce identical dose 
response curves for LPS-induced proliferation.
This figure compares the dose response curves obtained for LPS-induced 
proliferation of RBC depleted spleen cells ( 0  ) and B cells ( O X prepared as 
described in section 3.3.2. In this experiment cells were cultured in BCM ( 5 x
104 cells / 200 |il well) containing varying concentrations of LPS, and the level
of proliferation measured by ^H-TdR incorporation assay, as described in 
chapter 3. The data illustrated represents the mean of triplicate cultures ± 1 x 
SEM. Background proliferation (— —) is indicated.
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Figure 4.4. The dose response curve for LPS-induced B cell proliferation is dependent on 
the starting cell density and time of assay.
B cells were prepared as described in section 3.2 and cultured at different starting cell densities 
(10^ ( O ); 5 x 10^ ( ■ ); 2.5 x 10  ^( □  ) / 200 (il well) in BCM containing varying concentrations 
of LPS. At the time point indicated, proliferation was measured by ^H-TdR incorporation as 
described in chapter 3. To allow direct comparison between days, the data were plotted on the 
same scale. The inset in panel A shows the detail of B cell proliferation on day 1. The data 
illustrated represent the mean of triplicate cultures ± 1 x SEM.
Background proliferation: 10^ ( •  ); 5 x IO"* ( A ); 2.5 x 10^ ( A ) are indicated.
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was conventional, producing a dose-dependent increase in proliferation up to 10 pg/ml 
and forming a plateau at higher concentrations (Figure 4.4A and B). However, in 
cultures containing the highest dose of LPS (1 mg/ml) ^H-TdR incoiporation was 
slightly reduced (Figure 4.4B). Taken in isolation this feature might be interpreted as 
high dose inhibition by LPS, however, on subsequent days the level of ^H-TdR 
incorporation at 1 mg/ml was quite high, revealing a small lag in the response similar to 
that observed for ASC formation (Figure 4.1A-C) rather than complete inhibition (Figure 
4.4D and E). The other feature of note was that by days 3 and 4 the overall level of ^H- 
TdR incorporation had peaked, and the proportional relationship between starting cell 
number and proliferation had deteriorated (Figure 4.4C and D). Thus, on day 4 the 
overall level of ^H-TdR incorporation had declined, and the highest level of proliferation 
was obtained in cultures containing low to moderate starting cell densities (Figure 4.4D). 
The effect of these kinetics combined with the delayed response at the very high 
concentrations was to create a series of complex wave like curves that could be either 
bell-shaped, biphasic or essentially linear (Figure 4.4).
4.2.6. LPS-induced B cell proliferation depletes the media of essential 
nutrients, which causes a decline in 3H-TdR incorporation 
Although the LPS dose response curves appear complex, a relatively simple explanation 
of the kinetic changes observed for ^H-TdR incorporation in Figures 4.1 to 4.4, was 
that LPS stimulated B cells will grow to a limit set by the culture conditions. Hence, 
lower LPS concentrations, or reduced starting cell number would allow this limit to be 
reached later in culture, generating the wave-like features of the response curves (Figure 
4.4C-E). An alternative explanation was the generation of suppressor cells and / or 
cellular interactions which elicit different outcomes depending on the initial culture 
conditions. These two possibilities can be easily be distinguished by replenishing the 
media in which B cells are growing. The first hypothesis predicts that replenishing the 
medium would prolong B cell proliferation, whereas the second suggests that cell 
interactions are responsible and that media replacement will have no effect. To determine 
which of the two alternatives was correct, LPS-induced proliferation was measured in 
matched B cell cultures where the media was replenished with fresh media containing the 
starting concentration of LPS at 12 hourly intervals in one set of cultures but not in the 
other (Figure 4.5). Both the control (no replenishment) and the experimental culture 
generated almost identical dose response curves for the first 72 hrs (Figure 4.5), 
indicating that the media was not limiting proliferation during these early time points. 
However, after 72 hrs, the level of ^H-TdR incorporation in the control cultures declined 
to the background level over a period of 48 hrs (Figure 4.5). In contrast, in cultures 
which had received fresh media, the level of proliferation remained well above the
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Figure 4.5. Regular media replenishment prolongs 
LPS-induced B cell proliferation.
B cells were prepared as described in 3.2 and cultured in BCM (5
x 104 cells / 200 pi well) containing LPS (50 pg/ml). At 12 hourly 
intervals half the media was removed and replaced with fresh BCM 
containing 50pg/ml LPS ( 0  ). Replicate B cell cultures were 
prepared but remained undisturbed for the duration of the assay 
( O ). The response of control B cell cultures prepared and incubated 
in the absence of LPS and subjected to the same experimental regime 
are shown (media replenished - I  , undisturbed - □  ). At the time
points indicated B cell proliferation was measured by ^H-TdR 
incorporation as described in chapter 3. The data illustrated 
represent the mean of triplicate cultures ± 1 x SEM.
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background for the duration of the assay (Figure 4.5). These results are consistent with 
the premise that depletion of the media in high density cultures leads to an inability to 
maintain proliferation beyond day 3.
The experiment illustrated in Figure 4.5 indicated that replenishment of cultures with 
media containing LPS could prolong B cell proliferation. Before drawing a conclusion 
however, it was important to show that the prolonged ^H-TdR uptake in cultures in 
which the media had been replenished was not due to the provision of fresh LPS. The 
argument could be made that the LPS was depleted in the control cultures, and therefore 
at late times the two culture groups were not receiving the same level of stimulation. To 
distinguish between these two possibilities, B cells were cultured in media which 
contained LPS and the supernatants from these cultures harvested and stored after 2 to 4 
days. Fresh B cells were prepared and cultured in new media, or in the previously 
harvested supernatants to which LPS had been added. As illustrated in Figure 4.6 each 
of the cultures generated the same pattern of proliferation over time, where ^H-TdR 
incorporation reached a peak on day 2. Importantly, the level of ^H-TdR uptake was 
inversely proportional to the length of time cells had originally been grown in the 
supernatant (Figure 4.6). As the level of LPS would be the same, or greater, in the 
cultured supernatant than in fresh media these results discount the possibility that 
consumption of LPS was responsible for the down turn in proliferation. Instead they 
indicate that the depletion of media components caused the rapid reduction in ^H-TdR 
uptake after 72 hours (Figure 4.6).
4.2.7. The role of the antigen signal in altering LPS-induced antigen- 
specific antibody production
The observation that LPS-induced paralysis was not obligatory contradicted the 
conclusion reached by Coutinho and Möller (Coutinho et a i, 1975), and raised a 
question about the B cell response to LPS. If LPS does not induce B cell paralysis at 
high concentrations, what was the cause of the bell-shaped dose response curves 
observed by Coutinho and Möller (1975d) for ASC formation? The results illustrated in 
Figures 4.5 and 4.6 suggest that depletion of the media results in a decline in LPS- 
induced B cell proliferation. Although the down turn in LPS-induced proliferation did 
not correspond with a decline in ASC numbers under the culture conditions described in 
this chapter (Figures 4.1 and 4.2), it is possible that under the culture conditions 
employed by Coutinho and Möller media depletion may have played a role in the 
generation of their bell-shaped dose response curves. Alternatively their preparation of 
LPS could have contained toxic contaminants which at high doses of LPS were 
sufficient to inhibit B cell differentiation. However, neither media depletion nor toxic
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Figure 4.6. Depletion of the media results in a reduction in LPS- 
induced B cell proliferation.
B cells were prepared as described in section 3.2 and cultured (5 x 
105 cells/ml) in BCM containing LPS (50 pg/ml). The supernatants 
from these cultures were harvested on days 2, 3 and 4 and stored. Fresh 
B cells were prepared and cultured (5 x 10^ cells / 200pl well) in either 
BCM ( □  ) or the previously harvested supernatants (day 2 - I  , day 
3 - O  , and day 4 - % ) in the presence of LPS (50 pg/ml). The level 
of proliferation in these cultures was measured over a number of days
by -^H-TdR incorporation as described in chapter 3. The data illustrated 
represent the mean of triplicate cultures ± 1 x SEM. The background 
cpm for cells only is indicated ( EÜ3 ).
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contaminants would account for the down turn in the number of LPS-induced antigen- 
specific ASCs observed by Coutinho and Möller (Coutinho et a l, 1974a) at much lower 
overall LPS concentrations. As the number of cells involved in an antigen-specific 
response would be small, their rapid proliferation would not deplete the culture media 
sufficiently to cause the decline in antigen-specific ASCs. In addition, as the down turn 
in antigen-specific ASC numbers occurred at low doses of hapten-LPS it is unlikely that 
contaminants in Coutinho and Möller’s LPS preparation would have caused the 
inhibition of this response. An alternative explanation for the antigen-specific response 
has been proposed which suggests that the a slg-mediated (antigen) signal could inhibit 
LPS-induced antigen-specific ASC formation (Mamchak etal., 1995). This hypothesis 
predicts that the cross-linking of slg by a hapten coupled to a non-mitogenic carrier 
would induce a signal which could inhibit LPS-induced antigen-specific ASC formation 
in a manner similar to that postulated in chapter 2 for haptenated-LPS. In contrast, 
Coutinho and Möller's one signal model suggests that such a reagent would not 
influence the anti-hapten response (Coutinho et a l, 1975, Möller et al., 1975). To test 
the alternative hypothesis, B cells were cultured with LPS in the presence of TNP-Ficoll 
to provide a slg-mediated signal, and the number of anti-TNP ASCs measured.
4.2.8. Ficoll does not alter LPS-induced B cell proliferation or ASC 
formation
Prior to using TNP-Ficoll to determine its effect on LPS-induced anti-TNP ASC 
formation, it was necessary to determine if Ficoll alone had any effect on B cell 
behaviour. As illustrated in Figure 4.7 Ficoll did not induce proliferation above the 
background and had only a slight inhibitory effect on LPS-induced proliferation, 
whereas TNP-Ficoll had virtually no effect on LPS-induced B cell proliferation (Figure 
4.7). These results indicated that Ficoll was non-mitogenic and did not significantly alter 
LPS-induced proliferation. Next the effect of Ficoll on TNP-specific ASC formation 
was determined. A proportion of LPS stimulated B cells secrete antibodies that bind to 
TNP-BSA coated ELISpot plates (Figure 4.8). Increasing the coat concentration of 
TNP-BSA allows for more positive cells to be detected, presumably as the affinity cut 
off of detection is lowered. The addition of concentrations of Ficoll up to 5jig/ml did not 
affect the generation of TNP-BSA specific ASCs in culture (Figure 4.8).
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Figure 4.7. The effect of Ficoll on B cell proliferation.
B cells were prepared as described in section 3.2 and cultured in
BCM (5 x 104 cells / 200 pi well) containing Ficoll (5pg/ml) alone, 
or in combination with LPS (50pg/ml). Similar cultures were also 
prepared which contained TNP-Ficoll (5pg/ml) and LPS. After 3
days B cell proliferation was measured by ^H-TdR incorporation as 
described in chapter 3. The inset shows the detail of the 
background proliferation and that induced by Ficoll alone. The 
data illustrated represent the mean of triplicate cultures ± 1 x SEM.
The absence of LPS-induced high dose paralysis. 57
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Figure 4.8. Ficoll does not alter LPS-induced antigen-specific
ASC formation.
B cells were prepared as described in section 3.2 and cultured in 
BCM (5 x 10^ cells / 200 pi well) containing 50 pg/ml LPS alone 
( ®  ), or in combination with three different concentrations of Ficoll (5 
- □  , 0 . 5 - 0  , and 0.05 pg/ml - |  ). After 3 days the cells were
transferred to Elispot plates which had previously been coated with 
varying concentrations of TNP-BSA. The use of different TNP-BSA 
concentrations to coat Elispot plates made it possible to determine the 
effect of Ficoll on the LPS-induced formation of anti-TNP ASCs of
different affinities. The number of anti-TNP ASCs was then 
determined by Elispot assay as described in chapter 3. Background: 
cells only ( 9  ); Ficoll only: 5 pg/ml ( E3 ); 0.5 pg/ml ( □  ); and 
0.05 pg/ml ( ®) are indicated. The data illustrated represent the mean 
of triplicate cultures ± 1 x SEM, with the anti-BSA response subtracted.
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4.2.9. TNP-Ficoll  inhibits  the format ion  o f  LPS-induced antigen-  
specific ASCs
Having shown that Ficoll was a suitable non-mitogenic non-inhibitory matrix for 
haptenation, the effect of TNP-Ficoll on the LPS-induced anti-TNP response was 
determined (Figure 4.9). As before, the presence of Ficoll in B cell cultures containing 
LPS did not inhibit the formation of anti-TNP ASCs (Figure 4.9). In contrast, the 
addition of TNP-Ficoll to LPS-stimulated B cell cultures resulted in a dose-dependent 
decline in the number of antigen-specific ASCs (Figure 4.9). At a TNP-BSA coat 
concentration of 1 pg/ml the detectable number of anti-TNP ASCs was much lower than 
observed at higher coat concentrations which may reflect the small number of high 
affinity anti-TNP ASCs induced by LPS (Figure 4.9). However, the inhibition of anti- 
TNP ASC formation by TNP-Ficoll was still evident even at low TNP-BSA 
concentrations (Figure 4.9C). These results support the hypothesis that a slg-mediated 
signal can induce a decline in the number of LPS-induced hapten-specific ASCs.
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4.3. Discussion
The experiments described in this chapter were initially designed to reproduce the bell 
shaped dose response curves described by Coutinho and Möller (1994b) for LPS- 
induced ASC formation. However, they revealed that high doses LPS did not induce 
obligatory paralysis, although they could, under certain circumstances, cause a delay in 
B cell differentiation (Figure 4.1). Given the absence of LPS-induced paralysis the 
down turn in ASC number described by Coutinho and Möller (1994b) must have been 
due to some other cause. As described in chapter 2, the decline in the number of LPS- 
induced antigen-specific ASCs may have been due to the antigen signal, and the results 
illustrated in Figure 4.9 support this hypothesis. In addition, the results described in this 
chapter reveal that LPS can induce complex patterns of B cell proliferation (Figures 4.1 
and 4.4).
4.3.1. The complex pattern of LPS-induced proliferation conforms to a 
relatively simple model
Despite the apparent complexity of the dose response curves for LPS-induced B cell 
proliferation it was possible to generate similar curves through a relatively simple model. 
The wavelike features of the experimentally derived dose response curves can be 
explained as a combination of two independent patterns of proliferation. Figure 4 .10A, 
illustrates the expected changes in dose response curves with time of a cell with 
unlimited growth potential responding in conventional fashion to a titrated stimulus. At 
early time points the response will yield a typical sigmoidal curve with a plateau region 
of optimal stimulation (Figure 4 .10A). With time the proliferating cells will deplete the 
culture media, and the rate of growth will slow and begin to fall (Figure 4 .10A). Cells 
containing less stimulus will deplete the media more slowly, and will for a time contain a 
greater number of dividing cells (Figure 4 .10A). The utilisation of media generates a 
wave of bell curves, the peak of which occurs at lower concentrations with increasing 
time (Figure 4 .10A). Reducing the starting cell number would have the effect of 
lengthening the time it takes to reach the point of media depletion. As illustrated in 
Figures 4.5 and 4.6, the reduction in the rate of growth was due to depletion of the 
media and not to an intrinsic property of the B cells. The capacity of B cells to maintain 
prolonged growth if subcultured has previously been observed (Melchers et a i, 1975, 
Zauderer and Askonas 1976). As a first approximation of LPS-induced proliferation, 
the model illustrated in Figure 4.10A matches the observed B cell behaviour (Figures
4.1, 4.2 and 4.4). However, the experimental dose response curves exhibit an 
additional complexity. At very high concentrations of LPS (>1 mg/ml) the B cell 
response appears to be delayed (Figure 4.4). By altering the model of B cell 
proliferation in Figure 4 .10A by substituting the response at the highest LPS
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stimulus concentration
Figure 4.10. A model of B cell proliferation.
This figure depicts the expected dose response curves for two models of 
B cell growth. Panel A illustrates the predicted dose response curves 
over time for the proliferation of B cells with unlimited growth potential, 
where the cells are responding to the titrated stimulus in a conventional 
manner. Panel B shows the predicted dose response curves over time 
for the proliferation of B cells with unlimited growth potential, where 
high doses of the stimulus result in a delay in the response. Thus, the 
dose response curve for high concentrations of the stimulus (boxed 
section) in panel A has been used to replace the dose response curve for 
high concentrations of the stimulus of the following time interval in 
panel B.
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concentration (boxed section of curve) with that of the previous time interval, the delayed 
response can be incorporated into the model (Figure 4.10B). Through this method, 
complex dose curves were constructed (Figure 4 .10B), which contained the same wave­
like pattern of proliferation as observed experimentally (Figures 4.1 and 4.3). Thus, the 
combined effect of growth to a culture-imposed limit and a delayed response at very high 
concentrations of stimuli yields bell-shaped curves for proliferation of two different 
types. One appears early in culture and is caused by the delayed response at high 
concentrations of LPS (Figure 4.10B). The other appears later and seems to be an 
artefact of high density culture (Figure 4.10A).
4.3.2. Speculation on the cause of bell-shaped dose response curves for 
LPS-induced polyclonal ASC formation
Although the results obtained for LPS-induced B cell proliferation may be explained by a 
combination of media depletion and a delayed response at high doses of LPS, the bell­
shaped curves described for polyclonal ASC formation (Andersson et al, 1972) are 
more difficult to account for. The results described in this chapter indicate that B cells 
proliferate prior to differentiating to ASCs (Figures 4.1 and 4.2). It is possible that in 
Coutinho and Möller’s experiments, which were conducted at very high starting cell 
density (10^ cells/ml) the rapid proliferation of so many cells at high doses of LPS 
depleted the media before the B cells could undergo sufficient rounds of division to 
differentiate. However, this proposition was not supported by results from an 
experiment which used the same cell density as Coutinho and Möller, in which the 
proliferative response waned rapidly, but the number of ASCs increased with time and 
did not show any evidence of high dose paralysis (data not shown). Alternatively, the 
down turn in the total ASC numbers could have been the result of toxic contaminants 
within Coutinho and Möller’s preparation of LPS. If the toxic contaminants were 
present at low concentrations they might only exert their inhibitory effect at high 
concentrations of LPS, thereby mimicking high dose paralysis. Finally the results 
illustrated in Figure 4.1, reveal that under appropriate culture conditions high doses of 
LPS can induce a small decline in the number of ASCs, which generates dose response 
curves that are reminiscent of the bell-shaped curves described by Coutinho and Möller 
(1994b). Taken in isolation such dose response curves may have led to the conclusion 
that high doses of LPS-induce B cell paralysis.
4.3.3. Previous work on LPS-induced B cell activation which is 
inconsistent with the principle of high dose paralysis
Close examination of some original papers on the B cell response to LPS also revealed 
variations in the shape of the dose response curve for ASC formation with time. In one 
experiment the dose response curve for LPS-induced anti-DNP ASC formation did not
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show any evidence of high dose paralysis after 24 hours in culture. Instead the dose 
response curve was conventional, with the number of ASCs being proportional to dose 
(Coutinho et al., 1973). In this experiment the anti-DNP response was representative of 
the total antibody response, as LPS was not conjugated to the hapten and therefore could 
not be focussed to the B cell surface by anti-DNP slg. In contrast to the results obtained 
on the previous day, the dose response curve for day 2 showed evidence of a down turn 
in ASC number at high doses (100 ftg/ml) of LPS (Coutinho et a l, 1973). In addition 
to the change in the shape of the dose response curve over time, the number of ASCs 
had increased at all LPS concentrations between the days 1 and 2 (Coutinho et al.,
1973). Taken in isolation, the day 2 dose response curve could be interpreted as 
evidence of high dose paralysis. However, when the results from both days are 
considered it is clear that the shape of the dose response curve was determined by the 
time of assay. Thus, although it was possible to generate bell-shaped dose response 
curves for LPS-induced ASC formation, the shape of the curve appeared to be due to the 
culture conditions and time of assay, rather than obligatory high dose paralysis. The 
results described in Figure 4.1 suggest that the effect of high concentrations of LPS is to 
delay B cell differentiation, which could be misinterpreted as LPS-induced paralysis if 
the data for a single day were taken in isolation, as Coutinho and Möller may have done.
In addition, Coutinho and Möller’s published data was not always consistent on the 
degree, or time of onset of paralysis (Andersson et al., 1972, Coutinho et al., 1974a, 
Coutinho et al., 1975), and some of the B cell responses they observed were 
inconsistent with the behaviour predicted by a model which invokes high dose paralysis 
by LPS. For example, Coutinho and Möller examined the effect of a combination of 
sub-optimal concentrations of DNP-LPS and LPS on the anti-DNP ASC response 
(Coutinho et al., 1975). According to Möller and Coutinho's one signal model, a high 
dose of LPS in combination with DNP-LPS should induce a more severe inhibition of 
the optimal anti-DNP response than a low dose of LPS in combination with DNP-LPS. 
However, a detailed examination of the data reveals that the converse was true (Coutinho 
et al., 1975). Although these results do not conform to the behaviour that would be 
predicted if high doses of LPS induced B cell paralysis, they are consistent with the 
hypothesis that slg-mediated signals inhibit LPS-induced antigen-specific ASC 
formation. Further, the results from more recent experiments in which B cells were 
coated with anti-TNP antibodies (which were not capable of inducing an intracellular 
signal) and stimulated with TNP-LPS produced evidence of slg-mediated focussing but 
not of the LPS-induced paralysis (Alarcon-Riquelme et al., 1990) which would have 
been expected to occur if the tenet of high dose paralysis were correct.
An alternate view of B cell responses to LPS: the absence of high dose paralysis 64
4.3.4. The antigen signal can inhibit LPS-induced differentiation o f  
antigen-specific B cells
So far, the discussion has focussed on the polyclonal response induced by LPS and the 
view that the down turn in the number of ASCs at high doses of LPS was not due to 
paralysis, but rather was the result of an artefact of the culture conditions. Although this 
hypothesis may account for the bell-shaped curves for the total ASC number it cannot 
explain the bell curves obtained for antigen-specific responses. An alternative 
explanation for the dose response curves for LPS-induced antigen-specific ASC 
formation was proposed in which slg-mediated signals inhibit LPS-induced B cell 
differentiation (Mamchak et al., 1995). This hypothesis was supported by the 
experimental results obtained with TNP-Ficoll (Figure 4.10). As the presence of Ficoll 
alone did not inhibit LPS-induced ASC formation, the inhibitory effects of TNP-Ficoll 
(Figure 4.9) were probably due to the interaction between TNP and anti-TNP-sIg. 
Further support for the inhibitory role of slg-mediated signals can be obtained from the 
experiments in which B cells were stimulated with a combination of anti-Ig antibodies 
and LPS. In these experiments anti-Ig antibodies, or their F(ab)2 fragments, inhibited 
LPS-induced ASC formation in a dose-dependent manner (Andersson et al., 1974, 
Kearney et al., 1976, Andersson et al., 1978, Kearney et al., 1978, Sidman and 
Unanue 1978). The conclusion that slg-mediated signals inhibit LPS-induced ASC 
formation is inconsistent with Coutinho and Möller's one signal model. However, it 
does present an explanation for their antigen-specific dose response curves which does 
not invoke LPS-induced paralysis and is consistent with a regulatory role for the antigen 
signal in limiting the affinity of T-independent antibody responses (Mamchak et al, 
1995). The potential for slg-mediated signals to regulate the B cell response to LPS is 
examined further in chapter 5.
Chapter 5
Surface Ig-mediates two 
signals with different 
thresholds of initiation and 
sensitivity to cyclosporin A
slg-mediates two signals which differ in their sensitivity to CsA 65
5.1. Introduction
In chapter 2 a model was proposed that argued the ability of anti-Ig reagents to inhibit 
LPS-induced ASC formation (Andersson et a i, 1974, Kearney et a i, 1976, Andersson 
et a l, 1978, Kearney et a i, 1978), was the result of slg-mediated signals which actively 
regulated the affinity of antibody produced following TI type-1 B cell activation 
(Mamchak et al., 1995). One way to distinguish experimentally between this model and 
that described by Coutinho and Möller (1975), which invokes high dose paralysis by 
LPS, was to induce an antigen signal in B cells stimulated with LPS in the presence an 
inhibitor of slg-mediated signalling. A possible candidate was CsA, as this drug has 
been shown in vitro to inhibit slg-mediated signals, but not LPS-induced B cell 
responses (Dongworth and Klaus 1982, O'Garra et al., 1986, Klaus 1988). If CsA 
inhibits slg- and not LPS-induced signalling then it could be used to determine whether 
antigen stimulation is responsible for the bell shaped dose response curves which have 
been described for LPS-induced ASC formation (Andersson et al., 1972, Coutinho et 
al., 1973, Coutinho et al., 1975) as predicted by Mamchak and Hodgkin (1995). To 
examine whether CsA could be used in this way, it was important to first show that this 
drug would prevent the ability of anti-Ig reagents to inhibit LPS-induced ASC formation 
as originally shown by Andersson et a i, (1974). This chapter describes the results of 
experiments designed to test this prediction.
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5.2. Results
5.2.1. Goat anti-mouse IgM (galgM) induces different effects on B cell 
proliferation which vary according to antibody dose
To explore the role of the antigen signal in TI type-1 activation, B cells were stimulated 
with a combination of LPS and galgM. The anti-Ig antibody was used to trigger a 
signal from slg, and LPS was used as a TI type-1 B cell activator. CsA, which has been 
shown to inhibit slg-, but not LPS- induced responses (Dongworth et al., 1982,
O'Garra et al, 1986, Klaus 1988) was used to block slg-mediated signals in these 
cultures. Incubation of B cells with high doses (10-20 |ig/ml) of galgM  resulted in 
proliferation above the background (Figure 5.1). However, an unexpected feature of the 
dose response curve was the inhibition of proliferation at low to moderate concentrations 
(1 ng -1 |ig/ml) of galgM (Figure 5.1). The inclusion of 40 ng/ml CsA in these cultures 
inhibited proliferation (Figure 5.1). This dose of CsA completely inhibited galgM- 
induced ^H-TdR incorporation, while having only a small inhibitory effect on LPS- 
induced proliferation (Figures 5.1 and 5.2). As higher concentrations of CsA resulted in 
the inhibition of the LPS-induced ^H-TdR incorporation, whereas lower doses did not 
completely inhibit the B cell response to galgM  (data not shown), a concentration of 40 
ng/ml of CsA was used in all subsequent experiments. Also noteworthy was that 
addition of CsA to unstimulated B cell cultures resulted in a significant (~7()%) 
inhibition of the background proliferation (Figures 5.1 and 5.2). These results 
demonstrate that galgM was able to induce a measurable slg-mediated signal which was 
sensitive to the action of CsA. Having determined the B cell response to galgM and 
CsA, it was possible to test the hypothesis that slg-mediated signals are involved in the 
regulation of LPS-induced antibody production.
5.2.2. Anti-Ig mediated inhibition of LPS-induced ASC formation is 
CsA insensitive
In B cell cultures containing galgM and LPS, the presence of the anti-Ig antibody 
strongly inhibited ASC formation (Figure 5.3), as previously described (Andersson et 
al, 1974, Kearney et al., 1976, Andersson et al, 1978, Kearney et al, 1978). Given 
the inhibitory effect of CsA on galgM-induced proliferation it was anticipated that CsA 
would block the anti-Ig mediated decline in ASC number. However, as illustrated in 
Figure 5.3, CsA had almost no effect on the galgM-mediated inhibition of LPS-induced 
formation of ASCs. In fact the addition of CsA to cultures containing galgM and LPS 
caused a slight further reduction in the overall number of ASCs (Figure 5.3). These 
results show that not all B cell behaviour in response to slg-mediated signalling was CsA 
sensitive, and that the plan to use this drug to address the role of the antigen signal in 
regulating the affinity of TI type-1 antibody responses could not be pursued.
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Figure 5.1. GalgM-induced B cell proliferation is inhibited by CsA.
B cells were cultured in BCM (5 x 10^ cells / 200 jil well), containing 
varying concentrations of galgM ( O ). Replicate cultures were also 
prepared which contained galgM and 40 ng/ml CsA ( #  ). Cells were
incubated in a humidified atmosphere at 37°C and 5% CO^. After 3
days B cell proliferation was measured by ^H-TdR incorporation as 
described in chapter 3. Background proliferation: cells only (□  ) and 
CsA only ( E3 ). The data illustrated represents the mean of triplicate 
cultures, expressed with 1 x SEM.
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Figure 5.2 CsA inhibits galgM- and not LPS-induced B cell
proliferation.
B cells were cultured as described in Figure 5.1, in the presence of 10 
pg/ml galgM or 50 pg/ml LPS ( □  ). Replicate cultures were prepared 
which contained CsA (40 ng/ml) in combination with LPS, or galgM
( □  ). After 3 days B cell proliferation was measured by ^H-TdR 
incorporation as described in chapter 3. Background proliferation: cells 
only ( □  ) and CsA only (■  ). The data illustrated represents the mean of 
triplicate cultures, expressed with 1 x SEM.
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Figure 5.3 GalgM inhibition of LPS-induced ASC formation is
CsA insensitive.
The total numbers of ASCs formed after B cells were cultured as 
described in Figure 5.1 in the presence of varying concentrations of 
galgM and 50 pg/ml LPS (□ ), or galgM, LPS and 40 ng/ml CsA (■ ), 
was determined by Elispot assay. After 3 days in culture the B cells were 
transferred to Elispot plates coated with sheep anti-mouse Ig and the 
Elispot assay performed as described in chpater 3. Background antibody 
production: LPS only ( O ), LPS and CsA ( •  ), and cells only ( 0  ). 
The data illustrated represents the mean of triplicate culture, expressed 
with 1 x SEM.
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5.2.3. GalgM  alters LPS-induced proliferation in two opposing ways 
which differ in their sensitivity to CsA
In addition to monitoring the generation of ASCs, the proliferation of B cells stimulated 
with LPS and galgM  was also measured in the presence and absence of CsA (Figure 
5.4). In these cultures galgM  altered LPS-induced proliferation in two apparently 
contradictory ways. As illustrated in Figure 5.4, low doses (< 1 fig/ml) of galgM  
inhibited LPS-induced ^H-TdR incorporation, whereas higher antibody concentrations 
induced a dose-dependent increase in proliferation. The addition of CsA to these 
cultures did not affect the low dose inhibition of proliferation by galgM, but did prevent 
the increase in ^H-TdR incorporation at high doses of antibody (Figure 5.4). 
Furthermore, in the presence of CsA inhibition of LPS-induced proliferation by galgM 
followed the same dose response curve as obtained for the reduction in ASC number 
(Figure 5.5). It was also of interest to note that the low concentrations of galgM which 
inhibited LPS-induced B cell proliferation, were similar to those which significantly 
reduced the level of spontaneous ^H-TdR incorporation (Figure 5.1). Thus, galgM 
appeared to induce two independent effects on B cells which were dependent on dose. 
Low concentrations of galgM  inhibited spontaneous or LPS-induced proliferation and 
ASC formation, whereas high antibody concentrations promoted proliferation while 
inhibiting LPS-induced B cell differentiation to ASCs.
5.2.4. LPS-induced proliferation is inhibited by PMA
The results obtained with galgM and CsA indicate that the two slg-mediated signals 
differ in their sensitivity to CsA, with the inhibitory signal being CsA insensitive, 
whereas the positive signal for growth was CsA sensitive (Figures 5.1 and 5.5). While 
the ability of CsA to inhibit B cell proliferation induced by cross-linking of slg was as 
expected (O'Garra et al., 1986, Klaus 1988), the presence of an addition CsA 
insensitive signal which inhibited proliferation and ASC formation was a surprise 
(Figure 5.5). The inability of CsA to block the slg-mediated inhibition of LPS-induced 
B cell activation provided a clue as to the identity of the intracellular signalling 
components involved in the negative signal. One potential candidate was PKC, which is 
activated as part of the slg-mediated intracellular signalling pathways (Figure 1.4) 
(Cambier et al., 1990, Cambier et al., 1992, Cambier et al., 1994, Harnett 1994), and 
which induces a number of B cell responses that are insensitive to CsA, such as the up- 
regulation of MHC class-II (Klaus and Hawrylowicz 1984, Klaus 1988, Testi et al., 
1989). To test the hypothesis that PKC could be involved in the slg-mediated inhibitory 
signal, B cells were cultured with the phorbol ester, PMA, which is know to activate 
PKC
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Figure 5.4. Co-culture of galgM and LPS reveals different effects of 
slg mediated signals which differ in their sensitivity to CsA .
B cells were cultured as described in Figure 5.1, in the presence of LPS 
(50 pg/ml) and varying concentrations of galgM ( O ). Replicate cultures 
were also prepared which contained galgM, LPS and 40 ng/ml CsA ( #  ).
After 3 days B cell proliferation was measured by ' H-TdR incorporation 
as described in chapter 3. Background proliferation: LPS only (□  ), LPS 
and CsA ( ■  ), and cells only ( E3 ). The data illustrated represents the 
mean of triplicate cultures, expresed with 1 x SEM.
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Figure 5.5. Inhibition of LPS-induced proliferation and ASC formation by 
galgM  generates similar dose response curves in the presence of CsA .
This Figure overlays the data illustrated Figures 5.3 and 5.4 to dem onstrate the 
relationship betw een ASC num ber and proliferation. In the absence of CsA
(panel A) the dose response curves for ASC form ation ( •  ) and -^H-TdR 
incorporation ( O  ) diverge at g a lg M  concentrations which exceed 3 |ig /m l. 
H ow ever in the presence of CsA (panel B) a sim ilar dose response curve is 
generated for both ASC num ber and proliferation. Background proliferation: 
LPS with and w ithout CsA ( □  ) and cells only ( | |  ). Background ASC 
number: LPS with and without CsA ( ■  ) and cells only ( £3 ). As before the 
data illustrated represents the mean of triplicate cultures, expressed with 1 x 
SEM.
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(Berridge and Irvine 1984, Rejendra and Hokin 1990). Stimulation of B cells with PM A 
alone resulted in a decline in the background proliferation (Figure 5.6). A similar result 
was obtained when B cells were cultured with a combination of PMA and LPS. In these 
cultures PMA inhibited LPS-induced proliferation (Figure 5.6), as previously described 
(Högbom et a i, 1987, Gupta et al., 1988).
5. 2. 5. Different preparations of galgM  differ in their signalling capacity 
During the course of these experiments two different preparations of galgM  were tested, 
and it was found that the dose response curves for B cell proliferation differed between 
the two preparations (Figure 5.7). At low concentrations of galgM  the dose response 
curves for proliferation induced by the different batches of antibody virtually overlayed 
each other (Figure 5.7). However while the inhibitory effect of the two batches of 
antibody was very similar, their ability to induce proliferation differed. Thus, the 
concentration at which the different preparations of galgM  were able to induce 
proliferation above the background differed by approximately 10 fold, with batch 1 
being more stimulatory than batch 2 (Figure 5.7). These results indicate that the relative 
strength of the positive signal differed between preparations of galgM. More 
importantly the results suggest that the ability of galgM to induce the inhibitory signal 
was independent of the induction of the positive signal, indicating that the two slg- 
mediated signals are independently regulated.
cp
m
slg-mediates two signals which differ in their sensitivity to CsA 74
400000
300000
200000
100000
-4 -3 -2 -1 0 110 10 10 10 10 10
PMA concentration (ng/ml)
Figure 5.6. PMA inhibits LPS-induced B cell proliferation.
B cells were cultured in BCM (5 x 10^/ 200 pi well), in the presence of 
varying concentrations of PMA (O )• Replicate B cell cultures were also 
prepared which contained LPS (50 pg/ml) and PMA ( #  ). After 3 days
B cell proliferation was measured by ~ H-TdR as described in chapter 3. 
Background proliferation: cells only ( □  ) and LPS only ( ■  ). The data 
illustrated represents the mean of triplicate cultures, expressed with 1 x 
SEM.
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Figure 5.7. The response to different batches of galgM suggests that 
the inhibitory and stimulatory signals are independent of each other.
B cells were cultured in BCM (5 x 10  ^cells / 200 jil well) in the presence 
of varying concentrations of different batches of galgM - batch 1 ( 0 )
and batch 2 ( #  ). After 3 days B cell proliferation was measured by ^H- 
TdR incorporation as described in chapter 3. Background proliferation 
( □  ). The data illustrated represents the mean of triplicate cultures, 
expressed with 1 x SEM.
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5.3. Discussion
5.3.1. Surface-Ig mediated signals can inhibit LPS-induced ASC 
formation while promoting B cell proliferation
It has been accepted that TI type-1 antigens, such as LPS, are intrinsically stimulatory 
for B cells (Andersson et al., 1972, Andersson et al., 1973, Coutinho and Möller 
1973a, Coutinho et al., 1973b, Coutinho et al., 1975, Möller et al., 1975) and that 
during the immune response to these antigens, specificity is achieved through slg 
binding to epitopes within the TI type-1 antigen which focus it to the B cell surface 
resulting in the activation of antigen specific cells (Figure 4.1) (Coutinho and Möller 
1974, Coutinho et al., 1975, Coutinho et a l, 1975, Möller et al., 1975). In the 
alternative model proposed by Mamchak and Hodgkin (1995) it was suggested that B 
cells which receive a slg-mediated signal at the same time as the TI type-1 activation 
signal will be prevented from making antibody (Figures 2.3 and 5.8), resulting in a 
decline in LPS-induced ASC number and generating a bell shaped dose response curve, 
as observed by Coutinho and Möller (Coutinho et al., 1975). If correct, this model 
could account for the results obtained by Coutinho and Möller (1975d) whilst 
incorporating a signalling role for slg (Mamchak et al., 1995). The experiments 
described here were initially designed to test this proposal, and the results are consistent 
with the alternative explanation for the bell shaped dose response curves for LPS- 
induced ASC formation (Mamchak et al., 1995). However they indicate that a 
modification of the original model is required to account for the unexpected effects of 
slg-mediated signals on LPS-induced proliferation. As before, the antigen signal can 
inhibit LPS-induced ASC formation, but in B cells which strongly bind antigen (and 
which presumably have high affinity for antigen) this signal appears to also induce the 
cells divide more quickly while not secreting antibody (Figure 5.8). This modification 
would still result in a bell shaped curve for LPS-induced antibody production, as 
observed by Coutinho and Möller (1975). If correct antigen specific B cells would be 
induced to proliferate and not secrete antibody, however, it is not obvious as to why this 
mechanism may have evolved. It is possible that the antigen specific B cells expand to 
generate a memory cell population available for subsequent antigen exposure. 
Alternatively, the progeny of these cells might be activated to secrete antibody once the 
epitope density is reduced, either due to the presence of soluble antibody sequestering 
antigen or by antigen clearance. The appearance of highly antigen specific antibodies late 
in the response would expedite the complete eradication of the antigen.
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Figure 5.8. A model in which slg-mediated signals regulates the affinity of LPS-
induced ASCs.
A) B cells which express slg which has a low affinity for hapten will focus LPS to the cell 
surface and be induced to divide and differentiate to ASCs. These cells represent the 
majority of LPS-induced ASC and secrete low affinity antibodies. B) Surface Ig which 
binds the hapten with a moderate affinity results in the generation of the negative slg- 
mediated signal. In this instance the number of B cells which undergo LPS-induced 
proliferate and differentiation to ASC declines as the strength of the negative slg-mediated 
signal increases. C) Surface Ig which binds to the hapten with high affinity generate both a 
positive and negative slg-mediated signal. These B cells will proliferate but produce little or 
no antibody.
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While the experiments deseribed in this ehapter demonstrated that cross-linking of slg by 
galgM could inhibit LPS-induced ASC formation and at the same time promote 
proliferation (Figure 5.5), the results also reveal an additional inhibitory effect of 
galgM. At low concentration, or in the presence of CsA, galgM-induced a signal 
capable of inhibiting spontaneous and LPS-induced B cell proliferation (Figures 5.1 and 
5.5). The inhibitory effect of galgM on proliferation appears to be controlled by the 
same slg-mediated signal that inhibits LPS-induced B cell differentiation into ASCs 
(Figure 5.5). Although the inhibition of proliferation may be countered by the slg- 
mediated positive signal for growth, the positive signal does not affect the inhibition of 
ASC formation (Figures 5.5, and 5.8). Finally the positive CsA sensitive signal seems 
to be related to the ability of the anti-Ig reagent to promote B cell proliferation 
independently of LPS, a property previously determined to be a correlate of TI type-2 
antigenic stimulation (Peganha et al, 1991, Mond et al, 1995). The different effects of 
the two slg-mediated signals are summarised in Figure 5.9.
5.3.2. Speculation on the intracellular signalling components involved in 
the positive and negative slg-mediated signals
The use of CsA and PMA in these experiments has provided some indication of the 
secondary messengers which may be involved in the different slg-mediated signals 
(Figure 5.10). CsA inhibits a number of signalling events which occur as a result of 
calcium mobilisation and include the activation, and migration from the cytoplasm to the 
nucleus of transcription factors, such as NF-AT (Emmel et al., 1989, Bierer et ai, 1991, 
Jain et al, 1993, Venkataraman et al., 1994) and NF-kB (Emmel et al, 1989). The 
inhibitory action of CsA appears to be the result of the inhibition of the Ca-^/calmodulin 
dependent phosphatase, calcineurin (Liu et ai, 1991b, Clipstone and Crabtree 1992, 
Fruman et al, 1992, O'Keefe et al, 1992). Once inside the cell CsA specifically binds 
to a group of compounds called the cyclophilins, forming a ligand receptor complex 
(Handschumacher et al, 1984). The CsA-cyclophilin complex binds to, and inhibits the 
action of calcineurin (Liu et al, 1991b, Clipstone et al, 1992, Fruman et al., 1992, 
O'Keefe et al, 1992). Inhibition of calcineurin by CsA can prevent the 
dephosphorylation, and subsequent migration into the nucleus of NF-AT (Emmel et al, 
1989, Granelli-Pipemo et al, 1990, Bierer et al., 1991, Jain et al, 1993, Venkataraman 
et al., 1994). In this way the presence of CsA could block the activation and migration 
of NF-AT, and other transcription factors, which promote the expression of a number of 
genes (Jain et al, 1993), and thereby prevent slg-induced B cell proliferation.
slg-mediated two signals which differ in their sensitivity to CsA 79
g a lg M
outside B cell
inside
negative
T
• inhibits spontaneous division.
• inhibits LPS-induced growth.
• inhibits LPS-induced B cell 
differentiation.
• activated at low and high doses 
of galgM.
• CsA insensitive.
• mimicked by the action of PMA.
• induced at high and low antibody 
concentrations.
positive
▼
• stimulates proliferation.
• enhances LPS-induced growth.
• activated at high doses of galgM
• CsA sensitive.
• only induced by high 
concentrations of galgM.
Figure 5.9. A summary of the B cell response to the two slg-mediated
signals .
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cytoplasm
Figure 5.10. Components of slg-mediated signalling pathways which 
may constitute the positive and negative signals.
The model put forward in this chapter suggests that cross-linking of slg 
initiates two signals. The positive signal is inhibited by CsA, and may 
involve the activation of calcineurin. In contrast the negative signal is CsA 
insensitive, and may involve the activation of PKC. It is the activation, and 
interaction, of both pathways which is proposed to determine B cell 
behaviour.
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The failure of CsA to prevent galgM-mediated inhibitory effects, and the inhibition of 
LPS-induced proliferation (Figure 5.6) (Högbom et a l, 1987, Gupta et cii, 1988) and 
ASC formation by phorbol esters (Isakson and Simpson 1984, Högbom et al., 1987) 
suggests that the negative signal may involve the activation of PKC (Figure 5.10). 
However, the regulation of B cell responses by slg-mediated signals may not be quite 
this simple, as PKC is also a component of the intracellular signalling which results in 
the activation of B cells by both LPS (Gupta et a l, 1988, Klaus 1988, Shapira et al., 
1994) or anti-Ig reagents (Klaus 1988, Cambier et a l, 1990, Cambier et a l, 1992, 
Cambier et a l, 1994, Harnett 1994) (Figures 1.4 and 5.10). In addition, the 
combination of phorbol esters and calcium ionophores has been shown to induce B cell 
proliferation (Klaus et a l, 1986). Therefore, the B cell response may not be simply due 
to the activation of PKC, or the mobilisation of calcium, but could depend on the 
strength of, and interaction between, these and other signals. Although this hypothesis 
is speculative and requires further experimentation to determine the relationship between 
these two pathways and B cell behaviour, it does suggest that slg-mediated signals 
provide more information to the B cell about the nature of the bound antigen than has 
previously been anticipated.
5.3.3. Factors which could affect the type (positive or negative) of slg- 
mediated signalling
Irrespective of the intracellular signalling pathways involved, the data clearly implies that 
there are two paths. What then are the differences which result in the activation of each? 
While the cause of the divergent behaviour induced by galgM  is unknown, the results 
indicate that the B cell response is affected by the concentration (Figures 5.1 and 5.5) 
and batch of godgM (Figure 5.7). As galgM  is a polyclonal antibody different batches 
could vary in the frequency of anti-Ig antibodies which have a particular specificity and 
affinity for certain epitopes. The variation between batches of galgM  could result in 
differences in the pattern of slg-mediated signalling and subsequent B cell behaviour. 
Finally, the inhibitory effects of galgM  are unlikely to be due to co-ligation of slg and 
the FcyRIIB which results in Fc-mediated inhibition (Sidman and Unanue 1976, Phillips 
and Parker 1983) as the Fc region of goat antibodies are reported not to bind to FcyRIIB 
(Sieckmann et a l, 1978a, Sieckmann et a l, 1978b, Sidman and Unanue 1979). 
Therefore, galgM-mediated inhibition of proliferation and ASC formation would appear 
to be caused by slg-mediated rather than Fc-mediated signals. The influence of the 
specificity and affinity of anti-Ig reagents, and the role of Fc-mediated signals on slg- 
induced B cell behaviour is explored in the following chapter.
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The results described in this chapter suggest a model in which cross-linking of slg with 
galgM results in the induction of at least two independently regulated signals which 
have different functional consequences for the B cell. Clearly, one of the affects of slg- 
mediated signalling was to inhibit LPS-induced ASC formation. This result supports the 
model proposed in chapter 2 in which slg-mediated signals are responsible for the bell 
shaped dose response curves observed by Coutinho and Möller (1975) for LPS-induced 
ASC formation. Further, these results are consistent with the view that slg-mediated 
signals regulate the affinity of LPS-induced ASCs (Mamchak et al., 1995). Finally the 
data suggests that the pattern of slg-mediated signals is dependent on the specific 
physical interaction between slg and galgM. The effect of varying the physical form of 
the surrogate antigen and B cell behaviour is explored in the following chapter through 
the use of monoclonal antibodies.
Chapter 6
Monoclonal antibodies 
provide further evidence 
for the independent 
regulation of two slg- 
mediated signals
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6.1. Introduction
The antigen signal has been shown to have a number of different and apparently 
contradictory effects on B cell behaviour. One experimental approach which has been 
employed to examine the role of this signal has been to use anti-Ig antibodies as 
surrogate antigens. Anti-Ig stimulation of B cells has revealed that the resulting slg- 
mediated signal can induce a number of effects which include: increased cell size 
(DeFranco et al., 1982b, Klaus et al., 1985b), proliferation (Sieckmann et al., 1978a, 
Parker et al., 1979, Sidman et al., 1979, Klaus et al., 1985a, Brunswick et al., 1988), 
expression of cell surface markers (Mond et al., 1981, Lenschow et al., 1994), 
apoptosis (Hasbold et al., 1990, Parry et al., 1994a, Parry et al., 1994b) and, in 
combination with cytokines, antibody secretion (Kishimoto et al., 1975, Pe^anha et al., 
1991). These experiments have provided an insight into the role of the antigen signal in 
a number of different areas of B cell biology supporting the conclusion that anti-Ig 
reagents provide an effective way of examining the B cell response to antigen. However 
the use of anti-Ig antibodies to study the B cell response to antigen has often drawn 
criticism because of the different and sometimes contradictory responses these antibodies 
induced, leading to the proposition that B cell behaviour induced by anti-Ig antibodies 
was not representative of the B cell response to natural antigens (Möller 1978).
A hypothesis which could explain the variation in the B cell response to anti-Ig reagents 
is suggested by the results described in the previous chapter. According to this 
hypothesis the antigen signal is not immutable, but may instead be composed of a 
number of signals which can vary in strength and are independently triggered by B cell 
receptor engagement. Given this possibility, the question arises as to what triggers the 
different components of the antigen signal. It is probable that variations in the antigen 
signal are the result of physical differences in the specific interaction between slg and 
antigen. If correct this model would allow the re-interpretation of disparate results 
obtained with anti-Ig antibodies published in the literature, and provide a better 
understanding of how the B cell responds to antigen. Thus, this hypothesis was 
explored here through the use of different anti-Ig antibodies.
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6.2. Results
6.2.1. Variation in inhibitory and enhancing capacity of seven 
monoclonal antibodies
Initially seven mAbs were tested for their ability to induce B cell proliferation in the 
presence and absence of IL-4, and their responses compared to that of galgM (Figures 
6.1 and 6.2). Properties of the seven mAbs used in this experiment are summarised in 
Table 6.1.
Each of the mAbs had a different effect on B cell proliferation (Figures 6.1 and 6.2). 
Although proliferation in response to galgM  occurred in the absence of IL-4, the 
addition of this cytokine enhanced the level of ^H-TdR incorporation (Figure 6.1 A), as 
previously described (Howard et a l, 1982, Hodgkin et al., 1991a). The inclusion of 
IL-4 to B cell cultures stimulated with galgM also altered the shape of the dose response 
curve, as the low dose inhibition induced by galgM  alone was no longer apparent 
(Figure 6.1 A). Three of the mAbs, AMS-9.1, 1.19 and B7.6, were also able to induce 
proliferation in the absence of IL-4, and as observed for galgM  (Figures 6.1 and 6.2). 
The presence of IL-4 in these cultures enhanced the level of ^H-TdR incorporation 
induced by AMS-9.1, 1.19 or B7.6 (Figures 6.1 and 6.2), as previously reported 
(Julius et al., 1984, Goroff et al., 1986, Brines and Klaus 1991, Udhayakumar et al., 
1991). In addition while the anti-K antibody, 187.1, alone did not induce proliferation, 
the combination of 187.1 and IL-4 stimulated an increase in ^H-TdR incorporation like 
that observed for galgM  under similar culture conditions (Figure 6.1 A and B).
In contrast to the mitogenic mAbs, BET-2 and 331.1 did not induce proliferation, 
irrespective of the presence of IL-4 (Figure 6.1C and D). Both BET-2 and 331.1 
inhibited spontaneous proliferation in the absence of IL-4, in a manner similar to that 
observed for low doses (< 1 pg/ml) of galgM  (Figure 6.1 A, C and D). However in the 
presence of IL-4, B cell proliferation in response to a high dose (20 p.g/ml) BET-2 was 
slightly enhanced over that observed in the control (IL-4 only) cultures (Figure 6.1C), 
whereas the addition of IL-4 to cultures containing 331.1 did not alter the inhibitory 
effect of this mAb (Figure 6. ID). Thus, both 331.1 and BET-2 appeared to induce an 
inhibitory signal while causing little, if any, detectable positive response. A weak 
inhibition of spontaneous proliferation was also observed with low doses (< 5 |ig/ml) of 
AMS-9.1 in the absence of IL-4 (Figure 6. IE, inset). Finally unlike the other mAbs 
used in this experiment, AMS-15.1 did not produce any measurable effect on B cell 
proliferation, even in the presence of IL-4
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Table 6.1: Monoclonal anti-Ig antibodies
a n t i b o d y
B E T  -2
s p e c i f i c i t y i s o t y p e ra i s e d  in r e f e r e n c e
a n t i -m o u s e  p Ig G  1 ra t ( K u n g  e t  a l.,  1 9 8 1 , 
U d h a y a k u m a r  e t  a l., 
1 9 9 1 )
3 3 1 .1 2 a n t i -m o u s e  p Ig G 2 b ra t ( K in c a d e  e t  a l., 1 9 8 1 , 
U d h a y a k u m a r  e t  a l., 
1 9 9 1 )
B 7 .6 a n t i -m o u s e  p Ig G  1 ra t ( J u l iu s  e t  a l.,  1 9 8 4 , 
B r in e s  e t  a l.,  1 9 9 2 ).
1 8 7 .1 a n t i -m o u s e  k Ig G  1 ra t ( G i l l ig a n  e t  a l., 1 9 8 8 )
A M S -9 .1 a n t i - m o u s e  6 a I g G 2 a m o u s e
e x p r e s s in g
5 b
( S ta l l  e t  a l., 1 9 8 4 )
A M S -1 5 .1 a n t i - m o u s e  5 a Ig G 2 a m o u s e
e x p r e s s in g
5 b
(S ta l l  e t  a l., 1 9 8 4 )
1 .1 9 a n t i - m o u s e  6 Ig G 2 a ra t ( B r in e s  e t  a l.,  1 9 9 2 )
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Figure 6.1. Different anti-Ig antibodies display varying effects on B cell proliferation.
B cells were cultured in BCM containing varying concentrations of anti-lg antibodies at a starting cell density
of 5 x 104 cells / 200 pi well (O ). Replicate cultures were also prepared which contained anti-Ig antibodies in
combination with 100 U/ml of IL-4 ( •  ). After 3 days B cell proliferation was measured by ^H-TdR 
incorporation as described in chapter 3. Background proliferation: cells only ( □  ), and IL-4 only ( M  ) as 
indicated. For each anti-Ig dose cultures were prepared in triplicate and the data illustrated represents the 
mean of the response ± 1 x SE. A - galgM, inset shows detail of the response to galgM only; B - 187.1; C - 
BET-2, inset shows detail of the response to BET-2 with and without IL-4; D - 331.1, inset shows detail of the 
response to 331.1 with and without IL-4; E - AMS-9.1, inset shows detail of the response to AMS-9.1 only; 
F - AMS-15.1.
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Figure 6.2. Two anti-Ig mAbs which are mitogenic in the absence of IL-4.
Small percoll purified B cells were prepared as described in chapter 3 from CBA x
C57/B6 mice and cultured in BCM (2 x 10  ^ cells / 200 pi well) in the presence of 
varying concentrations of the anti-IgD mAb, 1.19 ( E 3  ), or the anti-IgM mAb, B7.6 
( EE3 )• Replicate wells were prepared which contained the either 1.19 or B7.6 in 
combination with 10 U/ml of IL-4. After 3 days B cell proliferation was determined
by ^H-thymidine incorporation, as described in chapter 3. Background proliferation; 
cells only ( H  ), and IL-4 only (E3) is indicated. The data illustrated represents the 
mean of triplicate cultures ± 1 x SE. This experiment was performed by Dr J. 
Hasbold (Centenary Institute, Sydney) who generously gave permission for the data to 
appear in this thesis.
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Figure 6. IF). Isotype matched control mAbs had no influence on the behaviour of the B 
cells, irrespective of the presence of IL-4 (data not shown).
Together the results illustrated in Figures 6.1 and 6.2 indicate that cross-linking of slg 
induces intracellular signals which result in B cell proliferation which can be enhanced 
by IL-4. In addition they reveal that some anti-Ig reagents (331.1) can inhibit 
spontaneous proliferation in a manner that is not sensitive IL-4 (Figure 6 .ID). Having 
established the pattern of B cell responses to anti-Ig antibodies alone, and in combination 
with IL-4, the effect of these mAbs on LPS-induced proliferation was examined.
6.2.2. Different anti-Ig antibodies have distinct effects on LPS-induced 
B cell proliferation
Figure 6.3 illustrates the effect of different anti-Ig antibodies on LPS-induced 
proliferation, and as described for the B cell response to mAbs and IL-4 the B cell 
behaviour differed between the various antibodies. As before the response to mAbs was 
compared to that induced by galgM , as described in chapter 5 (Figures 5.4 and 6.3A). 
The dose response curve generated by titrating 187.1 in the presence of LPS was 
reminiscent of that obtained with galgM  under similar culture conditions, with the 
exception that moderate to high doses (> 1 jig/ml) of 187.1 did not enhance LPS- 
induced ^H-TdR incorporation (Figure 6.3A and B). While low doses (< 1 |ig/ml) of 
187.1 inhibited LPS-induced proliferation, higher antibody concentrations generated a 
plateau of proliferation which extended over a twenty fold increase in antibody dose 
(Figure 6.3B). The addition of CsA to these cultures resulted in a more severe inhibition 
of LPS-induced proliferation. However in the presence of CsA the previously observed 
plateau in proliferation was still apparent but occurred at a substantially reduced level of 
^H-TdR incorporation (Figure 6.3B). Both BET-2 and 331.1 inhibited LPS-induced 
^H-TdR incorporation in a dose-dependent manner, generating response curves which 
were almost identical (Figure 6.3C and D, respectively). The addition of CsA to these 
cultures did not alter the shape of the dose response curve induced by either antibody, 
however, the overall level of proliferation was slightly lower (Figure 6.3C and D). The 
complete inhibition of LPS-induced proliferation by these anti-Ig reagents suggest that 
BET-2 and 331.1 are full agonists of the negative signal. Thus, while BET-2 and 331.1 
induced a similar inhibitory effect to that observed at low doses of galgM, these mAbs 
did not demonstrate any positive influence on LPS-induced proliferation even at high 
concentration (Figure 6.3).
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Figure 6.3. Anti-Ig antibodies have different effects on LPS-induced B cell proliferation.
B cells were cultured as described in Figure 6.1 in BCM containing LPS (50 fig/ml) and varyjng 
concentrations of anti-Ig antibodies (O ). Replicate cultures were also prepared which contained 
anti-Ig antibodies, LPS and CsA (40 ng/ml) ( •  ). After 3 days B cell proliferation was measured
by -^H-TdR incorporation as described in chapter 3. Background proliferation: LPS only ( □ ), and 
LPS and CsA ( ■ ) is indicated. The data illustrated represents the mean of triplicate cultures ± 1 x 
SE.
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In contrast to the other mAbs, the inclusion of AMS-9.1 to B cell cultures containing 
LPS resulted in a dose-dependent increase in the level of -^H-TdR incorporation (Figure 
6.3E). The positive effect of moderate to high doses (> 1 pg/ml) of AMS-9.1 on LPS- 
induced proliferation was CsA sensitive (Figure 6.3E). Thus, the effect of AMS-9.1 
was similar to that obtained with galgM  over the same dose range (Figure 6.3). In 
addition to the enhancing effect of AMS-9.1 on LPS-induced proliferation, low doses (< 
1 pg/ml) of this mAb weakly inhibited ^H-TdR incorporation (Figure 6.3E). In the 
presence of CsA inhibition by AMS-9.1 was more severe, however, as observed for 
187.1 the level of inhibition did not increase with dose, but instead formed a plateau 
which extended over a two log increase in antibody concentration (Figure 6.3). Finally, 
although the presence of AMS-15.1 in cultures containing LPS, or LPS and CsA, did 
result in a slightly lower level of ^H-TdR incorporation, the response was not dose- 
dependent (Figure 6.3F). Isotype matched control mAbs had no influence on LPS- 
induced proliferation (data not shown).
6.2.3. Determining the effect of co-ligation of slg and FcyRIIB on anti- 
Ig induced proliferation
The results described above clearly establish the different effects of anti-Ig reagents and 
imply that slg can mediate positive and negative signals. However a complication with 
the use of these reagents is the possibility of co-ligation of slg and FcyRIIB, which has 
been shown to inhibit B cell activation (Sinclair and Chan 1971, Ryan and Henkart 
1976, Sidman et al., 1979, Phillips et al., 1983, Phillips and Parker 1984). Given the 
inhibitory effects of Fc-mediated signalling it was important to determine their influence 
on the B cell response to anti-Ig antibodies. One way to examine the effect of Fc- 
mediated signals on the B cell response to anti-Ig reagents was through the use of the Fc 
blocking antibody, 2.4G2, which has been shown to be effective at preventing Fc- 
mediated inhibition (Unkeless 1979, Muta et al., 1994, Ashman et al., 1996). An 
alternative method was through the use of F(ab')2 fragments, which lack the Fc region 
but retain the ability to influence B cell behaviour (Andersson et al., 1974, Sidman et 
al., 1979, Boyd and Schrader 1981, Leptin 1985). Both experimental approaches were 
examined.
To determine the effect of 2.4G2 on anti-Ig-induced B cell proliferation 30 pg/ml of 
2.4G2 was included in B cell cultures containing anti-Ig reagents (Figure 6.4). This 
concentration was chosen as it had been shown to be in excess of the dose required to 
saturate Fc receptors without having an effect on B cell proliferation under various 
culture conditions (data not shown). In addition, similar doses of 2.4G2 have been 
shown to effective at preventing Fc-mediated inhibition (Wilson et al., 1987, Ashman et 
al., 1996) Co-culture of 2.4G2 with anti-Ig reagents revealed that it could enhance
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Figure 6.4. The effect of 2.4G2 on the B cell proliferative response to 
various anti-Ig antibodies.
B cells were cultured of BCM (5 x 10^ cells / 200 fil well) containing 20 |ig/ml 
anti-Ig antibody alone ( [^] ) or in combination with 30 (ig/ml of 2.4G2 ( [ ^  )• 
After 3 days the level of proliferation was determined by a -^H-TdR 
incorporation assay as described in the chapter 3. The illustrated data 
represents the mean of triplicate cultures ± 1 x SE. Inset shows detail of the 
response to BET-2.
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B cell ^H-TdR incorporation in response to godgM, 187.1 and AMS-9.1, while having 
no apparent affect on the response to BET-2, 1.19 or B7.6. It was of interest to note 
that in the presence of 2.4G2, the previously non-mitogenic 187.1, induced a level of 
^H-TdR incorporation which was equivalent to that obtained with galgM  alone, this 
result suggests that 187.1 could induce sufficient co-ligation of slg and FcyRIIB which 
masked its mitogenic potential (Figure 6.4).
6.2.4. Blocking Fc binding has different affects on anti-Ig inhibition of 
LPS-induced B cell proliferation and differentiation 
In subsequent experiments the role of Fc-mediated inhibition in determining the B cell 
response to co-culture with anti-Ig antibodies and LPS was examined (Figures 6.5.1 and 
6.5.2). The presence of 2.4G2 increased proliferation to varying degrees in response to 
five out of six anti-Ig reagents (Figures 6.5.1 and 6.5.2A-C). However in cultures 
containing BET-2, the addition of 2.4G2 did not have any apparent affect on 
proliferation. Thus, the two BET-2-induced dose response curves virtually overlayed 
each other (Figure 6.5. IB). In addition to determining the effect of 2.4G2 on anti-Ig 
and LPS-induced proliferation, its influence on ASC formation was also examined. The 
presence of 2.4G2 did not induce a marked change in the dose response curves for ASC 
formation, irrespective of the and-Ig reagent used however, cultures which contained 
2.4G2 had slightly higher numbers of ASCs (Figures 6.5.1 and 6.5.2D-F). These 
results demonstrate that a number of mAbs are able to inhibit LPS-induced ASC 
formation in a manner which is independent of the co-ligation of slg and FcyRIIB 
(Figures 6.5.1 and 6.5.2D-F). Further, the results obtained with BET-2 indicate that 
inhibition of LPS-induced proliferation can occur in the absence of Fc-mediated 
inhibitory signals.
Preventing co-ligation o f slg and FcyRIIB does not affect the slg-mediated inhibitory 
signal
Similar experiments to those described above were also conducted in the presence of 
CsA, which does not affect Fc-mediated inhibitory signals (Gottschalk et ai, 1994).
The dose response curves obtained for proliferation and ASC formation in cultures 
containing anti-Ig, LPS and CsA were unaltered by the addition of 2.4G2 (Figures 6.6.1 
and 6.6.2). These results indicate that preventing co-ligation of slg and FcyRIIB had no 
affect on the negative slg-mediated signal. However in the absence of CsA, 2.4G2 had 
a marked positive effect on proliferation in some cultures (Figures 6.5.1 and 6.5.2). 
Thus, the results illustrated in Figures 6.5.1-6.5.2 suggest that co-ligation of slg and 
FcyRIIB have different effects on the two slg-mediated signals resulting in the inhibition 
of the positive signal for growth without affecting the negative signal.
Additional evidence for a variable antigen signal 93
300000
250000
200000
150000
100000
50000
BET-2
250000
200000
150000
100000
40  "*.
50000
250000
200000
150000
100000
50000
anti-Ig concentration (pg/ml)
Figure 6.5.1. The influence of the Fc blocking antibody, 2.4G2, on the B cell response to co-culture with
different anti-Ig antibodies and LPS.
B cells were cultured in BCM (5 x 10^ cells/ 200 p.1 well) the presence 50 (ig/ml LPS and various concentrations of 
anti-Ig antibodies ( O ). Replicate B cell cultures were also prepared which contained anti-Ig antibodies, LPS and 30 
pg/ml 2.4G2 ( •  ). After 3 days the level of B cell proliferation was determined by ^H-TdR incorporation, and the 
numbers of ASCs determined by Elispot assay, as described in chapter 3. For proliferation each point represents the 
mean of triplicate cultures ± 1 x SE, whereas the number of ASCs was expressed as a percentage of the control (LPS 
or LPS & 2.4G2) response with the background (cells only or 2.4G2 only) subtracted. LPS-induced proliferation with 
( □  ) and with out 2.4G2 ( ■  ), background proliferation (------- ) is indicated.
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Figure 6.5.2. The influence of the Fc blocking antibody, 2.4G2, on the B cell response to co-culture with different
anti-Ig antibodies and LPS.
B cells were cultured in BCM (5 x 10  ^cells/ 200 |il well) the presence 50 |ig/ml LPS and various concentrations of anti-lg 
antibodies ( O). Replicate B cell cultures were also prepared which contained anti-Ig antibodies, LPS and 30 pg/ml 2.4G2 
( •  ). After 3 days the level of B cell proliferation was determined by -^H-TdR incorporation, and the numbers of ASCs 
determined by Elispot assay, as described in chapter 3. For proliferation each point represents the mean of triplicate 
cultures ± 1 x SE, whereas the number of ASCs was expressed as a percentage of the control (LPS or LPS & 2.4G2) 
response with the background (cells only or 2.4G2 only) subtracted. LPS-induced proliferation with ( |  ) and with out 
2.4G2 ( □  ), background proliferation (------- ) is indicated.
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Figure 6.6.1. The influence of the Fc blocking antibody, 2.4G2, on the B cell response to co-culture with
anti-Ig antibodies, CsA and LPS.
B cells were cultured in BCM (5 x 10^ cells/ 200 pi well) the presence LPS (50 (ig/ml), CsA (40 ng/ml) and various 
concentrations of anti-Ig antibodies ( □ ). Replicate B cell cultures were also prepared which contained anti-Ig 
antibodies, LPS, CsA and 30 pg/ml 2.4G2 (■ ). After 3 days the level of B cell proliferation was determined by ^H- 
TdR incorporation, and the numbers of ASCs determined by Elispot assay, as described in chapter 3. For proliferation 
each point represents the mean of triplicate cultures ± 1 x SE, whereas the number of ASCs was expressed as a 
percentage of the control (LPS & CsA or LPS, CsA & 2.4G2) response with the background (cells only or 2.4G2 only) 
subtracted. Proliferation: LPS only ( O  ) LPS and CsA ( •  ), LPS and 2.4G2 ( 0  ), LPS, CsA and 2.4G2 ( □ ), 
background (------- ) is indicated.
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Figure 6.6.2. The influence of the Fc blocking antibody, 2.4G2, on the B cell response to co-culture with
anti-Ig antibodies, CsA and LPS.
B cells were cultured in BCM (5 x 10^ cells/ 200 |il well) the presence LPS (50 pg/ml), CsA (40 ng/ml) and various 
concentrations of anti-Ig antibodies ( □ ). Replicate B cell cultures were also prepared which contained anti-Ig 
antibodies, LPS, CsA and 30 fig/ml 2.4G2 (■ ). After 3 days the level of B cell proliferation was determined by ^H- 
TdR incorporation, and the numbers of ASCs determined by Elispot assay, as described in chapter 3. For proliferation 
each point represents the mean of triplicate cultures ± 1 x SE, whereas the number of ASCs was expressed as a 
percentage of the control (LPS & CsA or LPS, CsA & 2.4G2) response with the background (cells only or 2.4G2 only) 
subtracted. Proliferation: LPS only ( O  ) LPS and CsA ( #  ), LPS and 2.4G2 ( 0  ), LPS, CsA and 2.4G2 ( □ ), 
background (------- ) is indicated.
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6.2.5. A comparison of B cell proliferation in response to intact anti-Ig 
antibodies and their F(ab’)2 fragments
Having determined the effect of 2.4G2 on anti-Ig induce B cell behaviour the influence 
of Fc-mediated signals on these response was examined through the use of F(ah’)2 
fragments of anti-Ig antibodies. This alternative experimental approach has the 
advantage of being able to compare the B cell response to the same antibody, with and 
without the presence of an Fc region. In these experiments the effect of intact rabbit anti­
mouse IgG (ralgG) and its F(ab’)2 fragment on B cell proliferation and differentiation to 
ASCs were compared (Figures 6.7 and 6.8). When B cells were cultured with ralgG or 
its F(ab’)2 fragment, only the F(ab’)2 fragment-induced ^H-TdR incorporation above 
the background (Figure 6.7A and B). In the presence of IL-4 however, both the intact 
ralgG and its F(ab’)2 fragment-induced proliferation with cultures containing the 
F(ab’)2 fragment-inducing more than twice the level of -^H-TdR incorporation than the 
intact ralgG at a similar dose (Figure 6.7A and B).
Anti-Ig F(a b ’)2 fragments inhibit LPS-inducedproliferation and ASCformation 
When used in combination with LPS both ralgG and its F(ab’)2 fragment inhibited 
proliferation, generating very similar dose response curves at antibody concentrations 
below 10 |ig/ml (Figure 6.7C and D). In response to a higher concentration of F(ab’)2 
ralgG the level of ^H-TdR incorporation increased, whereas in cultures containing 
ralgG the high dose enhancement of proliferation was not observed (Figure 6.7D and C 
respectively). The inclusion of CsA in these cultures lowered the over all level of ^H- 
TdR incorporation in response to either antibody (Figure 6.7C and D). While CsA did 
not alter the shape of the dose response curve for ralgG, it did inhibit the increase in 
proliferation observed at a high dose of F(ab’)2 ralgG. The dose response curve 
induced by F(ab’)2 ralgG in combination with LPS and CsA was reminiscent of that 
observed with 187.1 and AMS-9.1 under similar culture conditions (Figure 6.3) in that 
at high concentrations of antibody the degree of inhibition formed a plateau (Figure 
6.7D).
In addition to determining the effect of ralgG and its F(ab’)2 fragment on LPS-induced 
proliferation the formation of ASCs was also examined. Both ralgG and its F(ab’)2 
fragment cause a dose-dependent inhibition of LPS-induced ASC formation generating 
dose response curves which overlay each other (Figure 6.8). This result suggests that 
the inhibitory slg-mediated signal responsible for the decline in ASC number generated 
by the two anti-Ig reagents was similar. The similarity of the response to ralgG and its 
F(ab’)2 fragment supports the conclusion that co-ligation of slg and FcyRIIB is not 
required for inhibition of LPS-induced ASC formation.
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Figure 6.7. Rabbit algG  and its F(ab')2 fragment generated similar inhibitory dose response 
curves but differed in their ability to induce B cell proliferation.
B cells were cultured in BCM (5 x 10^ cells/ 200 |il well) containing various concentrations of 
ralgG  or its F(ab ' )2  fragment in the presence ( •  ) or absence of 100 U / ml IL-4 ( O ) (panels A and
B). Replicate cultures were prepared which contained ralgG  or F(ab ' )2  ralgG , in combination with 
50 fig/ml LPS ( O ) , or LPS and 40 ng/ml CsA ( •  ) (panels C and D). After 3 days B cell 
proliferation was measured by -^H-TdR incorporation, as described in chapter 3. Background 
proliferation: cells only ( □  ) ,  IL-4 only ( ■  ), LPS only ( □  ), LPS and CsA ( E3) is indicated. The 
data illustrated represents the mean of triplicate cultures ± 1 x SE.
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Figure 6.8. Inhibition of LPS-induced ASC formation by ralgG and its F(ab')2 fragment
generated virtually identical dose response curves.
B cells were cultured in BCM (5 x 10  ^ cells/ 200 pi well) containing various concentrations of 
ralgG ( O ) or its F(ab')2 fragment ( •  ) in combination with 50 fig/ml LPS. After 3 days the
number of ASCs was determined by Elispot assay, as described in chapter 3. The number of ASCs 
was expressed as a percentage of the LPS only response with the background subtracted. The data 
represents the mean of triplicate cultures.
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6.3. Discussion
The results presented in this chapter further illustrate the diverse range of responses that 
anti-Ig reagents are capable of producing when used to stimulate B cells. A hypothesis 
which might provide a consistent interpretation of anti-Ig induced B cell behaviour, 
suggests that the antigen signal consist of a number of different signalling components. 
The components of the antigen signal appear to be activated independently of each other, 
can vary in strength and regulate different B cell responses. According to this model the 
behaviour of the B cell is determined by the integration of the components of the antigen 
signal within the B cell, however, it not yet understood how this might occur. Thus far, 
the results suggest that slg-mediated signals can induce positive or negative effects on B 
cell behaviour, which are dependent on the strength and / or ratio of the different 
components of the antigen signal (Figure 5.10). The results described in this chapter are 
consistent with such a model (Figure 6.9). In addition, they suggest that it is the precise 
physical interaction between the surrogate antigen and its receptor that determines both 
the signal strength and which components of the antigen signal are activated.
Like galgM, a number of mAbs were able to inhibit proliferation and LPS-induced 
differentiation to ASCs through a CsA insensitive signal (Figures 6.1, 6.3, 6.5.1-6.8). 
In addition, certain mAbs were also able to induce proliferation in a manner which was 
sensitive to CsA (Figures 6.3 and 6.7). The CsA sensitive signal seems to be related to 
the ability of anti-Ig reagents to promote B cell proliferation independently of LPS 
(Figures 6.1 and 6.8), a property previously determined to be a correlate of TI-2 
antigenic stimulation (Brunswick et cii, 1988, Pe9anha et al., 1991). Further, the 
results describe in this chapter also illustrate the effect of IL-4 and co-ligation with 
FcyRIIB on slg-mediated signalling. While IL-4 enhances anti-Ig induced proliferation 
(Figures 6.1 and 6.2) as previously described (Howard et al., 1982, Hodgkin et al., 
1991a), the results presented in this chapter demonstrate that it cannot prevent the 
inhibition of proliferation by anti-Ig reagents (Figure 6.1). In addition, although Fc- 
mediated signals have been shown to inhibit anti-Ig induced proliferation (Figures 6.4- 
6.5.2 and 6.7) (Sinclair et al., 1971, Sidman et al., 1979, Phillips et al., 1983), co­
ligation of slg and FcyRIIB had no affect on the slg-mediated negative signal (Figures 
6.5.1-6.8). Finally, the ability of a mAb to transmit the negative signal for growth does 
not predict whether it will also be able to provide the positive signal, as illustrated by the 
results obtained for BET-2 and AMS-9.1. While BET-2-induced a strong negative 
signal it was apparently unable to generate the positive signal required to stimulate 
proliferation (Figure 6.3 and 6.5.1). Conversely AMS-9.1 predominantly generated a 
positive signal for growth in the absence of a strong negative signal
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Figure 6.9. A summary of the behaviour and charateristics of the 
different slg-mediated signals .
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(Figures 6.1, 6.3 and 6.5.1). These results support the view that the two slg-mediated 
signals are independently regulated, as proposed in chapter 5.
6.3.1. Differences in anti-Ig antibodies influence slg-mediated 
signalling
While the experiments described do not explore the biochemical events involved in slg- 
mediated signalling, the data clearly supports the hypothesis that slg can mediate a 
number of different signals. Given this possibility the question arises as to what causes 
the activation of the different signals from the same receptor. As each of the anti-Ig 
reagents differ physically from one another, it is likely these differences affect the 
interaction between the anti-Ig antibodies and slg, resulting in different patterns of 
signalling and subsequent B cell behaviour. The anti-Ig reagents used in these 
experiments differ in: affinity, isotype, epitope specificity, flexibility, ability to induce 
cross-linking of slg, and co-ligation of slg and FcyRIIB. Each of these differences may 
contribute to the way that the antibody binds to slg, however, as discussed below, no 
single factor can be identified as causing the variation in the B cell response. Thus, each 
of the surrogate antigens could be considered to have an intrinsic ability to induce an 
antigen signal(s), based on the sum of the influences of each factor on its interaction with 
slg.
The dose response curves for proliferation suggest that anti-Ig antibodies can be full or 
partial agonists for the slg-mediated negative signal.
One of the most obvious influences on the B cell response to anti-Ig reagents was that of 
antibody concentration. For the mitogenic antibodies, B cell proliferation increased with 
dose, indicating that above a certain threshold the onset of proliferation was related to the 
strength, or frequency, of the slg-mediated positive signal which appeared to be 
proportional to antibody concentration (Figures 6.1 and 6.2). A similar relationship 
between signal strength and dose was also observed for inhibition of spontaneous and 
LPS-induced proliferation by 331.1 and BET-2 (Figures 6.1, 6.3, and 6.5.1). The dose 
response curve for these antibodies suggests that they are full agonists for the negative 
signal. However for 187.1 the relationship between dose and the strength of inhibitory 
signal was not as simple, as the degree of inhibition induced by 187.1 formed a plateau 
at moderate-high antibody concentrations (Figure 6.3). Significantly the plateau of 
inhibition was also observed in the presence of CsA (Figure 6.3), excluding the 
possibility that this response was due to the generation of a positive signal. A similar 
inhibitory dose response curve was also generated by the F(ab’)2 fragment of ralgG 
(Figure 6.7D). Thus, it appears that 187.1 and the F(ab’)2 fragment of ralgG  represent 
partial agonists for the negative signal as the level of inhibition was not directly
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proportional to antibody concentration. The proposition that anti-Ig reagents may only 
be able to induce the partial activation of the various components of the antigen signal is 
discussed further in chapter 8.
The nature of the slg-mediated signal(s) can also be influenced by the efficiency with 
which the antibody induces cross-linking of slg. Anti-Ig reagents which are effective at 
cross-linking could potentially induce a positive signal for growth at a lower 
concentration than those that are poor cross-linkers. Increasing the level of slg cross- 
linking by coupling anti-Ig reagents to insoluble matrixes has been shown to induce B 
cell proliferation by previously non-mitogenic soluble antibodies (Parker 1975, 
Brunswick et al., 1988, Peyanha et a l, 1991, Udhayakumar et a l, 1991). However 
increased cross-linking of slg can also have an inhibitory effect on B cell growth as 
demonstrated by Parry et a l, (1994) who showed that mitogenic soluble anti-Ig reagents 
when immobilised would induce apoptosis (Parry et a l, 1994b). Thus, while increasing 
the degree of cross-linking induced by an anti-Ig antibodies frequently enhances the 
mitogenic potential of these reagents, it can also have deleterious consequences for the 
cell.
Epitope specificity and affinity alone cannot account for the different effects o f  anti-Ig 
antibodies.
Another factor which may influence the nature (inhibitory or stimulatory) of slg- 
mediated signalling is the epitope specificity of the anti-Ig reagents. It is possible that 
anti-Ig binding to different epitopes could induce specific patterns of slg-mediated 
signalling. In addition, epitope specificity may in part determine how effective an anti-Ig 
antibody is at inducing cross-linking of slg. However as with the effect of increased 
cross-linking, epitope specificity alone was insufficient to explain the different B cell 
responses, as illustrated by the results obtained for BET-2 and B7.6. Although these 
antibodies bind to the same epitope (Udhayakumar et al., 1991), they induce different B 
cell behaviour (Figures 6.1-6.3 and 6.5.1). One possibility which could account for the 
variation in the B cell response to these two anti-Ig reagents is that they differ in affinity; 
B7.6 binds with high affinity, whereas BET-2 is a low affinity antibody (Udhayakumar 
et a l, 1991). However, although a high affinity for its epitope may be necessary for a 
mitogenic antibody, it is not sufficient, as illustrated by AMS-15.1. AMS-15.1 binds to 
its epitope with high affinity (Goroff et al, 1986), however, as a soluble antibody it is 
not mitogenic (Figure 6.1). As discussed above, the coupling of anti-Ig reagents to an 
insoluble matrix can alter the B cell response. Thus, when coupled to sepharose beads 
AMS-15.1 was shown to induce B cell proliferation (Goroff et al., 1986). Not 
surprisingly these results indicate that the ability of an anti-Ig reagent to induce a positive 
signal for growth requires the interaction of a number of factors, and that high affinity
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and extensive cross-linking of slg promote the induction of this signal. Given these 
apparent constraints on the induction of the positive signal, it is of interest to note that 
low affinity does not prevent BET-2 from inducing a potent inhibitory signal. Thus, the 
physical characteristics of the surrogate antigens required to induce either slg-mediated 
signal appear to differ.
In addition the B cell response to anti-Ig reagents may be influenced by the isotype of the 
anti-Ig antibody. However differences in isotype are an unlikely explanation for the 
results described here, as 187.1, B7.6 and BET-2 are the same isotype but induce 
different responses (Figures 6.1-6.3, 6.5.1 and 6.5.2). In contrast, 331.1 and BET-2 
are different isotypes but produce almost identical dose response curves in the presence 
of LPS (Figure 6.3). Further, isotope matched controls do not induce a response or alter 
LPS-induced B cell behaviour (data not shown).
6.3.2. The slg-mediated positive signal for growth is inhibited by co­
ligation of slg and FcyRIIB.
It was also important to examine the possibility that the inhibitory dose response curves 
may be the result of Fc-mediated inhibition, rather than inhibitory signals from slg. The 
results obtained with 2.4G2 reveal that the influence of Fc-mediated inhibition on the 
dose response curves varied between the different anti-Ig reagents (Figures 6.5.1 and 
6.5.2). This could be because anti-Ig antibodies differ in their ability to induce the co­
ligation of slg and FcyRIIB. Some antibodies may have lacked the flexibility to bind 
both receptors at once and therefore, the presence of 2.4G2 would have no affect on the 
B cell response.
Blocking Fc binding of galgM , B7.6 and 187.1 enhanced LPS-induced proliferation 
without substantially altering the inhibition of ASC formation (Figures 6.5.1 and 6.5.2). 
Within the framework of the model, the increase in proliferation in the presence of 
2.4G2 suggests that the B cell is receiving a stronger positive signal for growth. As 
2.4G2 does not induce any measurable effect of ^H-TdR incorporation, it may be 
assumed that it promotes proliferation by preventing the co-ligation of slg and the 
FcyRIIB, and subsequent the inhibition of the slg-mediated positive signal for growth. 
The slg-mediated positive signal was shown to be sensitive to CsA (Figures 5.1 and 
6.3), and is therefore, likely to be dependent on the mobilisation of calcium (Figure 
5.10). This is consistent with the discovery that co-ligation of slg and FcyRIIB inhibits 
calcium mobilisation induced by slg cross-linking (Wilson et al., 1987). As illustrated 
in Figure 6.10, co-ligation of slg and FcyRIIB can result in the closing of a membrane 
ion channel which is required for influx of extracellular calcium
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Figure 6.10. The interaction between slg and FcyRIIB signals that could induce
Fc-mediated inhibition.
According to the model proposed in chapter 5, cross-linking of slg can result in the 
generation of a positive signal for growth which appears to involve the mobilisation of 
calcium (A). Co-ligation of slg and FcyRIIB has been shown to inhibit the mobilisation 
of calcium, possibly as a the result of the activation of SHIP and the subsequent 
dephosphorylation of components of intracellular signalling pathways (B). In this way 
Fc-mediated signals may inhibit the generation of the slg-mediated positive signal.
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ions in response to slg cross-linking (Choquet et al, 1993, Diegel et al, 1994). 
Although the mechanism by which this occurs has not been completely elucidated, the 
activation of the phosphatase SHIP in response to co-ligation of slg and FcyRIIB 
(D'Ambrosio et al, 1995, Chacko et al, 1996, Ono et al, 1996), can prevent the influx 
of extracellular calcium by dephosphorylating inositol 1,3,4,5-phosphate which is 
required to open the ion channel (Damen et al, 1996, Ono et al, 1996) (Figure 6.10). 
Thus, by inhibiting the co-ligation of slg and FcyRIIB, 2.4G2 may prevent intracellular 
signalling events which inhibit calcium mobilisation in response to cross-linking of slg 
(Figure 6.10).
6.3.3. Co-ligation of slg and FcyRIIB does not affect the slg-mediated 
inhibitory signal
While the effect of 2.4G2 on B cell proliferation indicates that co-ligation of slg and 
FcyRIIB can prevent the generation of mitogenic slg-mediated signals, a similar 
conclusion cannot be made for the generation of inhibitory signals from slg (Figure 
6.11). The results obtained for LPS-induced B cell differentiation in the presence of 
2.4G2 (Figures 6.5.1 and 6.5.2) indicate that anti-Ig antibodies are able to induce a 
slg-mediated signal which inhibits LPS-induced ASC formation in a manner which is 
independent of co-ligation of slg and FcyRIIB. This conclusion is supported by the 
inhibitory effect of the F(ab’)2 fragment of ralgG (Figures 6.7 and 6.8) and TNP-Ficoll 
(Figure 4.9) on LPS-induced B cell activation. Similar results have also been reported in 
the literature. F(ab’)2 antibody fragments have been shown to inhibit spontaneous and 
LPS-induced proliferation (Boyd et al, 1981, Leptin 1985) and ASC formation 
(Andersson et al, 1974, Warner and Scott 1991). In these experiments the inhibitory 
response induced by the F(ab’)2 fragments was equivalent to that obtained with the intact 
antibody. Further, in transgenic mice “natural” antigens have been shown to the inhibit 
LPS-induced ASC formation generating dose response curves which were similar to that 
obtained for anti-Ig mediated inhibition (Grandien et al, 1993). Combined all of these 
results indicate that Fc-mediated signals cannot account for inhibitory responses induced 
by anti-Ig reagents, and support the proposition that cross-linking of slg can generate a 
negative signal which is not dependent on co-ligation of slg and FcyRIIB (Figure 6.11).
In the previous chapter negative signalling by slg was proposed to involve the activation 
of PKC (Figure 5.6). Within the literature there is some debate as to whether or not co­
ligation of slg and FcyRIIB affects the activation of PKC or PLCy, which is required to 
activate PKC (Figure 1.4) (Gottschalk et al, 1994, Ono et al, 1996, Sarkar et al, 
1996). However although co-ligation of slg and FcyRIIB inhibits the propagation of 
certain slg-mediated signals it does not block them completely (Wilson et al, 1987),
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Figure 6.11. The influence of IL-4 or co-ligation with FcgRIIB on slg
mediated signalling.
This Figure illustrates how IL-4 or co-ligation of slg and FcyRIIB could 
influence the two slg-mediated signals. Panel A illustrates the influence of 
IL-4, which appears to enhance the slg-m ediated positive signal without 
effecting the negative signal. In contrast co-ligation of slg with FcyRIIB 
appears to inhibit the positive signal but does not affect the negative signal 
(panel B). Inset shows the relative signal strength o f both signals and the 
influence of either IL-4, or co-ligation of slg and FcyRIIB on the two slg- 
mediated signals.
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it is therefore, conceivable that sufficient PKC could still be activated to provide an 
inhibitory signal. Alternatively the negative slg-mediated signal may be delivered by 
another, as yet unidentified, component(s) of the antigen signal. Thus, co-ligation of slg 
and FcyRIIB promotes the inhibition of B cell activation by preventing the generation of 
the slg-mediated positive signal for growth, without altering the induction of the negative 
signal (Figure 6.11).
6.3.4. Does cross-linking of slgM or slgD induce different patterns of 
intracellular signalling and subsequent B cell behaviour ?
Although the number of mAbs tested in these experiments was small the results imply 
there may be some difference in the slg-mediated signalling generated by slgD and 
slgM. The anti-IgD antibodies appeared to be more capable of inducing a positive signal 
than generating negative signals (Figures 6.1-6.3 and 6.5.2). In contrast, the anti-IgM 
reagents were clearly able to induce both signals, but appeared to be more inhibitory than 
the anti-IgD mAbs (Figures 6.1,6.3 and 6.5.1). Within the literature there is evidence 
to support the proposition that cross-linking of slgD or slgM mediate different 
responses. However no consistent interpretation of the roles of slgD or slgM has been 
reached. While some authors have found evidence to indicate slgD-mediated signalling 
tends to have a positive effect on the B cell behaviour and that cross-linking of slgM had 
a predominantly negative effect (Brines et al., 1992, Carsetti et al., 1993), others have 
suggested that the converse is true (Phillips and Klaus 1993). There is also data to 
support the counter argument; that signals generated by either isotype are functionally 
equivalent and capable of inducing the same range of B cell behaviour (Leptin 1985, 
Goroff et al., 1986, Harnett et al., 1989, Brink et al., 1992, Roes and Rajewsky 1993, 
Parry et al., 1994a, Snapper et al., 1995a, Norvell and Monroe 1996). Given the 
contradictory nature of the experimental evidence it is not possible to come to a definitive 
conclusion about the role of slg isotype in determining B cell response. However as 
discussed above, the diversity of the B cell behaviour could be due to differences in the 
interaction between the (surrogate) antigen and slg, which could be translated into 
distinct patterns of intracellular signalling and thereby induce B cell responses specific to 
this interaction. Therefore, while the answer to the question whether or not slgM and 
slgD have different functions remains elusive, the results can be interpreted an 
supporting a model in which variations in the antigen signal determine the B cell 
response.
6.3.5. IL-4 enhances the positive slg-mediated signal without affecting 
the negative slg-mediated signal
Finally B cell behaviour in response to anti-Ig antibodies was also influenced by the 
presence of IL-4. Cultures stimulated with anti-Ig antibodies and IL-4 produced a range
Additional evidence for a variable antigen signal 109
of behaviour from; enhancing an existing proliferative response; to inducing strong ^H- 
TdR incorporation from previously non-mitogenic antibodies; to having no measurable 
affect on the B cell response (Figures 6.1, 6.2 and 6.7). These results support the view 
that there is a qualitative difference in the type of signalling induced by each antibody. In 
addition, they reveal that IL-4 enhances the positive slg-mediated signal without having 
any apparent affect on the inhibitory signal (Figures 6.1 and 6.11). IL-4’s effect on 
proliferation was probably as a result of is ability to enhance the strength of positive 
signal (Hodgkin et ai, 1991a), and counter the negative effects of Fc-mediated signals 
(Phillips et ai, 1988). However, IL-4 could not alter the dose response curves of anti- 
Ig reagents which were only able to induce a slg-mediated negative signal, as illustrated 
by the response to 331.1 (Figure 6 .ID, inset). Thus, these results support a model 
where cross-linking of slg initiates different signals within the B cell, and where the 
presence of IL-4 enhances only one arm of the signalling pathway (Figure 6.11).
The results described in this chapter are consistent with a model where slg mediates a 
number of independently regulated signals with different functional consequences. The 
ratio of these signals appears to be dependent on the type of interaction between slg and 
the surrogate antigen. In addition, the relative strengths of the antigen signals can be 
altered by a number of factors including Fc binding and the presence of cytokines such 
as IL-4. Further, the results suggest that “natural’ antigens could also be able to induce a 
similar variation in slg-mediated signals. If correct, this model represents a mechanism 
by which the B cell can regulate its behaviour so that the most appropriate response is 
generated for a particular antigen. A variable antigen signal would allow for a precise 
regulation of the B cell response. This hypothesis and its implications for B cell 
behaviour are discussed further in chapter 8.
Chapter 7
Sensitivity of B cell 
populations to multiple 
slg-mediated signals
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7.1. Introduction.
The results obtained in the previous chapter indicate that anti-Ig reagents initiate a 
number of slg-mediated signals which have different effects on B cell behaviour. While 
antibodies such as the polyclonal galgM and monoclonal 187.1 appear to be able to 
induce both stimulatory and inhibitory effects on B cell proliferation, other anti-Ig 
reagents seem to predominantly either inhibit or stimulate ^H-TdR incorporation 
(Figures 6.1, 6.5.1 and 6.5.2). Given the ability of AMS-9.1 and BET-2 to 
predominantly deliver a positive or negative signal for growth, respectively (Figures 6.1, 
6.5.1 and 6.5.2), and the fact that they bind to IgD and IgM, it was possible to examine 
the effect of the two opposing slg-mediated signals when delivered by independent 
sources. The ability to mix the ratio of the positive and negative signals could provide 
some insight into the relationship between the two signals, and how they jointly regulate 
B cell behaviour.
Further, as the results in chapters 5 and 6 indicated that the two slg-mediated signals 
were independently regulated it was of interest to examine the response of B cells from 
CBA/N mice. B cells from these immunodeficient mice do not proliferate in response to 
mitogenic anti-Ig antibodies (Sieckmann et a i, 1978a, Sieckmann et al., 1978b), and 
are therefore, presumably, unable to generate the positive slg-mediated signal.
However, it has not been determined as to whether or not CBA/N B cells are susceptible 
to the slg-mediated inhibitory signal. If the two slg-mediated signals are independent 
then it is possible that anti-Ig antibodies may be able to induce the negative signal in 
CBA/N B cells.
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7.2. Methods
7.2.1. Electronic sorting of B cells
B cells were prepared as described in section 3.2.2, washed in cold PBS containing 
0.1% BSA (0.1% BSA), and resuspended at approximately 10^ cells/50 pi in cold 0.1% 
BSA. Hybridoma supernatant containing the anti-FcyRIIB antibody, 2.4G2, was added 
to the cells and incubated on ice for 30 minutes. The cells were then washed and 
resuspended in 0.1% BSA at approximately 10^ cells/50 pi. B cells were then stained 
for slgD and CD23 expression with the anti-IgD antibody, AMS 15.1, coupled to PE and 
the anti-CD23 antibody, B3B4.1, directly conjugated to FITC, using dilutions of 
antibody which had previously been determined to be optimal. After a 30 minute 
incubation on ice, the cells were washed twice in cold 0.1% BSA and passed though 50 
pm membrane, to exclude aggregated cells. The B cells were counted and resuspended 
at 5 x 10^ cells/ml in 0.1% BSA All cell manipulations were performed under sterile 
conditions and the cells were stored on ice before and after sorting.
B cells were sorted using a FACStar plus flow cytometer (Becton and Dickenson, San 
Jose, CA). Cells were gated on forward and side scatter to distinguish the live cell 
population. Cells falling within the live cell gate were further divided into different 
populations based on slgD and CD23 expression. The B cells were sorted into 
sIgD^VCD23^1 and slgD^°/CD23^° populations. The selected cells were sorted into 
tubes containing 1 ml of HI FCS and stored on ice until sorting was completed. The 
cells were then washed in BCM, and the viable cell number determined by vital dye 
exclusion.
Antibodies used fo r  electronic sorting
The AMS-15.1-PE conjugate was prepared and provided by Dr J. Hasbold (Centenary 
Institute, Sydney). Sn containing the anti-FcyRIIB antibody, 2.4G2 was prepared from 
a hybridoma (ATTC HB 197). The anti-CD23 antibody B3B4.1 (Rao et al., 1987) was 
a gift from Dr P Lalor (WEHI, Melbourne).
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7.3. Results.
7.3.1. Anti-lg reagents that induce opposing slg-mediated signals 
stimulate B cell behaviour that can be approximated by the sum of the 
response to the two independent signals.
From the experiments described in chapters 5 and 6 it is clear that anti-lg reagents can 
induce both positive and negative slg-mediated signals. Although a number of 
antibodies are able to induce both signals, others seem to only induce a predominantly 
negative or positive signal (Figures 6.1, 6.5.1 and 6.5.2). Thus, it appeared that the 
two slg-mediated signals could be delivered independently.
To experimentally test this possibility the effect of varying the ratios of the two signals 
on proliferation was determined. B cells were stimulated with different combinations of 
BET-2 and AMS-9.1 and the level of ^H-TdR incorporation measured. This was done 
in the presence of LPS so that the influence of either signal could be more clearly seen 
(Figure 7.1). The effect of BET-2 and AMS-9.1 on LPS-induced proliferation has been 
described in chapter 6, and as previously observed BET-2 inhibited, whereas AMS-9.1 
enhanced LPS-induced ^H-TdR incorporation in a dose-dependent manner (Figure 
7.1 A). Figure 7.1, panels B and C, illustrates the effect of two different concentrations 
of BET-2 on the dose response curve for AMS-9.1 in the presence of LPS. As before, 
BET-2 inhibited proliferation, however, the response was not equivalent to that obtained 
with BET-2 and LPS alone. Thus, while the level of ^H-TdR incorporation was 
substantially reduced by BET-2, the positive effect of high concentrations AMS-9.1 was 
still apparent (Figure 7. IB and C). In a similar manner, the inclusion of a high 
concentration of AMS-9.1 increased the level of ^H-TdR incorporation in cultures where 
BET-2 was titrated in the presence of LPS (Figure 7. ID).
One possible explanation for the results illustrated in Figure 7.1 was that the inhibitory 
and stimulatory dose response curves represented the behaviour of different B cell 
populations. Previously it has been shown that distinct B cell populations differ in their 
response to various stimuli. Separation of splenic B cells on the basis of size into large 
and small B cells, has produced B cell populations which respond differently to anti-lg 
reagents and lipoprotein (Peganha et a l, 1991, Snapper et a l, 1995b). Furthermore, 
sorting B cells based on their expression of slgM or CD23 has resulted in populations 
that have different responses to LPS and mitogenic mAbs (Waldschmidt et al., 1992, 
Snapper et al., 1993, Oliver et al., 1997). Thus, a hypothesis was formed in which the 
effects of BET-2 and AMS-9.1 were independent and operated on distinct B cell 
populations. This hypothesis predicts that although both populations respond to LPS
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Figure 7.1. The combined effect of different anti-Ig reagents on LPS-induced B cell proliferation may be 
approximated by the sum of the response to each antibody.
B cell were prepared as described in chapter 3 and cultured in BCM (5 x IO** cells/ 200 (il well) with AMS-9.1 
( © ) or BET-2 ( 0  ) in combination with 50 fig/ml LPS (panel A). Additional cultures were also prepared 
containing LPS (50 (ig/ml) and a fixed concentration of one antibody (lower right corner), titrated against a
second antibody ( 0 )• After 3 days the level of proliferation was determined by -^H-TdR incorporation assay, as 
described in chapter 3. The data illustrated represents the mean of triplicate cultures ± one standard error. The 
second set of dose response curves represent the sum of the response to AMS-9.1 and BET-2 as illustrated in 
panel A ( %  ). Background proliferation: cells only ( Q  ), LPS only ( |  ), and LPS in combination with 
either AMS-9.1 or BET-2 at the concentration which appears in the lower right corner of panels B-E (— — —).
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one will be insensitive to BET-2 inhibition but enhanced by AMS-9.1, whereas the other 
population would be inhibited by BET-2 and unaffected by AMS-9.1. Therefore, if 
correct the behaviour of cells stimulated with a combination of BET-2 and AMS-9.1 
would represent the sum of the response of distinct B cell populations. Following this 
prediction the effect of combining the two slg-mediated signals was determined 
arithmetically by adding means and dividing by two. The dose response curves 
generated in this way are illustrated in Figure 7.1, panels B-E, and reveal that this 
treatment of the data generated dose response curves that were a fair approximation of 
those obtained experimentally. The similarity between the experimentally and 
arithmetically derived dose response curves provides support for the hypothesis that the 
response represented the sum of the behaviour of different B cell populations and 
justified an attempt to explore this issue experimentally. This hypothesis was examined 
in two ways Initially B cells were separated into different populations as described in 
sections 3.3.2 and 7.2.1. The second approach was to examine the response of B cells 
from CBA/N mice. The B cell population from these immunodeficient is dominated by 
the slgD^0 population, whereas the slgD^i population is virtually absent (Scher 1982a, 
Hardy et al., 1983). In each case the B cell response to anti-Ig reagents alone or in 
combination with IL-4, LPS and CsA was examined.
7.3.2. The response of small and large B cells to anti-Ig reagents imply 
that the two populations differ in their sensitivity to the different slg- 
mediated signals.
B cells were separated by percoll purification into large and small B cell populations and 
the effect of anti-Ig reagents on proliferation determined (Figure 7.2). As previously 
described for unseparated B cell cultures, different anti-Ig antibodies varied in their 
ability to induce or inhibit proliferation (Figures 6.1 and 6.2) with similar differences 
observed in small and large B cell cultures (Figure 7.2). In addition, the effect of each 
antibody on small or large B cell proliferation was consistent with the response induced 
in unseparated B cell cultures. However,, there were some differences between the 
responses of the two populations. As illustrated in Figure 7.2, mitogenic anti-Ig 
antibodies induced a greater proportional increase in ^H-TdR incorporation in cultures 
containing small B cells, than in large B cell cultures. Thus, high doses (5-20 ftg/ml) of 
187.1-induced an increased ^H-TdR incorporation over the background level in cultures 
containing small B cells (Figure 7.2A). In contrast 187.1 failed to induce proliferation 
above the background in large B cell cultures (Figure 7.2A). A similar pattern of 
proliferation was obtained with B7.6, where in response to high doses of B7.6 small B 
cells incorporated ^H-TdR above the
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Figure 7.2. Anti-lg induced proliferation in small and large percoll purified B cells .
Large ( O ) and small ( •  ) percoll purified B cells were prepared as described in section 3.2 and
cultured in BCM (5x10^ cells/ 200 pi well) containing varying concentrations of different anti-lg
reagents and 2.4G2 (30 fig/ml). After 3 days the level of proliferation was determined by a ^H-TdR 
incorporation assay as previously described in chapter 3. Background proliferation: large cells ( □  ), 
and small cells ( |  ), Each point represents the mean of triplicate cultures ± one standard error. Inset 
panel B illustrates the detail of the small B cell response to B7.6.
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background, albeit weakly (Figure 7.2B). In addition, it is of interest to note that 
separation of splenic B cells into small and large populations revealed that cultures 
containing large B cells had a high background rate of proliferation when compared to 
small B cells. This observation suggests that the high background for proliferation seen 
in unseparated B cell cultures (Chapters 4 to 6) was due to ^H-TdR incorporation by the 
large less dense B cells present in these cultures.
In contrast to 187.1 and B7.6, stimulation with BET-2 and 331.1 did not induce 
proliferation in either B cell population, but rather inhibited the background level of ^H- 
TdR incorporation of the large B cells (Figure 7.2C and D). In cultures containing small 
B cells BET-2 inhibited background proliferation, whereas 331.1 had little appreciable 
effect (Figure 7.2C and D). Inhibition of the background was also apparent at low doses 
(<1 pg/ml) of 187.1 in both large and small B cell cultures (Figure 7.2A). In addition, 
B7.6-induced a dose-dependent inhibition of ^H-TdR incorporation in large B cell 
cultures, and at low doses (< 7 pg/ml) inhibited the proliferation of small B cells (Figure 
7.2D inset). These results suggest that small B cells may be more sensitive to the 
positive signal for growth than the large B cells. Conversely the large B cells appear to 
be more sensitive to anti-Ig mediated inhibition of the background proliferation.
7.3.3. IL-4 is more effective at enhancing the slg-mediated positive 
signal in the small B cells than in large B cells.
The addition of IL-4 to small and large B cell cultures containing 187.1 or B7.6 
enhanced the mitogenic signal delivered by these mAbs (Figure 7.3A and B, 
respectively). The positive effect of IL-4 on 187.1-induced proliferation was apparent 
on both small and large B cells, and generated almost identical dose response curves 
which were off set by an approximately three fold difference in antibody concentration 
(Figure 7.3A). As the proliferative response of small B cells was initiated at lower 
antibody concentrations it appeared that these cells were more sensitive to the positive 
signal for growth than the large B cells. Another feature of the response to 187.1 and 
IL-4 was that in large B cell cultures moderate doses (~1 fig/ml) of 187.1-induced a 
weak inhibition of proliferation (Figure 7.3A). The apparent greater sensitivity of small 
B cells to mitogenic anti-Ig antibodies was also evident in the response B7.6.
Stimulation of small B cells with B7.6 and IL-4 resulted in a dose-dependent increase in 
proliferation, whereas in large B cell cultures low doses (< 1 fig/ml) of B7.6 inhibited 
the proliferation to approximately 50% of the background (Figure 7.3B). Flowever,, at 
higher concentrations of B7.6 the level of ^H-TdR incorporation increased but remained 
below the background (Figure 7.3B). In contrast to 187.1 and B7.6, the addition of IL- 
4 did not result in B cell proliferation in response to BET-2 or 331.1, nor did it prevent
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Figure 7.3. Variation in the anti-Ig induced proliferative response of small and large percoll 
purified B cells in the presence of IL-4.
Large ( O ) and small ( •  ) percoll purified B cells were prepared as described in section 3.2 and 
cultured in BCM (5x10^ cells/ 200 |il well) containing varying concentrations of anti-lg reagents, 2.4G2 
(30 |ig/ml) and IL-4 (100 U/ml). After 3 days the level of proliferation was determined by a ^H-TdR 
incorporation assay as described in chapter 3. Background proliferation: large cells and IL-4 ( □  ), 
small cells and IL-4 ( ■ ). The data illustrated represents the mean of triplicate cultures, ± one standard 
error. Insets in panels C and D illustrate the detail of the B cell response to BET-2 and 331.1, 
respectively.
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the inhibition of the background proliferation of large B cells by these antibodies (Figure 
7.3C and D). Surprisingly the highest dose of 331.1-induced a slight increase in ^H- 
TdR incorporation in large B cells (Figure 7.3D, inset). The results obtained with 331.1 
in this experiment differ from those described previously (Figure 6.1). The differences 
in the two dose response curves could be attributed to 2.4G2 which was present in the 
small and large B cell cultures (Figure 7.3), but not in the unseparated B cell cultures 
(Figure 6.1). The results indicate that the effect of IL-4 was to enhance the slg-mediated 
positive signal for growth without influencing the inhibitory signal, as previously 
described (Figures 6.1 and 6.11).
Combined, the results illustrated in Figures 7.2 and 7.3 are approximately consistent 
with the hypothesis that the inhibitory and stimulatory dose response curves represent 
the behaviour of different B cell populations. These results suggest that small B cells are 
more sensitive to the positive signal for growth, whereas large B cells appear to have a 
higher sensitivity to the slg-mediated inhibitory signals. Alternatively the large B cells 
may have a lower sensitivity to the mitogenic signal which could allow the inhibitory 
signal to dominate the response. However, is clear that there is considerable overlap in 
the behaviour of the two populations which, if the hypothesis is correct, may reflect a 
lack of purity of the two putative B cell populations. Having determined the pattern of 
behaviour of these two populations of B cells in response to stimulation with anti-Ig 
antibodies in the presence and absence of IL-4, the effect of these reagents on LPS- 
induced proliferation was examined.
7.3.4. In combination with LPS anti-Ig reagents-induce very similar 
dose response curves for small and large B cell proliferation.
The proliferative response of large and small B cells to anti-Ig antibodies in the presence 
of LPS is illustrated in Figure 7.4. In this experiment the two B cell populations had an 
almost identical response to LPS alone, and generated very similar dose response curves 
following culture with LPS and various anti-Ig reagents. The dose response curves 
illustrated in Figure 7.4 were consistent with the results obtained with the same 
antibodies in unseparated B cell cultures (Figures 6.3, 6.5.1 and 6.5.2). Thus, as 
previously described (Figure 6.3) 187.1 and galgM-induced dose response curves 
which provided evidence of inhibitory and stimulatory effects, whereas BET-2 only 
induced an inhibitory effect on proliferation (Figure 7.4, panels A, E and C 
respectively). However, while 331.1 generated a similar response in small and large B 
cells, the dose response curve differed somewhat to that described for unseparated B cell 
cultures (Figure 6.3). Previously co-culture with 331.1 and LPS resulted in a profound 
inhibition of proliferation (Figure 6.3), whereas in this experiment 331.1 only induced a
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Figure 7.4. The influence of anti-Ig reagents on LPS-induced proliferation of small and large
percoll purified B cells .
Large ( O ) and small ( •  ) percoll purified B cells were prepared as described in section 3.2, and
cultured in BCM (5x10^ cells/ 200 (ll well) containing varying concentrations of different anti-Ig 
reagents, 2.4G2 (30 (ig/inl) and LPS (50 |ig/ml). After 3 days the level of proliferation was measured 
by ^H-TdR incorporation as described in chapter 3. Background proliferation: LPS only large cells
( □ ), small cells ( ■ ). Cells only - large (----- ) and small (------). The data illustrated represents the
mean of triplicate cultures ± one standard error.
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mild inhibition which did not continue to increase with antibody concentration at doses 
greater than 2 fig/ml (Figure 7.4D). The decline in the severity of inhibition by 333.1 
could have been due to the presence of 2.4G2 in these cultures. Finally although each B 
cell population appeared to be susceptible to the stimulatory or inhibitory slg-mediated 
signal, the results suggest that small B cells are more sensitive to both slg-mediated 
signals than large B cells. This result is in contrast to those illustrated in Figures 7.2 and 
7.3 which suggest that large B cells are more sensitive to the inhibitory slg-mediated 
signals.
7.3.6. Electronic sorting of B cells into two distinct B cell populations
As discussed previously, the anti-Ig induced dose response curves could have been 
affected by the purity of the percoll purified B cell populations. Thus, in these cultures it 
is possible that the dose response curve obtained for one population was influenced by 
contaminating cells from the other population. This may be particularly important when 
examining differences in proliferation in the presence of a potent mitogen like LPS.
Given the differences in the response of percoll purified small and large B cells it 
appeared possible that the variation in the response might be more clearly defined in 
highly purified B cell populations defined by cell surface phenotype. Snapper et at, 
(1993) have reported that B cells which express sIgM^°/sIgD^VCD23^^ proliferate more 
vigorously in response to anti-5- or anti-p-dextran than B cells with a 
slgM^VslgD^°/CD23^° phenotype. In contrast, B cells which express low levels of 
CD23 B cells have been shown to be more responsive to LPS than CD 23^ B cells 
(Snapper et al., 1993, Oliver et ai, 1997). As the small B cell population has been 
shown to principally consist of B cells which are slgM ^/sIgD ^, and the large B cell 
fraction to be dominated by slgM^VsIgD^0 B cells (Bartell and Hodgkin, unpublished 
data), it was feasible that the variation in the response of large and small B cell 
populations reflected a difference in the behaviour of slgM ^/sIgD ^ and slgM^VsIgD^0 
B cells. To determine if the variation in the response to anti-Ig reagents became more 
obvious when comparing purified B cell populations, splenic B cells were electronically 
sorted into sIgD^VCD23^^ and sIgDl°/CD23^° B cell populations and their response to 
anti-Ig antibodies examined.
From the results obtained in chapter 6 it was clear that some anti-Ig reagents can alter B 
cell proliferation. As the aim of this experiment was to determine the effect of anti-Ig 
antibodies on the proliferative response of sIgD^VCD23^ and sIgD^°/CD23^° B cells it 
was necessary to use an antibody which would not influence B cell proliferation. AMS- 
15.1 was chosen, as this antibody had been shown to have little effect on B cell 
proliferation (Figures 6.1 and 6.3). B cells were sorted into sIgDhi/CD23^i and 
sIgD^°/CD23^°, as illustrated in Figure 7.5. Post-sort analysis revealed that 82% of the
Sensitivity of B cell populations to multiple slg-mediated signals 121
sIgDhi/CD23hi and 85% of the sIgD^°/CD23^° fell within the sort gates, and that the two 
populations did not overlap (Figure 7.5B and C). When the two populations were 
examined on the basis of slgD expression alone the purity of the slgD*0 and slgD^i B 
cell populations was greater than 95% (Figure 7.5D and E). Thus, the sorted B cell 
populations have a high degree of purity but maybe more appropriately described as 
slgD^i and slgD^0. Following sorting the slgD^i and slgD^0 B cells populations were 
placed in culture with anti-Ig antibodies in combination with IL-4 or LPS and the level of 
^H-TdR incorporation determined after 2.5 days (Figures 7.6 and 7.7).
7.3.7. Anti-Ig reagents induce different patterns of proliferation in 
slgD^i and slgl)^° B cell populations
As previously described, the B cell response to mAbs was dependent on the antibody 
used and its concentration and as illustrated in Figure 7.6 the response was also 
determined by the B cell population. Although the background proliferation of both 
sIgDl° and slgD^i B cells was inhibited to varying degrees in response to a low dose of 
each of the mAbs, the pattern of proliferation differed between antibodies when used at 
high doses (Figure 7.6A and B). Thus, the high dose of B7.6 or AMS-9.1 induced an 
increase in the level of ^H-TdR incorporation by approximately two fold over the 
background in cultures containing slgD^i B cells, whereas the same dose of 187.1 or 
331.1 did not induce proliferation (Figure 7.6A). In the cultures containing sIgD^° B 
cells only a high dose of AMS-9.1 was able to induce proliferation above the 
background (Figure 7.6B). Stimulation with the 331.1, B7.6 or 187.1 inhibited the 
background proliferation of slgD^0 B cells (Figure 7.6B). As the slgD ^ B cells 
predominantly represent small B cells, and the slgD^0 B cells characterise large B cells 
(Bartell and Hodgkin, unpublished data), these results are in agreement with those 
described in Figure 7.2, which indicate that small B cells are more sensitive to the 
positive slg-mediated signal.
The inclusion of IL-4 in cultures containing slgD^i or slgD^0 B cells enhanced anti-Ig 
induced proliferation, as previously described (Figures 7.3, 6.1 and 6.2). However, the 
effect of IL-4 on anti-Ig induced proliferation was considerably more dramatic in cultures 
containing slgD^i B cells (Figure 7.6C). In these cultures the combination of IL-4 and 
the high dose of B7.6, 187.1 or AMS-9.1 resulted in a more than ten fold increase in 
^H-TdR incorporation over that obtained with antibody or IL-4 alone (Figure 7.6).
While the enhancing affect of IL-4 on proliferation was also observed in cultures 
containing slgD^0 B cells, its influence was much weaker. Thus, stimulation of slgD^0 
B cells with a high dose of 187.1 or AMS-9.1 in combination with IL-4 caused a two 
fold increase in ^H-TdR incorporation over the background (Figure 7.6D). So far, the
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Figure 7.5. Purity of B cell populations following electronic sorting based 
on slgD and CD23 expression.
Spleen cells were prepared form CBA/H mice and depleted of T cells as 
described in section 3.2. These cells were then stained for slgD and CD23 
expression as outlined in section 7.2.1, gated on live cells and sorted into two
populations sIgD^°/CD23^°(R2 - panel B) and sIgD^VCD23^ (R1 - panel C), 
Panels D and E illustrate the purity of the two populations when assessed on 
slgD expression alone. Finally panel A shows the expression of slgD and 
CD23 on live T cell depleted spleen cells prior to sorting.
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Figure 7.6. sIgD*1'/CD23*1‘ and sIgD*°/CD23*° B cells differ in their proliferative response 
to anti-Ig reagents, irrespective of the presence of IL-4.
B cells were purified by flow cytometry based on slgD and CD23 expression into IgD*1'/CD23^1' 
and IgD*°/CD23^° B cell populations as described in section 7.2.1. These cells were cultured in
BCM (4 x 1()4 cells/ 200 pi well) containing different anti-Ig antibodies alone (panels A and B), or 
in combination with 100 U/ml IL-4 (panels C and D). After 60 hours the cells were pulsed with 
^H-TdR to determine the level of proliferation as described in chapter 3. The data illustrated 
represents the mean of triplicate cultures ± one standard error. Background proliferation: cells 
only ( □  ) and IL-4 only ( H  )• Inset in panel D illustrates the detail of the response of
IgD*°/CD23*° B cells to 1 pg/ml of 331.1, B7.6, 187.1 and AMS-9.1 in the presence of IL-4.
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Figure 7.7. Anti-Ig antibodies have a similar effect on LPS-induce proliferation of both 
sIgDhi/CD23hi and sIgD,0/CD23l0 B cells .
B cells were purified by flow cytometry based on slgD and CD23 expression into IgD^VCD23^* 
and IgD*°/CD23*° B cell populations as described in the section 7.2.1. These cells were cultured 
in BCM (4 x 10  ^cells / 200 pi well) containing different anti-Ig antibodies and LPS (50 |ig/ml).
After 60 hours the cells were pulsed with -^H-TdR to determine the level of proliferation as 
described chapter 3. The data illustrated represents the mean of triplicate cultures ± one standard 
error. Background proliferation: LPS only ( H ) and cells only ( □  ).
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results obtained with highly purified IgD^ and IgD^° B cell populations mirror the 
results described for small and large B cells (Figures 7.2 and 7.3), indicating that while 
the two B cell populations are susceptible to both slg-mediated signals that they differ in 
their sensitivity to these signals.
7.3.8. Anti-Ig antibodies have similar affects on LPS-induced 
proliferation o f  slgD ^i and IgD^° B cells
In contrast to the differences in the response of slgD^ and IgD^° B cells illustrated in 
Figures 7.5 and 7.6, in the presence of LPS the two populations behaved in a similar 
manner (Figure 7.7). Thus, slgD*^ and IgD^° B cells incorporated equivalent amounts 
of 3H-TdR in response to stimulation with LPS alone, and the inclusion of 331.1, B7.6 
or 187.1 to these cultures inhibited the LPS-induced proliferation of both B cell 
populations (Figure 1.1 A and B). Only the response to AMS-9.1 differed from this 
inhibitory pattern, as the addition of a high dose of AMS-9.1 enhanced LPS-induced 
proliferation (Figure 1.1 A and B). When the two B cell populations were compared the 
increase in LPS-induced ^H-TdR incorporation in response to AMS-9.1 was slightly 
higher in cultures containing IgD*° B cells (Figure 1.1 A and B). These results, and 
those described in Figure 7.6, indicate that both B cell populations were susceptible to 
the stimulatory and inhibitory affects of anti-Ig reagents. Although there appear to be 
some differences in the sensitivity of the two populations to the slg-mediated signals in 
cultures containing anti-Ig alone, or anti-Ig and IL-4, in the presence of LPS the overall 
response of the both slgD*1* and IgD^0 B cells was remarkably similar (Figure 7.7).
7.3.9. The response o f  B cells from CBA/N mice
In addition to examining the anti-Ig induced behaviour of different B cell populations, it 
was of interest to determine the response of B cells from CBA/N mice to these 
antibodies. In CBA/N mice B cell development is impaired which results in a decline in 
the number of slgD^i B cells (Hardy et a i, 1983) and the loss of the CD5+ B cell 
population (Hayakawa et a i, 1986). Thus, the B cell compartment is principally made 
up of slgM^VsIgD*0 B cells (Scher 1982a, Hardy et ai, 1983). The results illustrated in 
Figure 7.6 indicate that anti-Ig reagents alone or in combination with IL-4 can induce 
proliferation in sIgD^° B cells from normal mice. However, similar stimulation of 
CBA/N B cells does not induce proliferation (Sieckmann et al., 1978a, Sieckmann et 
al., 1978b). Despite the absence of proliferation in response to mitogenic antibodies, 
anti-Ig stimulation of B cells from CBA/N mice has been shown to induce the up- 
regulation of MHC class-II (Hawrylowicz et al., 1984) and an increase in cell size 
(DeFranco et a i, 1982a). Thus, slg on CBA/N B cells can clearly activate intracellular 
signalling pathways. However, the extent of activation of these signalling pathways
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appears to be reduced in CBA/N B cells when compared to B cells from normal mice 
(Rigley et al., 1989, Lindsberg et a i, 1991). Given the impaired slg-mediated 
signalling ability in CBA/N B cells, it was of interest to determine if anti-Ig reagents 
could induce the slg-mediated negative signal which was proposed in chapters 5 and 6 to 
inhibit LPS-induced B cell proliferation and differentiation.
LPS-induced proliferation is impaired in B cells from CBA/N mice 
Initially LPS-induced proliferation of B cells from CBA/H and CBA/N mice were 
compared (Figure 7.8). While B cells from both mouse strains proliferated in response 
to LPS, B cells from CBA/N mice incorporated less ^H-TdR at each dose of LPS than 
CBA/H controls (Figure 7.8). In addition, the concentration of LPS required to induce 
proliferation above the background was higher in CBA/N B cells than in the controls. 
These results suggest that the two B cell populations differ in their sensitivity to LPS.
The lower level of LPS-induced proliferation in B cells from CBA/H mice when 
compared to normal controls has been previously observed by Scher et al., (1975) and 
Klaus et a i, (1986) (Scher et al., 1975, Klaus et al., 1986).
Anti-Ig antibodies inhibit LPS-induced proliferation o f B cells from CBA/N mice 
Having determined the response of B cells from CBA/N mice to LPS, the influence 
galgM on proliferation was examined. Stimulation of B cells with galgM  and IL-4 
induced proliferation in B cells from CBA/H mice, as previously described (Chapter 6), 
but did not induce proliferation in B cells from CBA/N mice (Figure 7.9B). The 
inability of mitogenic anti-Ig reagents to induce proliferation of CBA/N B cells was 
consistent with the results previously obtained by Sieckmann et al., (1978a and b). 
When combined with LPS, galgM-induced a U shaped dose response curve in the 
control B cells (Figures 7.9C, 5.4 and 6.3). In contrast, in cultures containing B cells 
from CBA/N mice, galgM  inhibited LPS-induced proliferation but did not produce an 
increase in ^H-TdR incorporation at high doses of antibody (Figure 7.9C). Inhibition of 
LPS-induced proliferation by galgM  inhibition was dose-dependent up to 2 |ig/ml of 
antibody, however, at higher antibody concentrations the level of proliferation formed a 
plateau (Figure 7.9C), generating a dose response curve which was similar to that 
obtained for 187.1 and LPS (Figure 6.3). Finally in the presence of CsA, galgM  
inhibited LPS-induced proliferation of the B cells from both mouse strains (Figure 
7.9D). Thus, while galgM  was unable to induce ^H-TdR incorporation in B cells from 
CBA/N mice, it was able to inhibit LPS-induced proliferation in these B cells.
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Figure 7.8. LPS-induced proliferation in B cells from CBA/H and
CBA/N mice.
B cells were prepared from either CBA/H ( O ) or CBA/N ( •  ) mice as
described in section 3.2 and cultured in BCM (5 x 10  ^ cells / 200 pi well) 
containing various concentration of LPS. After 3 days the level of proliferation 
was determined by ^H-TdR incorporation assay as described in chapter 3. The 
data illustrated represents the mean of triplicate cultures, ± one standard error. 
Background proliferation: CBA/H cells only (□  ) and CBA/N cells only ( I  ).
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Figure 7.9. GalgM inhibits LPS-induced proliferation of CBA/N B cells but fails to deliver 
a detectable positive slg-mediated signal.
B cells were prepared from either CBA/H ( O ) or CBA/N ( •  ) mice as described chapter 3 
and cultured in BCM (5 x 10^ cells/ 200 pi well) which contained varying concentrations galgM 
alone (panel A) or in combination with: 100 U/ml IL-4 (panel B); 50 pg/ml LPS (panel C); or LPS 
and 40 ng/ml CsA (panel D). After 3 days the level of proliferation was determined by -^H-TdR 
incorporation assay as described in chapter 3. The data illustrated represents the mean of triplicate 
cultures ± one standard error. Background: panel A - cells only CBA/H ( ^  ) and CBA/N (■  ); 
panel B - IL-4 only CBA/H ( □  ) and CBA/N ( ■  ); panel C - LPS only CBA/H ( □  ), and
CBA/N ( B ); panel D - LPS and CsA CBA/H ( □  ) and CBA/N ( I  ). Inset in panel A 
illustrates the detail of the galgM-induced response of B cells from CBA/H and CBA/N mice.
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LPS-induced differentiation of CBA/N B cells is inhibited by galgM  
The ability of galgM to inhibit LPS-induced CBA/N B cell responses was also apparent 
when the ASC response was examined (Figure 7.10). While the dose response curves 
for LPS-induced differentiation into ASCs was very similar between the two strains of 
mice, cultures containing B cells from CBA/N mice generated fewer ASCs (Figure 
7.10A). The low number ASCs obtained from CBA/N B cell cultures, when compared 
to cultures containing CBA/H B cells, is consistent with the view that CBA/N B cells are 
less sensitive to LPS. The addition of CsA to these cultures did not significantly alter the 
number of ASCs obtained from cultures containing B cells from CBA/N mice, whereas 
the addition of CsA resulted in a decline in ASC number in cultures containing CBA/H B 
cells (Figure 7.10B), as previously observed (Figure 5.3). Thus, although B cells from 
CBA/N mice are unable to generate the positive signal for growth as a result of cross- 
linking slg, it is clear that they are susceptible to the inhibitory signals delivered by 
galgM  which cause the downturn in LPS-induced proliferation and ASC formation 
(Figures 7.9 and 7.10).
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Figure 7.10. GalgM inhibits LPS-induced ASC formation in B cells from both CBA/H and 
CBA/N mice, irrespective of the presence of CsA.
B cells were prepared from either CBA/H ( O ) or CBA/N ( •  ) mice as described in chapter 3, 
and cultured in BCM containing LPS (50 |ig/ml) and various doses of galgM. Additional cultures 
were also prepared which contained LPS, galgM and CsA (40 ng/ml). After 3 days cells were 
washed and transferred to Elispot plates which had been coated with salg to determine the total 
number of ASCs by Elispot assay as described in chapter 3. The data illustrated represents the 
mean of triplicate cultures ± one standard error. Background: CBA/H - panel A LPS only, and 
panel B LPS and CsA ( □  ), cell only ( A ), CBA/N -panel A LPS only and panel B LPS and 
CsA ( I  ), and cells only ( A ).
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7.4. Discussion
The experiments described in chapter 6 indicated that cross-linking of slg can mediate a 
number of different signals which appear to be independent of each other, and have 
diverse functional consequences for the B cell. A simple explanation for the data was 
that the different slg-mediated signals were acting on distinct B cell populations. In this 
chapter this hypothesis was examined through the use of AMS-9.1 and BET-2. 
Stimulation of unseparated B cell cultures with various combinations of BET-2 and 
AMS-9.1, in the presence of LPS, generated dose response curves which could be 
roughly approximated by the sum of the response to each antibody (Figure 7.1). The 
results illustrated in Figure 7.1 support the hypothesis that each slg-mediated signal was 
acting on a different B cell population. This hypothesis was pursued by purifying B 
cells into distinct populations and examining the proliferation of each population in 
response to similar stimuli (Figures 7.2-7.4, 7.6 and 7.7).
Initially the results obtained with percoll and electronically purified B cell populations 
appeared to provide additional support for the hypothesis that the inhibitory and 
stimulatory responses were coming from different B cell populations (Figures 7.2, 7.3 
and 7.6). However, these results also revealed that each of the B cell populations did 
not exclusively respond to one or other of the slg-mediated signals. Instead each B cell 
population was shown to be susceptible to both slg-mediated signals with varying 
degrees of sensitivity (Figures 7.2-7.7). Despite the differences in the response of the 
distinct B cell populations to anti-Ig reagents alone, or in combination with IL-4 (Figures 
7.2, 7.3 and 7.6), in the presence of LPS each of the B cell populations behaved in a 
similar manner (Figures 7.4 and 7.7). This was particularly evident when comparing the 
response of electronically purified slgD^i and slgD^0 B cell populations (Figure 7.7). 
Given the high degree of purity of the electronically sorted B cells (Figure 7.5) and the 
similarity of the response of the two populations (Figure 7.7), it appears that the initial 
hypothesis that the different effects of anti-Ig reagents represented the response of 
distinct B cell populations was not correct.
7.4.1. An alternative model of B cell behaviour suggests that the two 
slg-mediated signals are delivered to the same cell 
The similarity in the results obtained for the slgD^i and slgD^0 B cell populations 
(Figure 7.7) imply that the two slg-mediated signals are transmitted to the same cell, and 
that the response will depend on the mode of signal integration with in the B cell. As 
before it is possible to develop a hypothesis about the mode of integration, and to test it 
by comparing the predicted dose response curves to the experimental data. The slg- 
mediated signals could be integrated in a number of different ways, however, one simple 
way would be if the negative signal reduced by a constant proportion (dependent on
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dose) the positive signal induced by LPS alone, or LPS in combination with mitogenic 
anti-Ig antibodies. The dose response curves generated by this mode of signal 
integration were plotted against the experimental data. As illustrated in Figure 7.11, the 
predicted dose response curves provide a good but not exact fit for the experimental data. 
Dose response curves generated by a proportional model of signal integration did 
however, provide a better fit for the experimental data than those generated by using the 
sum of the two opposing slg-induced responses (Figures 7.11 and 7.1, respectively). 
While further experiments will be required to asses the precise mode of signal 
integration, the important conclusion can be drawn that the two signals are being 
transmitted independently to the same B cell and that the consequence may have a simple 
mathematical solution.
7.4.2. B cells from CBA/N mice retain the ability to respond to the slg- 
mediated negative signal
Although sIgD^° B cells from non-immunodeficient mice respond to both slg-mediated 
signals (Figures 7.6 and 7.7), B cells from CBA/N mice, which principally consist of 
sIgD^° B cells (Scher et a i, 1976, Scher 1982a, Hardy et al., 1983), appear to only be 
susceptible to the inhibitory slg-mediated signal (Figures 7.9. and 7.10). The inability 
of B cells from CBA/N mice to proliferate in response to mitogenic anti-Ig reagents, 
while retaining their susceptibility to anti-Ig mediated inhibition, could be due to the 
point mutation within the btk gene (Rawlings et al., 1993, Thomas et al., 1993). This 
mutation has been shown to influence slg-mediated calcium mobilisation (Rigley et al., 
1989, Lindsberg et al., 1991). Thus, although anti-Ig reagents induce calcium 
mobilisation in B cells from CBA/N mice, the response is much lower than that observed 
in B cells from normal mice (Rigley et al., 1989, Lindsberg et al., 1991). These results 
imply that CBA/N B cells do not proliferate in response to anti-Ig reagents because of a 
defect in calcium signalling. In addition, as CBA/N B cells respond to the negative slg- 
mediated signal in the absence of any detectable positive signal (Figure 7.9) the results 
support the conclusion that the two slg-mediated signals are independently regulated.
In addition to inhibiting LPS-induced proliferation and differentiation to ASCs of B cells 
from CBA/N mice (Figures 7.9 and 1.10), anti-Ig antibodies have also been shown to 
induce an increased rate of cell death these cells (Anderson et al., 1996). The decline in 
viable CBA/N B cell number was shown to occur at antibody concentrations which were 
mitogenic in small percoll purified B cells isolated from non-immunodeficient mice 
(Anderson et al., 1996). In the presence of CsA the previously mitogenic antibodies 
induced a decline in viability normal B cells, but did not alter the response of B cells 
from CBA/N mice (Anderson et al., 1996). These results imply that the CsA sensitive
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Figure 7.11 A model of the effect of AMS-9.1 and BET-2 on LPS-induced proliferation 
suggests that the B cell response is the product, rather than the sum of the two independent
signals.
This figure illustrates three dose response curves for LPS-induced B cell proliferation in the 
presence of different combinations of AMS-9.1 and BET-2. The experimental dose response curves 
( O X and an arithmetically derived dose response curves based on the sum of the B cell response to 
either antibody ( #  ) have been previously described in Figure 7.1. In addition this figure
illustrates a second arithmetically obtained dose response curve based on the product of B cell 
response to either antibody ( © ). The method used to generate the second set of arithmetically 
derived dose response curves is described in section 7.4. This second model of B cell behaviour 
generated dose response curves which provided a better fit for the experimental data. Thus, these 
results indicate that the B cell response to co-culture with AMS-9.1 and BET-2 represents a 
proportional response to each signal in all B cells, rather than the behaviour of distinct B cell 
populations. Background: LPS only ( ■ ) and cells only ( □ ).
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slg-mediated signal may also help maintain the viability of B eells. This could occur 
through the increased expression of the cell survival gene bcl-xL■ Mitogenic anti-Ig 
reagents have been shown to up regulate the expression of bcl-xL in normal, but not 
CBA/N, B cells (Anderson et ai,  1996, Solvason et al ,  1998). In addition increased 
expression of bcl-xL has been shown to be blocked by CsA (Anderson et al ,  1996). 
Combined these results suggest that the slg-mediated positive signal which induces 
proliferation could also promote B cell survival.
7.4.3. Further speculation on the role of slg isotype in determining the 
B cell response
In comparing the responses of the sIgDhi/CD23^^ and sIgD^°/CD23^° B cells, it was 
apparent that mAbs which induced proliferation in both populations where able to bind 
slgD (Figure 7.6). In contrast, anti-IgM mAbs only induced proliferation in cultures 
containing B cells with a sIgD^i/CD23^^ phenotype (Figure 7.6C and D). These results 
are consistent with those obtained by Snapper et al,  (1993) who found that anti-IgM or 
-IgD reagents induced equivalent amounts of proliferation in B cells with a 
sIgM^°/sIgD^VCD23^^ phenotype, but that anti-IgD reagents induced a more vigorous 
response in cultures containing B cells with a sIgM^VsIgD^°/CD23^° phenotype 
(Snapper et al,  1993). It was of interest to note that in both experiments the mitogenic 
effects of anti-IgD mAbs were not dependent on a high level of slgD expression. These 
results imply that cross-linking of slgD may be prone to inducing the positive signal for 
growth, as discussed in chapter 6. However, given the variability in the B cell response 
to anti-Ig reagents it is also possible that the ability of AMS-9.1 to induce proliferation 
was not dependent of the isotype to which it bound. Thus, as before no definitive 
conclusion can be drawn about the different patterns of intracellular signalling activated 
by cross-linking slgD or slgM.
The experiments described in this chapter examined the possibility that the two slg- 
mediated signals acted on different B cell populations. However, the results indicate that 
each of the B cell populations examined was susceptible to both negative and positive 
slg-mediated signals. These results indicate that the behaviour described for the 
unseparated B cells (Chapters 5 and 6) represented a reasonable approximation of the 
response of distinct B cell populations. The experiments with B cells from CBA/N mice 
indicate that although these cells do not proliferate in response to mitogenic anti-Ig 
reagents, they are still susceptible to inhibitory slg-mediated signals. Thus, these results 
support the conclusion that the positive and negative slg-mediated signals are 
independently regulated. In addition, the results described in this chapter suggest that 
these is an additional level of specificity in the B cell response to antigen, which is 
determined by the sensitivity of distinct B cell populations to different signals.
Chapter 8 
General discussion
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8.1. A model in which slg-mediates two independently regulated signals 
which have different effects on B cell behaviour
This thesis describes the effect of slg-mediated signalling on TI type-1 B cell activation, 
as characterised by the B cell response to LPS. The results reveal that cross-linking of 
slg can induce the activation of two independently regulated intracellular signalling 
pathways which differ in their effect on B cell proliferation and differentiation to ASCs, 
and in their sensitivity to CsA, IL-4 and FcyRIIB-mediated signals (Table 8.1). The 
type of slg-mediated signal (positive or negative) induced appears to be dependent on the 
specific physical interaction between the antigen receptor and its ligand. A model in 
which the specific interaction between slg and antigen can result in different patterns of 
intracellular signalling may provide a coherent explanation for the varied, and 
occasionally contradictory, B cell responses induced by both anti-Ig reagents and natural 
antigens. Thus far, the two slg-mediated signals have been referred to as negative or 
positive, based on their effect on LPS-induced B cell behaviour. However, as these 
signals appear to mediate a number of effects which are not so easily defined (discussed 
below) they will be referred to as the CsA insensitive or CsA sensitive signal, 
respectively, in this discussion.
8.2. How valid is the use of anti-Ig antibodies as a substitute for natural 
antigens?
The conclusion that ligation of slg can induce the activation of independently regulated 
signalling pathways was based on experiments using anti-Ig reagents as a substitute for 
natural antigen. While the use of anti-Ig antibodies has been subject to criticism (Möller 
1978), both anti-Ig reagents and natural antigens have been shown to induce similar B 
cell behaviour (Andersson et al.t 1974, Hasbold et a i, 1990, Grandien et al., 1993, 
Hartley et al., 1993, Lenschow et al., 1994, Mond et al., 1995). This suggests that 
surrogate and natural antigens are capable of inducing similar patterns of intracellular 
signalling. Many of the studies using natural antigens have employed transgenic B cells 
that express antigen receptors with a uniform affinity for a defined antigen (Nemazee and 
Biirki, 1989b, Grandien et al., 1993, Hartley et al., 1993, Cooke et al., 1994). This is 
in contrast to experiments that use anti-Ig reagents (Andersson et al., 1974, Mond et al., 
1981, Hasbold et al., 1990, Pe^anha et al., 1991, Lenschow et al., 1994). In these 
studies the specificity and affinity of the antigen receptor differs within the B cell 
population, whereas the substitute antigen remains the same. Thus, while experimental 
systems using transgenic B cells or anti-Ig antibodies have artificial elements, both 
approaches can provide valid and complementary information about the B cell response 
to antigen. In addition, the experiments described in this thesis have identified anti-Ig 
reagents that predominantly induce the CsA sensitive or insensitive signal. These
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Table 8.1 A summary o f the characteristics o f the two slg-mediated signals
c h a r a c te r is t ic s C sA  in s e n s i t iv e  s ig n a l
(negative)
C s A  s e n s i t iv e  s ig n a l
(p o sitiv e )
antibody dose • in d u ced  o v e r a  ran g e  o f  
an ti-Ig  co n c en tra tio n s
• o n ly  in d u ced  a t h igh  
an ti-Ig  c o n c en tra tio n s
sensitivity to CsA • in sen sitiv e • sen s itiv e
response to IL4 • no  e ffec t • e n h a n ced
response to Fc- 
mediated signals
• no  e ffec t • in h ib ited
possible
intracellular
messengers
• in h ib itio n  o f  L P S - 
in d u ced  B ce ll ac tiva tion  
P M A  im p lies  a  p o ss ib le  
ro le  fo r  P K C
• C sA  sen sitiv ity  in d ica tes  
th a t C a ^ +  m o b ilisa tio n  and  
ca lc in eu rin  ac tiv a tio n  are 
o b lig a to ry .
interaction between 
the two slg- 
mediated signals
• the  C sA  sen s itiv e  h as no  
e ffec t on  the in h ib itio n  o f  
A S C  the  C sA  in sen sitiv e  
signal
• o v e rc o m e s  in h ib itio n  o f  
p ro life ra tio n  by  the C sA  
in sen s itiv e  s ig n a l
response o f slgD^i 
vs sIgD^° B cell 
populations
• b o th  B ce ll p o p u la tio n s  
are  sen s itiv e  to  th is  s ig n a l
• b o th  B ce ll p o p u la tio n s  
a re  sen s itiv e  to  th is  s ignal. 
H o w e v e r , s lg D ^ i B ce lls  
ap p e a r to  be m o re  
re sp o n s iv e  th an  th e  sIgD ^° 
B ce lls .
CBA/N mice • in h ib its  L P S -in d u c e d  B 
cell ac tiva tion
• n o t d e tec tab le
B cell behaviour • in h ib its  b a c k g ro u n d  an d  
L P S -in d u c e d  p ro life ra tio n  
an d  A S C  fo rm a tio n
• s tim u la te s  o r e n h a n ces  B 
ce ll p ro life ra tio n
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antibodies could be used to characterise the intracellular signalling events involved in 
either pathway. While such a study is beyond the scope of this thesis, it may be worth 
pursuing as it could provide insight into how different antigens subtly alter the pattern of 
slg-mediated signalling and thereby regulate the B cell response.
8.3. Speculation on the influence of other B cell surface receptors on 
slg-mediated signals
The effect of IL-4 and 2.4G2 on the B cell response to anti-Ig antibodies clearly indicates 
that signals from other cell surface receptors can have different effects on the two slg- 
mediated signals. One obvious candidate is the CD21/CD 19/CD81 complex. Previous 
work has shown that co-ligation of this receptor and slg can have a synergistic effect on 
anti-Ig induced B cell proliferation (Carter et al., 1992). This may be due to signals 
mediated by the CD21/CD19/CD81 complex that enhance the positive slg-mediated 
signal for growth, as observed for IL-4 (Chapter 6). Support for this suggestion may be 
derived from the enhancing effect of co-ligation of slg and the CD21/CD19/CD81 
complex on slg-mediated calcium mobilisation (Bradbury et al., 1993, Lankester et al., 
1996). While it is clear that signals from the CD21/CD19/CD81 complex can promote B 
cell activation by anti-Ig reagents (Carter et al, 1992, Matsumoto et al., 1993, O'Rourke 
et al., 1998) the role of these signals, if any, in the experiments described in this thesis 
has not been determined. It is possible that residual complement within the FCS may 
have been able to bind to anti-Ig reagents forming immune complexes capable of cross- 
linking slg and the CD21/CD19/CD81 complex, thereby promoting B cell proliferation. 
However, this would presumably only play a minor role in the B cell response to anti-Ig 
antibodies as the concentration of fixable complement in heat inactivated FCS would be 
low.
A second B cell receptor that can influence slg-mediated signalling is CD22. Ligation of 
CD22 results in the phosphorylation of its cytoplasmic tail and subsequent recruitment 
and activation of phosphatases such as SHP-1 that down regulate the antigen signal 
(Doody et al., 1995, Cornall et al, 1998). Thus, it is possible that intracellular signals 
generated by CD22 could inhibit the slg-mediated positive signal for growth in a similar 
manner to that described for FcyRIIB (Chapter 6). Finally, the expression of CD45 is 
obligatory for slg-mediated calcium mobilisation (Justement et al., 1991), therefore, 
CD45 may directly promote the generation of the CsA sensitive slg-mediated signal. 
Alternatively, CD45 may indirectly promote the slg-mediated inhibitory signal by 
promoting the phosphorylation tyrosine residues within the cytoplasmic tail of negative 
regulators of the antigen signal, such as CD22 (Healy and Goodnow 1998). While 
discussion about the interaction between the two slg-mediated signals and signals 
induced by other B cell surface receptors is speculative, it may be possible to determine
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the interaction between these signals experimentally through the use of anti-Ig mAbs that 
predominantly induce one component of the slg-mediated signals and B cells from 
knockout mice.
Irrespective of the relationship between slg-mediated signals and those induced by other 
B cell surface receptors, the unique interaction between slg and antigen appears to be 
able to generate different patterns of intracellular signalling that are specific for the 
particular slg / antigen combination. It is proposed that these antigen-specific patterns of 
slg-mediated signalling regulate the B cell response. If correct, such a system would 
allow for a coordinated response by the B cell that is principally driven by its interaction 
with antigen. This hypothesis has implications for the regulation of B cell behaviour, 
some of which are discussed below.
8.4. Surface Ig-mediated signals regulate Tl type-1 B cell activation 
According to Coutinho and Möller’s (1975) one-signal model, LPS-induced B cell 
activation occurs in the absence of an antigen signal, and the downturn in LPS-induced 
ASC number is due to high dose paralysis. However, the results presented in this thesis 
reveal that high dose paralysis is not obligatory, and indicate that the antigen signal can 
promote LPS-induced proliferation while inhibiting the formation of ASCs. The 
inhibitory effect of anti-Ig antibodies on LPS-induced ASC formation is consistent with 
the work of Andersson et al., (1974 and 1978), Kearney et al., (1976 and 1978) and 
Grandien et al., (1993). In addition, these results identify a previously unrecognised 
role for slg-mediated signalling in regulating LPS-induced B cell activation that may 
result in the proliferation of antigen specific B cells and the production of low affinity 
antibody (Chapter 2).
A further speculative point may be made about LPS-induced B cell activation that 
concerns cells which express antigen receptors specific for LPS. Andersson et al., 
(1972) have shown that within the B cell population there are cells that express slg 
which specifically bind to epitopes within LPS. These cells principally recognise 
epitopes within the O-antigen (Rietschel et al, 1994). As described for anti-Ig 
antibodies or natural antigens, antigen recognition by LPS-specific B cells could result in 
the activation of one or both slg-mediated signals. As the O-antigen is highly variable it 
is possible that a large number of B cells can bind to it with varying degrees of 
specificity (Figure 8.1, A). Thus, the number of B cells that bind LPS via their antigen 
receptor would be dependent on the specificity of slg and the concentration of LPS 
(Figure 8.1, B). If correct, B cells that express an antigen receptor with a high degree of 
specificity for LPS would be the first to receive the slg-mediated CsA insensitive signal
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Figure 8.1. The effect of slg specificity for, and concentration of, LPS 
on the B cell response.
This figure illustrates how slg specificity and LPS concentration could effect LPS-induced B 
cell activation. Within a B cell population a number cells will express slg that are specific 
epitopes within LPS. The distribution of LPS specific B cells is illustrated in Panel A. While 
the majority of B cells will express slg with a low specificity ( S  ), some cells will have slg 
with a high specificity for LPS ( ED ). The number of B cells that bind LPS via slg is 
proportional to the concentration of LPS (B). At a given concentration of LPS B cells that 
express LPS-specific slg will bind suffient LPS to induce slg-mediated signalling that can 
inhibit LPS-induced ASC formation (C). In contrast, at the same LPS concentration B cells 
that have slg with a low specificity for LPS may be able to focus it to the B cell surface 
without initiating an inhibitory signal and will proliferate and differentiate into ASCs (C). If 
correct, this model would result in the secretion of a high concentration of antibody with a low 
specificity for LPS, and the proliferation of B cells with a high degree of specificity for LPS 
in the absence of antibody production.
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that inhibits ASC formation (Figure 8.1, C). In contrast, B cells that express antigen 
receptors with a low specificity for LPS may be able to focus it to the B cell surface 
without triggering this signal (Figure 8.1, C). These B cells could then undergo LPS- 
induced differentiation to ASCs as proposed by Coutinho and Möller (Coutinho et al, 
1975). Such a system would promote a low affinity anti-LPS antibody response which 
could be effective at clearing antigen due to the high number of responding cells.
8.5. What role do the two slg-mediated signals have in TI type-2 B cell 
activation?
The activation of B cells by TI type-2 antigens has been shown to require extensive 
cross-linking of slg (Mond et al., 1979, Pe^anha et a l, 1991). This is dependent on the 
physical form of the antigen, in particular its valency. Changes to the physical form of 
these antigens alters their ability to induce B cell activation, as illustrated by the response 
to different forms of flagellin (Feldmann et al, 1971), and soluble anti-Ig antibodies vs 
anti-Ig-dextran (Pe9anha et a l, 1991, Snapper et a l, 1995a). The results described in 
this thesis suggest that differences in the physical form of the antigen can effect its 
interaction with slg in a manner that can be translated into distinct patterns of slg- 
mediated signalling that result in different B cell responses . While it is clear that B cell 
activation by TI type-2 antigens requires the generation of the slg-mediated CsA 
sensitive signal (Yamada et al, 1993), the involvement of the CsA insensitive signal is 
less certain. As the two slg-mediated signals can be activated independently it is 
possible that TI type-2 antigens do not induce the CsA insensitive signal. Alternatively, 
these antigens could activate both slg-mediated signals and a particular ratio of the two 
may be required to induce B cell activation. As the pattern of slg-mediated signalling 
induced by TI type-2 antigens that results in B cell activation is not known, elucidating 
the ability of these antigens to induce the activation of the different slg-mediated signals 
requires further study.
8.6. The CsA insensitive slg-mediated signal may promote T cell 
dependent B cell activation
In contrast to TI type-2 antigens, TD antigens are generally small protein aggregates 
which are unable to induce extensive cross-linking of slg (Parker 1993). As discussed, 
the ability of anti-Ig reagents to induce cross-linking of slg affects the B cell response 
(Chapter 6). Non-mitogenic or inhibitory soluble antibodies can induce proliferation 
when coupled to an insoluble matrix (Parker 1975, Goroff et a l, 1986, Brunswick et 
al, 1988, Pe^anha et a l, 1991, Udhayakumar et a l, 1991). Thus, for certain 
antibodies the ability to induce the CsA sensitive signal that promotes proliferation 
appears to be related to the density of slg cross-linking they induce. However, as some 
soluble antibodies inhibit B cell proliferation, it is likely that the CsA insensitive signal is
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not as dependent on the density of slg cross-linking. Therefore, it is possible that TD 
antigens that are not able to induce extensive cross-linking of slg are still able to induce 
the CsA insensitive signal. While this signal in combination with LPS results in the 
inhibition of proliferation and antibody production, the same signal could also promote 
TD B cell activation by up regulating cell surface molecules involved in T cell / B cell 
collaboration. This prediction is supported by experiments in which anti-Ig antibodies 
have been shown to induce increased expression of MHC class-II molecules in a CsA 
insensitive manner (Mongini et al., 1992). Thus, according to the hypothesis presented 
in this thesis the up regulation of MHC class-II could be the induced by activation of the 
CsA insensitive component of the antigen signal. While exploring the role of the 
different slg-mediated signals in TD B cell activation is beyond the scope of this thesis, it 
may be possible to examine this question through the use of mAbs that induce only one 
component of the antigen signal, and determining their effect on the expression of B cell 
surface molecules and T cell / B cell collaboration.
These examples illustrate how different slg-mediated signals could influence B cell 
activation. If slg does mediate more than one signal after interaction with antigen, its 
effect would not be limited to influencing B cell activation. A model in which slg can 
generate multiple signals may also be applicable to B cell development in the bone 
marrow, affinity maturation in germinal centres and the induction of tolerance. In each 
instance it has been proposed that the antigen signal is involved in the positive and 
negative selection of B cells (Freitas et al., 1991, Gu et al., 1991, Goodnow 1992, 
Nossal 1992, Nossal 1994, von Boehmer 1994). The activation of, and the interaction 
between, different slg-mediated signals could determine the fate of B cells during 
selection. The view that the fate of B cells is in part determined by differential slg- 
mediated signalling is supported by results from Healy et al., (1997) who have shown 
that the pattem of slg-mediated signalling differs between tolerant and naive B cells 
(Healy et al., 1997). In addition, the effect of the slg-mediated signals would be 
dependent on the maturation state of the cell, as illustrated by the inhibitory effect of anti- 
Ig antibodies on immature B cells compared to their mitogenic effect on mature B cells 
(Sieckmann et al., 1978a, Boyd et al., 1981, Hasbold et al., 1990, Brines et al., 1991). 
As it may now be possible to identify the intracellular messages involved in the CsA 
sensitive and insensitive slg-mediated signals, it would be of interest to examine the role 
of these different signalling pathways in B cell development and affinity maturation. 
Finally, if the antigen signal in B cells is composed of more than one independently 
regulated pathway, where each pathway can induce a different response, then this may 
also hold true for other cell types. A similar model, which is briefly described below, 
has been proposed for T cells.
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8.7. The antigen signal regulates T cell behaviour in a similar manner to 
that described for B cells
The T cell and B cell antigen receptors are remarkably similar in structure, the signals 
they induce, and in their association with co-receptors (reviewed in Cambier 1992, 
Cambier et al., 1994, Weiss et al., 1994, DeFranco 1995, Cantrell 1996). If the B cell 
antigen receptor is able to induce different independent signals with varying thresholds 
of activation, might not the same hold true for T cells? A model has been described 
which suggests that the T cell antigen receptor may induce differential signalling (Sloan- 
Lancaster and Allen 1996). Sloan-Lancaster and Allen’s model (1996) was based on 
experiments where the peptide antigen recognised by a specific TCR has been altered 
with a conservative amino acid substitution, generating an altered peptide ligand (APL). 
They proposed that APL binding to the TCR induced a different pattern of intracellular 
signalling than that induced by the original peptide, and that the pattem of signalling 
determined the T cell response (Sloan-Lancaster et al., 1996). Thus, stimulation of Th 
type-2 cells by the original peptide antigen induced: proliferation, IL-4 production, and 
the provision of B cell help (Evavold et al., 1993, Sloan-Lancaster et al., 1993). In 
contrast, stimulation of the same cells with an APL induced IL-4 production and the 
generation B cell help but not T cell proliferation (Evavold et al., 1993, Sloan-Lancaster 
et al., 1993). This phenomenon of partial T cell activation has also been described for 
Th type-1 cells, where stimulation with APLs resulted in the generation of cytolytic 
activity and the up regulation of IL-2 receptor expression, but not proliferation or 
cytokine production (Evavold et al., 1993, Sloan-Lancaster et al., 1993). The partial 
activation of T cells by APLs could be considered to be a form of inhibition of the T cell 
response, as after interaction with APLs the T cell is rendered unresponsive to the 
original ligand (Sloan-Lancaster et a l, 1993). More recently, it has been shown that the 
interaction of agonist, partial agonist and antagonist peptides with the TCR can induce 
distinct patterns of intracellular signalling (Chau et al., 1998). Thus, as the T cell 
responses to antigen binding the TCR can be separated from each other, it has been 
suggested that T cell activation should not be considered an “all or none” phenomenon, 
but rather a collection of possible responses (Sloan-Lancaster et a l, 1993).
The model proposed by Sloan-Lancaster and Allen (1996) and the model described in 
this thesis for slg-mediated signalling in B cells have a number of similarities. In both 
models the antigen signal may differ according to the physical form of the antigen, the 
response of these lymphocytes represents a collection of possible responses rather than 
being “all or nothing”, and the behaviour is governed by the pattern of the antigen signal. 
In addition, both B cells and T cells require the antigen signal to induce Ca^+ 
mobilisation for complete activation (Cambier et al., 1994, Sloan-Lancaster et al.,
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1996). The similarity in the behaviour of B cells and T cells suggests that the activation 
of both cell may be regulated in a similar manner.
8.8. Conclusion
This thesis presents a model in which the regulation of B cell responses is determined by 
the activation of different slg-mediated signals. As the B cell responses can be separated 
from each other, it is thought that the response to antigen is not “all or nothing”, but 
rather represents a pool of possible responses. It is proposed that the physical form of 
the antigen determines the pattem of slg-mediated signalling and thereby regulates the B 
cell response. In this way the antigen signal(s) may represent the key regulators of B 
cell behaviour. This model is complementary to that proposed by Sloan-Lancaster and 
Allen (1996) in which the TCR can mediate different signals which induce distinct 
patterns of T cell behaviour (Sloan-Lancaster et ai, 1996). Finally, the implications of 
an antigen receptor that can induce different intracellular signalling following the 
interaction with antigen, when placed in a broader context, may ultimately lead to a better 
understanding of the regulation of the antibody response.
Chapter 9 
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